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Mechanisms of Functional Tricuspid Valve Regurgitatiçtn in Ischemic Cardiomyopathy.
Chairperson: Carlos M.G. Duran, M.D., Ph.D.
In heart failure, the presence of functional mitral r% #gitation secondary to a
myocardial infarction (MI) is known to double mortality. While the mechanism of
functional mitral regurgitation has been extensively studied, the mechanism of a
concomitant functional tricuspid regurgitation has been neglected. We hypothesized that
MI alters not only the geometry of the left ventricle but also of the right ventricle leading
to both ischemic mitral and tricuspid regurgitation (IMR & ITR). We also hypothesized
that these geometric alterations modulate mechanical stresses resulting in molecular
changes. To answer these hypotheses, the following Aims were designed: 1) complete an
anatomy study of the normal tricuspid valve following the established principles applied
to the mitral valve; 2) perform an in vivo sonometric study of the functional anatomy of
the atrioventricular valves in order to clarify their relationships; 3) compare in sheep the
data obtained with transthoracic echocardiography (TTE) with those acquired with
sonomicrometry. Evaluation of the reliability of the echo geometric data is essential
given its value because of its non-invasiveness. 4) develop a reproducible animal model
of IMR and ITR and analyze the resulting geometrical changes 5) search for variations in
eNOS and nNOS expression at increasing distance from the MI as an indicator of
cardiomyocyte stretch.
Results 1) An original terminology of the tricuspid valve useful to surgeons and
cardiologists was developed; 2) we showed how the mitral and tricuspid valves are linked
by the septum; 3) TTE in sheep provides precise information needed for the non invasive
follow up of the LV remodeling; 4) an original animal model of IMR and ITR was
developed with the percutaneous selective injection of ethanol. Specific geometrical
distortions of both ventricles that resulted in IMR and ITR were found; 5) we showed that
the expression of eNOS was correlated with the distance from the MI and thus the
amount of stress.
Conclusion: This data suggest that IMR and ITR are caused by a geometrical distortion
of both atrioventricular valves and that this macroscopic remodeling was associated with
an up-regulation of eNOS that may be correlated with an adapatative process of the
stretched cardiomyocytes.
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Introduction

The clinical symptoms of heart failure are due to inadequate performance of the
heart. Heart failure develops gradually following a myocardial infarction, as the
myocardium is progressively remodeled [1]. The degree of myocardial remodeling
determines the alterations in ventricular size, shape and function [2]. Left ventricular
remodeling may be associated with the presence of a functional mitral regurgitation that
following an ischemic event is known to double mortality [3]. While functional mitral
regurgitation has been extensively studied the presence of a concomitant functional
tricuspid regurgitation has been generally ignored. In a retrospective study of patients
with functional mitral regurgitation from ischemic origin, we observed a concomitant
functional tricuspid regurgitation in 30% of the cases. The mechanisms at the origin of
functional ischemic tricuspid regurgitation remain unknown.
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Background
1: Ischemic Heart Failure with Mitral and Tricuspid Regurgitation
1-1: Heart Failure: A Major Health Problem.
The clinical syndrome of heart failure is a major health problem in the western
countries. It is estimated that 4.6 million Americans are currently treated for heart failure
and that 550,000 new cases are diagnosed each year [4]. Heart failure is the reason for at
least 20 percent of all hospitalizations among persons older than 65. The rate of
hospitalizations for heart failure has increased by 159 percent during the nineties. An
estimated $5,501 was spent for every hospital discharge diagnosis of heart failure, and
another $1,742 per month was required to care for each patient after discharge [2]. In
France, 85 to 93% of the economic cost of heart failure is attributable to hospitalizations,
most of them avoidable [5]. Substantial efforts have been made to identify and treat the
factors that predict recurrent hospitalizations.
Mortality associated with heart failure remains high in spite of advances in
therapy. Symptomatic heart failure continues to confer a worse prognosis than the
majority of cancer, with one-year mortality of approximately 45 percent [6,7]. Senni et al.
reported, in a community-based survey, 76 percent and 35 percent survival rates at oneyear and five-years, respectively [8]. Large epidemiologic surveys have not documented
any meaningful change in overall death rates.

Heart failure is clinical syndrome of signs and symptoms caused by inadequate
performance of the heart. Currently, complex blends of structural, functional, and
biologic alterations are evoked to account for the progressive nature of heart failure. Only
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the combination of several animal models of heart failure can explain more fully the
cascade of mechanisms: the hemodynamic model is focused on the altered load of the
ventricle while the neurohumoral model recognizes the importance of the reninangiotensin-aldosterone axis and the sympathetic nervous system in the progression of
cardiac dysfunction. Some studies have scrutinized myocytes from failing hearts in an
attempt to detect abnormal signaling, gene expression, or contractile protein structure.
Microbiologie changes and increased levels of circulating neurohormones are
only part of the response seen after initial insult to the myocardium. Jessup et al. defined
the left ventricular remodeling as the process by which mechanical, neurohormonal and
possibly genetic factors alter ventricular size, shape and function [2]. Remodeling occurs
after several clinical conditions such as myocardial infarction, cardiomyopathy,
hypertension, and valvular heart disease. Its hallmarks include loss of myocytes,
hypertrophy and increased interstitial fibrosis [9,10].

1-2: Ischemic Heart Failure
The effect of the underlying cause of heart failure on survival is unclear. In
general, patients with heart failure due to left ventricular dysfunction are classified
broadly in two groups: those with cardiomyopathy due to ischemic causes and those with
cardiomyopathy due to non-ischemic causes. Misclassification of causes of heart failure
may result when cardiomyopathy is diagnosed clinically because one-third of patients
with cardiomyopathy due to non-ischemic causes have clinical angina [4]. In France, one
in two hospitalized patients with heart failure is classified as an ischemic cardiomyopathy
[11]. In an analysis of 3,787 patients with left ventricular dysfunction who underwent
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coronary angiography, an underlying cause of ischemia was a significant independent
predictor of mortality [12]. Five-year survival for patients with ischemic heart disease
was 59 percent.
Ischemic heart failure is mostly due to coronary atherosclerosis. During the
1980s, the age-adjusted mortality due to coronary artery disease decreased considerably
in the United States [13] and in other countries [14]. This favorable trend was due partly
to a decrease in the rate of fatal myocardial infarction and also to the decline of risk
factors for coronary disease [13], which strongly influence the severity of atherosclerosis.
Severity of atherosclerosis is a major predictor of survival in patients with coronary
artery disease [15]. Death seems to have been delayed and occurs a longer time after a
myocardial infarction [2]. However Enriquez-Sarano et al. showed that the prevalence of
atherosclerosis remained the same from 1980 to 1989 [16]. These findings likely explain
the increased prevalence of patients with heart failure symptoms from ischemic
cardiomyopathy.

1-3: Ischemic Mitral Regurgitation
1-3-1: Significance of Isehemic Mitral Regurgitation
Mitral regurgitation (MR) in heart failure can be organic or functional. Organic
implies a disease of the mitral valve itself and functional implies a “normal” mitral valve.
For example, after a myocardial infarction, a rupture of one of the papillary muscle can
occur resulting in an organic mitral regurgitation and in acute massive heart failure.
Functional means that the mitral valve is normal on macroscopic appearance and MR
may be due to annular dilatation (type 1 in Carpentier’s functional classification of MR)
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or alternatively to restricted motion of the leaflets (type 111b in Carpentier’s functional
classification of MR) [17]).
The incidence of functional ischemic mitral regurgitation (IMR) after acute
myocardial infarction (Ml) has been reported to be between 13% [18] and 39% [19].
Barzilai et al. reported a one-year mortality of 36% compared with 15% in patients
without MR [20]. Lehmana reported a one-year mortality of 18.2 % for patient with mild
MR and 60% for those with moderate or severe MR [18]. In a retrospective analysis of
11,848 patients with significant coronary disease (>75% stenosis of one or more coronary
arteries), ejection fraction, age, and number of diseased vessels were also predictors of
poor outcome but less significantly compared to presence of mitral regurgitation. An
inverse relationship exists between degree of mitral regurgitation and prognosis [21]. In a
study of 303 patients, Grigioni et al. showed that the presence of MR doubles the long
term (5-years) mortality [3]. These findings are the same even in cases with mild or
moderate regurgitation [22]. Therefore, presence of functional MR is an independent
predictor of poor prognosis in ischemic heart failure.

1-3-2: Mitral Regurgitation and Localization of the Ischemic Event
Lehman et al. [18] reported a significant difference (p<0.01) in the presence of
MR following an ML Mitral regurgitation was present in 21% of patients after anterior
Ml (20/96 patients) compared with 6% of patients after inferior Ml (6/106 patients).
However, Barzilai et al. [19] reported a MR with 46% of the anterior Ml patients (11/24
patients) and 35% with the inferior Ml patients (12 of 34 patients).
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Localization of Ml is not the only parameter that determines the presence of MR.
Kumanohoso et al. showed that global LV dilatation and dysfunction were significantly
less pronounced in 43 patients with inferior Ml compared to 61 patients with anterior ML
However, the percentage of MR was very significant in inferior Ml patients compared to
those with anterior Ml patients (p<0.0001) [23]. Kono et al. reported that the left
ventricular shape was the primary determinant of functional MR in heart failure [24].
Change of ventricular shape, size and function or “remodeling” after myocardial
infarction is associated with functional mitral regurgitation.

1-3-3: Mechanisms of Ischemic Mitral Regurgitation
The mechanism responsible for functional ischemic mitral regurgitation (IMR)
remains uncertain, although specific anatomic abnormalities of the left ventricle (LV)
have been proposed. They are mitral annulus dilatation, chamber enlargement,
dysfunction of the papillary muscle and associated dysfunction of the ventricular wall
[25]. Coexistence of these characteristics in the failing heart makes the identification of
the precise abnormality responsible for the IMR difficult.

- Dilatation of the mitral annulus
Experimental models of acute ischemic MR, using sonomicrometry array
localization [26], myocardial marker technology or three-dimensional echocardiography
[27,28], showed distortions in the geometry of the mitral annulus, just after myocardial
infarction. In an animal model of chronic ischemic MR using sonomicrometry array
localization, Gorman et al. showed that the end systolic annular area increased from
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647±44 mm^ to 1,094±173 mm^ (p=0.01). The annular dilatation oecurred equally along
the anterior (47±5.6 mm to 60.2±4.9 mm, p=0.001) and posterior (53.8±3.1 mm to
68.5±8.4, p=0.005) portions of the annulus [29]. Using radiopaque marker technology in
the same ovine model of chronic ischemic MR, Tibayan et al. obtained the same results.
Mitral annular diameter, septo-lateral and commissure-commissure dimensions increased
significantly with the severity of the IMR at seven weeks [30](Figure 1). They also
demonstrated the flattening of mitral annulus, which is normally a saddle shaped
structure. These experimental results are comparable to what has been observed in the
human. In a prospective analysis of the degree of functional IMR in 128 patients with
systolic LV dysfunction, the mitral annulus from these patients were compared with 21
normal controls by echocardiography. Diastolic and systolic mitral annular areas were
significantly larger than in control group (9.5±L7 mm and 7.7±1.8 mm versus
6.9±0.8mm and 4.4±0.7 mm, respectively) [31]. In an analysis of geometric alterations of
the mitral apparatus with magnetic resonance imaging, Yu et al. showed that there was a
significant difference (p=0.008) in the antero-posterior diameter between patients with a
remodeled LV after myocardial infarction without MR (28.7±4.5mm) and patients with
IMR (45.6±13.4 mm) [32]. The consequence of annular dilatation is shortening of the
coaptation plane of both the anterior and posterior leaflets. At most, it can result in lack
of coaptation and a central leak (type 1, Carpentier’s ftmctional mitral regurgitation
classification) [17].
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Figure 1: Mitral Annulus dilatation in IMR.
The dilatation occurred in antero-posterior and septo-lateral directions.
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- Chamber enlargement
Dilatation of the heart after an isehemie event is the first eharaeteristie of
myocardial remodeling. The cardio-thoracic index is always increased in heart failure on
a chest X-ray. All experimental studies and human observations of IMR showed an
increased volume of the LV. Patients without any IMR can also present with LV
enlargement. However, enlargement of the LV seems to be more prevalent in eases in
which patients present with an IMR. In a comparative analysis of patients after an
ischemic event, LV end-diastolic (LVED) and LV end-systolic (LVES) volumes were
significantly larger for patients with IMR than patients without IMR (239±84 ml and
148±65 ml versus 202±68 ml and 120±47 ml; p<0.001) [25]. This more pronounced LV
enlargement, which is demonstrated in other human [31-33] and animal [34,35] studies,
is also associated with a greater index of sphericity (the heart appeared more spherical)
[25]. This sphericity of the heart may explain the worsened clinical symptoms and poorer
prognosis of these patients according to Torrent-Guasp [36] who described the helical
heart as a muscular band scrolled on itself. In case of dilatation of the heart, the
longitudinal orientation of the scrolled muscular band becomes more transversal
decreasing its twisting during the contraction and thus, the ejection of the blood [36].

- Tethering effect
The greater volume of the heart is associated with increased longitudinal and
transverse measurements of the heart. LVED and LVES diameters and inter papillary
muscle distances are reported increased in human and animal studies [28,30-32,34,35].
The increased longitudinal diameter also can be measured by the distance between the tip
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of the posterior papillary muscle and the anterior part of the mitral annulus. This distance
is called the “tethering distance”. The inferoposterior wall bulges outward, displacing the
attached posterior papillary muscle outward and apically [27].
During the enlargement of the LV, in the case of IMR, the distance between the
tip of the posterior papillary muscle and the mitral annulus increases. Because of the low
elasticity of the fibrous tissue of the chords and the mitral leaflet, the chords and more
particularly the basal chords, tether the leaflets. Therefore, the enlargement of the heart is
responsible for a tethering effect on both mitral leaflets. Leaflets motion is restricted and
because of the movement of the coaptation point toward the apex, a central MR results
[37](Figure2).
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Figure 2: Tethering effect on the anterior leaflet observed on an ischemic MR patient in
systole.

The anterior leaflet shape mimics a tent. The coaptation point of both leaflets is
apically displaced. The association of annular dilatation and tethering effect result in
massive MR.
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- Dysfunction of the papillary muscles and associated dysfunction of the ventricular wall:
Damaging the posterior papillary muscle was an early method to produce an
experimental model of IMR and study the function of the papillary muscle [38]. In
previous human case reports, IMR murmur following myocardial infarction was
associated with development of heart failure. Autopsy of two patients showed non
ruptured papillary muscles and chordae. In one case, extensive scars were found in the
ventricle wall at the base of the papillary muscle. In the other case, the papillary muscle
was infareted [39]. In the most popular chronic IMR animal model of Llaneras et ah, MR
appears after infarction of the posterior papillary muscle and the relative left ventricle
wall [35]. Messas et al., using an acute ovine model of IMR, showed that inferior
ischemia, which did not involve the posterior papillary muscle, was associated with IMR.
In their experiment, the ischemia and therefore the dysfunction of the papillary muscle
even decreased the amount of MR [28]. The amount of IMR varies with loading
conditions [37]. The dynamic variability of IMR is enhanced by the report of Pierard and
Lancelloti [40], who described IMR as being responsible for pulmonary edema. A
comparative study of patients with left ventricular dysfunction, trivial MR and acute
pulmonary edema or non history of acute pulmonary edema showed significant
association between exereise-induced ehanges in the effeetive regurgitant orifice area and
pulmonary edema.

1-4: Functional Tricuspid Regurgitation in Cases of Ischemic Heart Failure
Functional tricuspid regurgitation (TR) has the same definition as funetional MR.
The valve is leaking, but appears macroscopically normal.

12
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1-4-1: Significance of Functional Tricuspid Regurgitation:
The tricuspid valve is the right-sided atrioventricular valve and its study has
always lagged behind those of other cardiac valves. Ineidence of tricuspid insufficiency is
higher than expected and surgical management does not have the expected clinical results
[41]. Patients with severe left ventricular dysfunction who developed functional MR are
associated with poor prognosis [18,21,25]. In these patients, right ventricular dysfunction
and presence of TR have been shown to be an independent predictor of mortality [42-44].
Greater LV enlargement and higher prevalence of echocardiographic functional
MR were associated with functional TR in a comparative study of 117 patients in heart
failure. In the same study, estimated I-year event-free (cardiae transplantation or death)
survival was 68% in patients without TR and 30% in patient with TR (p-0.0002).
Presence of TR was also a marker of right ventricle (RV) systolic dysfunction, RV
dilatation and RV hypokinesia [42]. These criteria were defined as indicators of a poor
prognosis in congestive heart failure associated with coronary artery disease by Polak et
al. [45].

1-4-2: Mechanism of Functional Tricuspid Regurgitation:
The mechanism of functional TR was never studied with the same aecuracy as
was applied to study the mechanism of functional MR. Functional TR is the most
frequent cause of tricuspid disease. In a retrospective study of 80 patients who presented
a hemodynamically significant tricuspid regurgitation, etiology of TR was functional in
85.5% (68) of patients. The most common functional cause was pulmonary artery
hypertension (80%) while ischemic (25%) and non-ischemic cardiomyopathy (8%) were
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also common [46]. In a postmortem study of patients with pure TR, Waller et al reported
that 47 % of all cases of TR were functional [47].
The suspected mechanism of functional TR is right ventricular enlargement and
abnormal leaflet coaptation. The tricuspid annulus, which is mostly muscular, follows the
dilatation of the right cavities. The causes of RV enlargement are ischemic or non
ischemic cardiomyopathy and pulmonary hypertension leading to chronic right
ventricular hypertension. Causes of pulmonary hypertension are divided into primary
pulmonary hypertension (precapillary) or secondary pulmonary hypertension. Of these
causes left-sided valvular disease are common [46]. In the case of IMR, LV pressure
filling may develop secondary to pulmonary hypertension [44]. The total perimeter of the
tricuspid annulus is 100-120 mm. This annulus circumference can reach 150-I70 mm in
the case of ftmctional TR [47,48]. Annulus dilatation is not homogeneous. In a
postmortem study, Deloche et al. showed that the posterior and anterior portions of the
annulus dilated far more than the septal portion [49] (Figure 3). Annulus dilatation results
in lack of coaptation of the leaflets and therefore regurgitation.
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Figure 3: Dilatation of the tricuspid annulus in the case of functional tricuspid
regurgitation (Modified from Deloche et al. [49]).

Dilatation affects mainly posterior and anterior annulus. Numbers indicate the change of
length in percentage found by Deloche et al [49].
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1-4-3: Alternative meehanisms
Besides the annulus dilatation, another mechanism was cited by Carpentier et al.:
“Excessive dilatation o f the right ventricle maintains an abnormal tension o f the
chordae, impairing the free motion and therefore perfect coaptation o f the leaflets” [50].
Anterior displacement of the tricuspid leaflet tips was described 10 years later by Mikami
et al. [51]. However, in a study of eleven patients. Come and Riley showed that in 5
patients with failure of systolic leaflet coaptation, tricuspid annular dilatation appeared to
play a major role [52]. Severity of tricuspid regurgitation was correlated with the degree
of apical displacement of the leaflets in an extensive echocardiography study of Sagie et
al [53]. In summary, mechanisms of functional regurgitation in the case of ischemic TR
(ITR) remain unclear. Right ventricular enlargement, tricuspid annulus dilatation and
restrictive motion of the leaflets as in IMR are three possible origins.

1-5: Surgical Approach of Ischemic Heart Failure
1-5-1: Repair of Ischemic MR
The optimal management of moderate IMR remains controversial. Some authors
argue that revascularization alone without any mitral maneuvers is adequate therapy.
Potential reversibility of ischemic MR following revascularization alone may not justify
longer surgery mixing mitral repair or replacement and revascularization [54].
While functional IMR is related to the location and extent of the infarct,
successful reperfusion alone does not reduce mortality, nor does it reliably restore
valvular competence [33] [55].
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- Annuloplasty
Mitral annuloplasty is performed in nearly 80% of patients with ischemic mitral
regurgitation [56]. Undersizing the mitral ring is the technique of choice in cases of IMR
(type IIIB dysfunction, restricted leaflet motion in systole only) [54]. Authors who
worked on an ovine model advocated a complete and undersized ring as a prosthetic
annuloplasty. The dilatation of the mitral annulus occurs in all the annulus, therefore the
ring has to be complete and sizing the ring on the dilated intertrigonal distance may result
in selecting a ring that is too large [29,30]. The insertion of an undersized ring on a
dilated annulus may lead to ring dehiscence because of excessive tension on the sutures.
Multiple overlaping sutures around the annulus can reinforce the sutures and prevent this
complication [57].
However, mitral annuloplasty is sometimes inadequate. In 30% of patients
recurrent MR occurs following annuloplasty for IMR. In a retrospective study of 585
patients who underwent annuloplasty alone for repair of IMR, 28% of patients had 3+ or
4+ MR 6 months after the operation. In this study the use of a Peri-Guard armuloplasty
ring, higher grade preoperative MR, jet direction or complex and more severe
preoperative LV dysfunction were associated with a higher risk of recurrence of high
grade MR than Cosgrove bands and Carpentier rings [58]. In a retrospective study of 100
patients who underwent mitral annuloplasty and revascularizations for ischemic MR, the
incidence of recurrent MR was 29% [59]. From 48 patients who underwent
revascularization and ring annuloplasty for IMR and left the operating room with <1+
MR, Matsunaga et al. reported 15 patients who had recurrent IMR. In these patients, LV
dysfunction and enlargement and papillary muscle displacement were greater than in the
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other 33 patients who did not have any recurrent IMR [60]. In a retrospective analysis of
126 patients who underwent mitral annuloplasty in case of IMR, analysis showed no clear
survival benefit conferred by the surgery [61].
All these studies showed that annuloplasty alone in cases of ischemic MR seemed
to be insufficient. One of the reasons was that the annulus prosthesis addressed only the
mitral annulus dilatation, but did not influence the other mechanisms responsible for
ischemic MR. Other procedures, which involve the sub-valvular mitral apparatus, have
been described.

- Chordal cutting
In cases of functional IMR, the laterally displaced postero-lateral papillary muscle
[27] tethers the anterior mitral leaflet (Figure 1) through the stay chords. The anterior
mitral leaflet has a characteristic tent-shape and this angulated bend limits its ability to
coapt effectively. Messas et al. reported experimentation on sheep with reduction of the
amount of IMR by chordal cutting compared with controls [62]. Several patients were
operated on with this procedure (personal observation of cases in Paris, France), however
no human studies have been published. Only two cases with no follow-up were reported
in 2004 in a Japanese journal [63]. Experimentation on sheep showed the importance of
these chords as essential for the valvular-LV geometry. Rodriguez et al. showed that
cutting second order chords did not prevent acute IMR and resulted in LV systolic
dysfunction in sheep [64] [65]. Goetz et al. showed that the anterior mitral stay chords,
which connect the papillary muscle to the fibrous trigones, suspend the aorto-mitral
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angle. Transection of these chords increased the papillary muscles - fibrous trigones
distances and narrowed the aorto-mitral angle in systole and diastole by 5 degrees [66].
The true function of the anterior mitral basal “stay” chords is not yet known.
Collagen fiber orientation of anterior mitral leaflet suggests that local stress be directed
from papillary muscles over these chords and to fibrous trigone [67,68]. It seems that the
stay chords are like pillars that support the anterior mitral leaflet as a vault. Therefore
cutting these chords could be dangerous.

- Surgical relocation of the papillary muscle
Kron et al., aware of mitral annuloplasty failure in ischemic mitral regurgitation,
reported 18 patients with previous inferior myocardial infarction who underwent
posterior papillary muscle relocation associated with revascularization and armuloplasty.
This new technique consisted of adding a suture between the left trigone and the postero
lateral papillary muscle associated with an armuloplasty. This suture brings the papillary
muscle tip closer to the annulus and therefore allows coaptation of the mitral leaflets.
This surgical procedure is performed in patients whose LV end-systolic diameter is
moderately dilated (<6 cm) [56]. In case of larger dilatation (>6 cm end-systolic LV
diameter), surgical relocation of the posterior papillary muscle can be done with a Dor
procedure. A Dor procedure consists of a surgical resection of the ventricular wall at the
level of the infarction. A suture is placed on the collar of the myomectomy, which
reduces the neck of the scars and an endoventricular patch is secured inside the ventricle.
This procedure is designed to re-shape the LV and relocate the posterior papillary muscle
by giving a more ellipsoid shape to the heart [69,70]. Hvass et al. reported 10 patients
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with ischemic mitral regurgitation who underwent a “sling procedure” associated with a
mitral annuloplasty. The sling procedure consisted of a Gore-tex tube placed around the
two papillary muscles through the trabeculations of the heart. The tube was tightened
until the papillary muscles were in close contact. Results showed significant
improvement in echocardiography and clinical data [71]. All these surgical relocations of
the displaced papillary muscle are associated with an annuloplasty. The results involve
only small numbers of patients and further clinical studies have to be reported to draw
conclusions.

- Mitral Valve Replacement
In a comparative review of 223 patients, short-term outcome showed that
mortality rate was doubled for patients who underwent mitral valve replacement versus
repair (30 days mortality 20% versus 10%). Five-year complication-free survivals were
64% for repair and 47% for replacement. However, the statistical analysis suggested an
outcome linked primarily to the NYHA functional class and independent from the type of
surgery. The authors concluded in this study that replacement and repair were both
possible choices and could be left up to the surgeon, the acuteness of the presentation and
the pathophysiology involved. In cases where the predominant presentation was a large
annulus dilatation, annuloplasty and mitral valve reconstruction had excellent results
[72]. Gillinov et al. studied, retrospectively, 482 patients who underwent mitral valve
replacement (n=85) or mitral valve repair (n=397) during a 12-year period. Their findings
were similar to the results of Grossi et al. in that most patients benefited from mitral
valve repair. For the sickest patients, survival after repair and replacement were similar
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[73]. According to Miller, a role remains for mitral valve replacement using a
bioprosthesis in cases of complex and long predictable repair and for surgeons who do
not often do repair procedures and that mechanical valves, given the limited life
expectancy of these patients, would not provide any benefit [74].

1-5-2: Repair of functional TR: Critical annulus diameter:
Repair of functional TR is based on the idea that the cause of regurgitation is the
lack of leaflet coaptation due to annulus dilatation. Therefore the search for a “critical
annulus diameter” beyond which the tricuspid regurgitation should not be ignored by the
surgeon is very important. In 1983, Ubago et al. used a right ventriculogram to quantify
TR. They showed that the indexed mean maximum diameter for the tricuspid annulus
was 21 mm/m^ among patients without regurgitation, 31 mm/m^ among patients with
mild regurgitation and 37 mm/m^ among patients with moderate or severe TR. The
authors concluded that the critical annulus diameter was 27 mm/m^ [48]. In a
transthoracic echocardiography study of 11 patients with functional TR, Come et al.
reported a mean diastolic aimulus diameter of 51 mm in the four-chamber view and 54
mm in the short axis view. Fifteen control patients had a mean annulus diameter of 34
mm in the four-chamber view and 33 mm in the short axis view [52]. Using
intraoperative transeosophageal echocardiography, Goldman et al. measured the largest
tricuspid annulus diameter from the base of the septal leaflet to the insertion of the
anterior leaflet in the free right ventricular wall. When TR was 0-2+, annulus diameter
was 26 mm in 36 patients. When TR was 2-4+, annulus length was 39 mm [75].
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Therefore, 30 mm appears to be the critical length for these authors who did not describe
differences in systolic and diastolic diameter.
Differentiation between organic and functional disease can be done preoperatively by echocardiography. Analysis of leaflet thickness, irregularities, doming and
the presence of a transvalvular gradient is a clear indication of organic disease. Annulus
dilatation, present in both organic and functional disease is more pronounced in
functional TR. In a postmortem study. Waller et al. showed that patients with functional
TR had a much larger annulus than patients with organic disease [47]. However, no
hemodynamic and angiographic differences were found between organic and functional
disease [57].

-Tricuspid annuloplasty
Surgical techniques for functional TR are based on reduction of the tricuspid
armulus. To reduce the tricuspid annulus allows the coaptation of the three leaflets. An
early method of plicature of the posterior annulus was described by Kay [76]. This
method was abandoned because of the difficulty in determining the amount of plicature
necessary. The remaining annulus was also not supported and could dilate later. A partial
suture which encircled and narrowed the annulus was described by De Vega [57] and
Cabrol [77]. However, this technique is rarely used today because of the late recurrence
of tricuspid regurgitation resulting from the suture cutting through or breaking [57]. Total
flexible prosthetic rings can correct dilatation and deformation of the annulus. These
rings are sized and shaped and give optimal orifice area and the annulus can be reduced
selectively at the point of excessive dilatation [50,78]. Surgical techniques for implanting
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a tricuspid annuloplasty ring are very similar for all types of rings. The dangerous part of
this surgery is the proximity of the atrio-ventricular node along the septal leaflet. In a
retrospective study of 790 patients with functional TR, McCarthy et al. [79] showed that
tricuspid valve armuloplasty did not consistently eliminate functional TR. Four
techniques of armuloplasty were used and regurgitation severity remained stable with
Carpentier-Edwards ring (p=0.7), increased with the Cosgrove-Edwards band (p=0.05)
and remained unstable with the De Vega (p=0.002) and Peri-Guard (p=0.0009)
procedures during the follow-up. Risk factors for TR recurrence included higher
preoperative regurgitation grade, poor LV function, permanent pacemaker and repair type
different from armuloplasty. At one-month postoperatively, prevalence of 3+ or 4+ TR
was 15% for each of the different procedures and the size of ring was not a factor in the
failure.

- Tricuspid valve replacement in case of functional tricuspid regurgitation
Presence of functional TR is not an indication for tricuspid valve replacement
[57]. Tricuspid valve replacement is a high-risk procedure. McCarthy [79] reported a
37% mortality rate in cases of reoperation for functional TR. However, patients were
referred late to the surgeon with hepatic and renal dysfunction. Poveda et al. reported a
39% hospital mortality rate in patients with rheumatic disease between 1974 and 1993
[80]. If the replacement is performed after a subsequent open-heart procedure, Hornick
et al reported a mortality of 50% for patients operated between 1985 and 1993 [81].
Tricuspid armuloplasty has a better prognosis than tricuspid valve replacement. However,
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failure of annuloplasty in a number of patients questions whether this technique is
appropriate or not.

2: Ultrastructure of the Myocardium
2-1: The Sarcomere
The myocardium is composed of fibers arranged in parallel. The fiber is made up
of longitudinally arranged cardiomyocytes, which are the contractile cells of the heart.
The cardiomyocytes are made up of hundreds of myofibrils, which contain many
mitochondria and an elongated centrally located nucleus. Cardiomyocyte size varies from
10 to 20 pm in diameter and from 50 to 100 pm in length. The longitudinally oriented
myofibrils are formed by interdigitating myosin and actin filaments, which are the
contractile elements of the cell. The repeating units of contractile elements, the sarcomere
(from 1.5 to 2.2 pm in length), produces a regular pattern of dark and light areas. The
dark Z bands are localized at the extremities of the sarcomere and support the attachment
of the actin filaments. In the middle of the sarcomere are the thick myosin filaments. The
interdigitating intersections produce dark and light zones within the sarcomere under
microscopy (Figure 4). They contain an intricate sarcotubular system of tubules, vesicles
and cisternae. The sarcoplasmic reticulum (SR) is a plexiform labyrinth of vesicles that
tend to be oriented parallel to the myofibrils, which they surround. The periodic
invagination of the sarcolemma by transversely oriented tubules constitutes the T-tubules.
At the level of Z band, both T-tubules and SR present dilatation -the cisternae of the SRcreating a triadic junction. The sarcotubular system plays an important role in both
electrical impulse conduction and electromechanical coupling [82].
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Figure 4: Electron microscopy of human cardiomyocyte (freeze fracture of the SR
surrounding the myofibrils, x 26,000).

The sarcomere between two Z bands (Z) presents two light I bands (I) constituted by
thin actin filaments attached to Z bands. The A band (A) is the dark area between two 1
bands that contains both actin and myosin filaments. In the center of the A band is the
lighter H zone constituted of myosin filament only. The M line (M) constituted by
excrescence of the myosin forms the dark thin line in the middle of the A band. SR:
sarcoplasmic reticulum (Modified from Nicholas J. Severs, The cardiac muscle cells
BioEssays 22:188-199)
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2-2: Myocardial Excitation-contraction Coupling
The calcium ion (Ca^^) plays a central role in the action potential generated along the
surface of the myocyte to initiate contraction in the cardiomyocyte. The initiation of the
action potential corresponds to the opening of sodium (Na^ channels that initiates a very
rapid influx of Na^, which produces the electrical spike during phase zero of the action
potential. During the plateau phase of the action potential, there is a slow inward flux of
Ca^^ through Ca^^-channels in the sarcolemma (myocardial cell membrane) into the
intracellular fluid (sarcoplasm). The action potential spreads from the sarcolemma down
the T-tubules, which allows the entire activation of the myocyte. At the level of the
triadic junction, the calcium release channels of the SR or ryanodine receptors are opened
by the Ca^"^ that enters through voltage gated L-type calcium channels in the sarcolemma.
The SR releases a large amount of Ca^^ in the sarcoplasm. These Ca^^ ions binds to
troponin C (protein in the actin filament that inhibits the interaction between actin and
myosin) and allows the interaction between actin and myosin, permitting the sarcomere
to contract. Relaxation occurs when the rise in sarcoplasmic Ca^^ increases the uptake of
Ca^^ into the SR by the calcium pump known as the Sarco-Endoplasmic Reticulum
Calcium ATPase (SERCA) located mainly along longitudinal tubules of the SR. The
strength and velocity of tension developed by the sarcomere are directly related to the
amount of Ca^^ available to induce contraction. Stimulation of sarcolemmal P-adrenergic
receptors increases the intracellular concentration of cyclic AMP (cAMP), which
augments contractility by increasing Ca^^ entry through calcium chaimel and also
facilitates relaxation by phosphorylation of Troponin 1 (reduces Ca^^ affinity) and of
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phospholamban. This protein when phosphorylated increases the rate of Ca^^ uptake into
the SR [83].

2-3: Sarcomere Stretch and Cardiac Function
The preload, the afterload, the contractility, the compliance and the heart rate
regulate the contraction of the heart. The preload corresponds to the Frank-Starling law of
the heart; the mechanism by which any increase in diastolic volume causes an increase in
systolic performance. It establishes the initial muscle length of the cardiac fibers prior to
contraction. The afterload is the sum of all the loads against which the myocardial fibers
must shorten during systole. The contractility corresponds to the speed and shortening
capacity of the heart. The compliance corresponds to the capacity of the heart to fill at
any diastolic pressure and the heart rate is the frequency of contraction. These five factors
are interrelated and determine the myofibril stretch or length, a principal determinant of
cardiac performance [83]. Changes in muscle length not only change the number of actinmyosin bridges that can be formed to develop force but also affect the amount of force
produced by the same amount of Ca^^ activation [84]. Lengthening the sarcomere
promotes enhanced Ca^^ binding to troponin C and an increase in contractile force in
response to the release of Ca^^ from the SR. Length or stretch of the sarcomere modulates
the contraction via the excitement Ca^"^ release process [85]. The Anrep effect or
homeometric autoregulation corresponds to the adaptation of the cardiomyocyte to an
abrupt change in length. This change of length in vivo or in vitro increases the Ca^^
concentration in the sarcoplasm and in parallel the development of contractile force [84].
At normal filling pressures, a myocardial sarcomere length of the LV varies from 2.07
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pm at end-diastole to 1.8 pm at end-systole [86]. The resting tension of the sarcomere
increases markedly between 2.0 and 2.2 pm and the actin and myosin myofilaments are
optimally overlapped to provide maximal forces when the myocardial sarcomere
measures 2.2 pm after fixation. When the sarcomere is stretched beyond 2.2 pm, the
myocardium become very stiff and resting tensions rise greatly while developed tension
starts to decline [83]. A number of stimuli such as pressure and volume overload and MI
are responsible for the stretch of cardiomyocytes, thus the sarcomeres. Following
myocyte loss, a portion of the ventricle is disabled resulting in failure to eject a normal
quantity of blood. There is an increase in intraventricular end-systolic volume that is
added to the blood entering the ventricle during the diastole. This overload volume
creates an increased mechanical stress that stretches the myocardium [83]. The sarcomere
lengths increase ultimately to 2.2 pm in endocardial, midwall and epicardial areas, where
at this point, further increases in diastolic volume produces a very large increase in
diastolic pressure. This limits acute ventricular dilatation and there does not appear to be
any overstretch (beyond 2.2 pm) of the sarcomeres. Excessive stretch of the
cardiomyocyte may lead to myocyte damage and even death [87]. The adaptations of the
heart (or ventricular remodeling) to chronic distending forces are an increase in myofibril
length with addition of new sarcomeres in series (hypertrophy) as well as a ventricular
dilatation to maintain the cardiac output [88]. The Laplace relationship (T=(P x r)/2h
where T=ventricle wall tension, P=LV pressure, r=radius and h=wall thickness) describes
the increased workload created by the increased volume for the heart. Wilson et al. [89]
showed that, eight weeks after induction of an anterior MI, the ventricle wall stretch
measured by the percentage of lengthening of wall segments was heterogeneous. The
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lengthening of the wall segments in a remodeled ventricle was directionally greater
within the MI region: Further from the Ml, less stretch applied on the cardiomyocytes.
Following a MI, the mechanical stress exerted by the overload volume associated with
ventricle geometrical alterations does not stretch the myocardium homogeneously. The
fall of cardiac output that follows the loss of myocytes is also compensated by a variety
of physiological mechanisms [2]. These adjustment mechanisms try to preserve the
cardiac function within physiological range to maintain the patient symptomatic or
minimally symptomatic after the initial event. Heart failure may then develop
progressively and at some point the patient will develop symptoms [90]. The activation of
the adrenergic nervous and salt -and water- retaining systems preserve pressure and
cardiac output, and the activation of vasodilatory molecules, such as natriuretic peptides,
prostaglandins and nitric oxide, counteract the systemic vasoconstriction resulting from
excessive activation of the renin angiotensin aldosterone and adrenergic systems [91].
These compensatory mechanisms may also participate in the remodeling process and the
development of contractile dysfunction [1,2,91,92].
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Aim of the Study
The presence of functional mitral regurgitation secondary to an ischemic event is
frequent and known to double mortality. While its mechanism has been extensively
studied and its surgical treatment standardized the presence, importance and mechanism
of a concomitant functional tricuspid regurgitation has been generally neglected. The
interest and therefore knowledge of the tricuspid valve has always lagged behind the
mitral valve. Because of the paucity of clinical signs when diseased and the imprecision
of available diagnostic tools, the tricuspid valve has been generally ignored by
cardiologists and surgeons. In a previous retrospective study of patients with mitral
regurgitation from ischemic origin, we observed the presence of a concomitant and
significant functional TR in 30% of cases. Based on this finding, we hypothesized that
infarction alters not only the geometry of the LV, but also of the RV, leading to both
IMR and ITR. These geometric alterations also modulate mechanical stresses
resulting in molecular ehanges. To test these hypotheses, the following
experimentations were performed.
Before analyzing the geometrical dimensions of both ventricles in heart failure, it
was necessary to complete three experiments in normal hearts in order to understand the
common elements of both atrioventricular valves. The tricuspid valve presents many
variable anatomical characteristics [93] compared to the mitral valve. Therefore, to
analyze the constant anatomical characteristics of the tricuspid valve, we performed an
anatomical study of the tricuspid valve (including an original terminology) (Experiment
1). Secondly, to clarify the geometrical changes and the relationship of the normal mitral
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and tricuspid valves during the cardiac cycle, we performed an in vivo study of the
functional anatomy of both valves using invasive sonomicrometry technology
(Experiment 2). Thirdly, following a MI, heart failure develops progressively and
repetitive analysis of the ventricle measurement is needed to understand the geometrical
changes of the ventricles. The use of the non-invasive trans-thoracic echocardiography
seemed more appropriate than the invasive sonomicrometry technology on a chronic
heart failure animal model. Therefore, given the lack of published information of trans
thoracic echocardiography in sheep, we compared the trans-thoracic echocardiographic
data with the sonomicrometric data (Experiment 3) to assess the reliability of the transthoracic echocardiography in sheep. Then, we developed a reproducible animal model of
ischemic heart failure leading to IMR and ITR and analyzed the geometrical changes of
both atrioventricular valves using trans-thoracic echocardiography (Experiment 4).
Lastly, recent advance in molecular physiology of the cardiomyocyte showed that
endothelial and neuronal nitric oxide synthase (eNOS & nNOS) contribute to sustain
normal excitation/contraction coupling and to response to stretch [94]. The mechanical
stress that stretches the cardiomyocyte has a direct impact on the excitation/contraction
coupling of the cell as previously seen. Therefore, to analyze the molecular change
associated with the geometrical alterations, we searched for regional variations in eNOS
and nNOS expressions at increasing distance from the Ml given the fact that the further
from the MI the less stretch is applied to the cardiomyocytes [89] (Experiment 5).
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Normal Heart Experiments
Experiment 1: A Unified Functional Terminology for the Mitral and Tricuspid
Valves
The tricuspid valve has been traditionally described as formed by three leaflets
and three or more papillary muscles [49] [50] [95], although a recent anatomical study
describes it as a bicuspid valve with endless variations in leaflet scallops, chords, and
papillary muscles [93]. A precise nomenclature has been developed for the mitral valve,
however, no such terminology is available for the tricuspid valve. To understand the
tricuspid anatomy and develop a tricuspid valve terminology similar to the existing mitral
valve nomenclature, we studied 50 porcine hearts. The use of porcine heart was justified
by its availability and the fact that in all higher vertebrates, the morphogenetic programs
in the heart are the basically similar [96]. The study was designed as a search for
parameters common to both atrioventricular valves that would lead to a unified
terminology easy to apply in clinical practice.

Experiment 2: Geometrical Changes of the Mitral and Tricuspid Valves during the
Cardiac Cycle.
A simultaneous study of both valves and ventricles in an ovine model allows the
understanding of the close anatomic and physiologic relationships between the LV and
RV.
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Experiment 3: Echocardiography Data versus Sonomicrometrics Data.
Reliability of the use of transthoracic echocardiography (TTE) for the
measurement of distances between intracardiac structures was shown by the comparison
of sonomicrometric measurements and TTE measurements in normal sheep.

Heart Failure Experiments
Experiment 4: Induction of a Postero-lateral Infarct by Percutaneous Injection of
100% Ethanol and Analysis of LV and RV Geometrical Changes.
We developed an original percutaneous method of inducing Ml consisting of the
selective injection of pure ethanol in branches of the circumflex artery leading to a
posterior-lateral Ml that by ± 8 weeks resulted in significant IMR and ITR and analyzed
the geometrical change of both ventricles by TTE.

Experiment 5: Change in eNOS and nNOS Expression with the Distance from the
Infarct in an Ovine Ischemic Heart Failure Model
The changes of molecular expression and localization of eNOS and nNOS were
measured at increasing distances from the postero-lateral Ml. A correlation between these
changes and the distance from the myocardial infarction was analyzed.
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EXPERIMENTS

Experiment 1: A Unified Functional Terminology for the Mitral and
Tricuspid Valves
1: Background: Anatomy of the Human Mitral and Tricuspid Valves
1-1: Mitral valve anatomy
The mitral valvular apparatus derived its name from the bishop’s mitre. It is
located between the left atrium and the left ventricle (LV) and allows the blood to flow
from the left atrium to the left ventricle. The mitral annulus, the leaflets, the chordae
tendinae and the papillary muscles are the four elements that constitute the mitral valve.

1-1-1: The mitral annulus
The mitral annulus forms the junction between the left atrium and the left
ventricle, and is the insertion of the anterior and posterior mitral leaflets. More an area
than a true anatomically identifiable fibrous structure between the left atrium and the left
ventricle, the mitral annulus can be defined by its function. It is described by Kumar et al.
as “part o f the circular area that surrounds the base o f the left ventricle and encompasses
the inlet, inflow or mitral orifice separated from the outflow orifice by the aortic curtain,
which stretches between the two fibrous trigones o f the heart ” [97]. These two fibrous
structures, the right and left trigones, collagenous thickening of the fibrous skeleton of
the heart, can be consistently isolated in hearts. The right trigone (Tl) is a fibrous
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junctional area between the membranous septum, the mitral, the aortic and the tricuspid
valves and was considered by Zimmerman et al. as the central body of the heart [98]. The
left trigone (T2) is situated between the mitral valve and the left coronary cusp leaflet of
the aortic valve. The shape and size of the mitral annulus varies continuously during the
cardiac cycle as it was shown in dogs [99] and later in the human by Ormiston et al., who
showed that the mitral annular area increases gradually during diastole and then decreases
until midsystole. The mitral area starts to increase again during late systole [100].
Sonomicrometry array localization, marker angiography and three dimensional
echocardiography were also used to confirm its dynamic changes during the cardiac cycle
and to assess the saddle configuration of the mitral annulus with the commissures located
at the low point of the saddle [26,101,102]. The hyperbolic paraboloid shape of the
saddle configuration decreases the stress on leaflets during systole [101].

1-1-2: The leaflets
Anterior and posterior leaflets constitute the tissue portion of the valve (Figure 5).
The anterior leaflet has a semicircular shape and is attached to two-fifths of the
circumference of the mitral annulus. The free edge is not indented and there is continuity
between the left coronary and non-coronary cusps of the aortic valve and the anterior
mitral leaflet between the two trigones (Figure 6). The posterior leaflet is quadrangular
and attached to three fifths of the mitral annulus. In an anatomical post-mortem study of
50 mitral valves, Ranganathan et al showed that the division of the mitral leaflets into
anterior and posterior leaflets was possible in 98% of the cases by identifying the
commissural areas. The posterior leaflet was tri-scalloped in 92% of the hearts with one
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middle scallop more prominent in 84% of cases [67]. The posterior leaflet height is half
that of the anterior leaflet height. However, the tissue area of both leaflets is the same and
is twice the size of the orifice area delimited by the mitral annulus. These leaflets are
separated one from the other by the commissures. The commissures are posteromedial
and anterolateral according to their anatomical position in the body. Some leaflet tissue is
delimited at the level of the commissures and can be called commisural leaflets. Distinct
ridges that define the leaflet closure area (or coaptation surface) exist on the atrial side of
the leaflets [67].
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Figure 5: The mitral leaflets o f a pig heart.

Atrial face after section of the ventricle through the posterior wall.
Anterior leaflet: A,
Posterior leaflet: P

I
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1-1-3: The chordae tendineae:
The connection between the papillary muscles and the leaflets, the chordae
tendinae are classified according to the site of insertion between the free margin and the
base of the leaflets. Tandler et al divided the chords in three orders and Lam et al.
subdivided the three orders by describing the commissural, strut and basal chordae [68].
Marginal chordae (primary chordae) are inserted into the free margin of the leaflets. They
are made up of the commissural chordae, branches of cleft chordae of the posterior leaflet
and the rough zone chordae of the posterior and anterior leaflets.
Intermediate chordae (secondary chordae) are inserted beyond the free margin o f the
leaflets. They are made up of those that arise from each papillary muscle and insert into
the ventricular aspect on the rough zone of the anterior and posterior mitral leaflet and by
the main stems of the elefl ehordae of the posterior leaflet. Lam et al. described among
them two particularly strong and thick, tendon-like chordae that insert into the
undersurface of the body of the anterior leaflet and stretch toward the anterior mitral
annulus and called them strut chordae [68]. Leonardo Da Vinci wrote, on his anatomical
drawing of the heart, “prima” in front of these presumably chordae (Leonardo da Vinci,
Anatomic Drawings, Windsor Collection, Windsor, United Kingdom). These stay
chordae remain under the same pressure during the entire cardiac cycle [103] (Figure 6).
Basal chordae are limited to the posterior leaflet. They are attached to the leaflet base
connecting it to the mitral annulus and the myocardial tissue of the posterior leaflet.
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Figure 6: The stay chords.

The strut or stay chords (A & B) and their insertion on the anterior mitral leaflet
(ventrieular view). C shows the continuity between the left coronary and non-coronary
cusps of the aortic valve and the anterior mitral leaflet between the two trigones.
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1-1-4: The papillary muscles:
Two papillary muscles arise from the LV wall approximately one-third the length
of the LV from the apex. They are anterolateral and posteromedial, aeeording to their
anatomical position. They connect the mitral leaflet to the ventricle wall through the
ehordae tendinae. They are anchored in the LV wall among the trabeculae cameae of the
myocardium. Each papillary muscle provides chordae to half of the eorresponding mitral
leaflet and eommissure (Figure 3). The morphology of these papillary muscles is very
variable and difficult to describe. Ranganathan et al. described three different types,
according to their insertion in the LV wall [104].
-Finger-like: One third of the muscle arises in the LV cavity and there are no
trabeculation.
-Tethered: The papillary muscle is hardly seen and only its tip arises in the LV
eavity.
-Mixed: The papillary muscle presents both previous eharacteristics.
This classification was modified in 1996 by Rhamsheyi et al. who described 4 types of
papillary muscles from 65 human hearts [105]:
-Type 1= Finger-like: Papillary muscles well individualized and non-subdivided
corresponded to 63% of the antero-lateral and 41% of the postero-medial.
-Type 11: Papillary muscle is divided longitudinally in two parts. The chordae to
the posterior leaflet are on one head and the chordae for the commissural and the anterior
leaflet are on the other head (7% of the anterolateral and 39% of the posteromedial
papillary muscles).
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-Type III: Papillary muscle divided into several heads. One head supports all the
chordae for the commissural area (15% of the anterolateral and 7% of posteromedial
papillary muscle).
-Type IV: Papillary muscle divided in several complex heads with several
insertion bases. One thin muscular band supports very short commissural chordae (15%
anterolateral and 13% posteromedial papillary muscles).
The vasculature of the papillary muscles is also variable. The anterolateral
papillary muscle is vascularized by branches of the left anterior deseending artery. The
posteromedial papillary muscle is vascularized by branches of the right coronary or of the
obtuse marginal artery. This is independent of the dominance of the right or left coronary
[106]. Ranganathan et al. described in 10 human hearts the micro-vascularization of the
papillary muscles. One or more of long penetrating vessels that originate from the artery
on the epicardial surface of the heart supplied each papillary muscle. During their course
through the wall, these vessels branched and anastomosed with adjacent arteries. A
central artery supplies the free portion of the papillary muscle. In case of many trabecular
attachments, the long penetrating intramyoeardial vessels were eoursing through them
[104].

1-1-5: Anatomical and surgical classification
Indentations and scallops of the posterior leaflets associated with relationship with
chords and papillary muscles are used to classify the areas of the mitral valve.
Two different anatomical nomenclatures are used to analyze the segmental valve (Figure
3 and Table 1). The Carpentier classification delimits both leaflets in three eorresponding
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areas according to the main scallops of the posterior leaflet and recognizes two
commisural areas or leaflets. The Duran classification delimits the anterior leaflet in two
parts and the posterior leaflet in four parts and two commissural areas according to their
attachment to the papillary muscles [97].

Table 1: Correspondence o f Carpentier and Duran nomenclatures of the mitral valve.
A: anterior leaflet, P & PM; posterior leaflet, C: commissural leaflet

Anterior leaflet

Posterior leaflet

Commissural leaflets

Carpentier
A1
A2
A3
PI
P2
P3
Cl
C2

Duran
A1
A2
PI
PM1,PM2
P2
Cl
C2
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Figure 7: Classifications of the mitral valve. Black: Duran’s and Grey: Carpentier’s

Carpentier (gray) and Duran classification (black) are represented together. The black
lines delimit the chordae repartition while the gray lines delimit the scalloped
segmentation of the leaflets.

PM1
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C1
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1-2: Tricuspid valve anatomy
The tricuspid valvular apparatus was named from the predominant presence of
three leaflets. It is located between the right atrium and the right ventricle and allows the
blood flow to go from the right atrium to the right ventricle. It is, like the mitral valve,
constituted of four elements: the tricuspid annulus, the leaflets, the chordae tendinae and
the papillary muscles.

1-2-1: The tricuspid annulus
The tricuspid annulus is more an area where the leaflets are attached to the
myocardium between the right atrium and the right ventricle than an actual fibrous ring.
The absence of an encircling fibrous structure may explain the change in geometry during
the cardiac cycle. The geometry changes were demonstrated in a sheep study by Hiro et
al [41]. The annulus expanded almost homogeneously during the cardiac cycle from
4.8±0.8 em^ to 6.1 ±0.9 cm^. The septal part of the annulus expanded by 10 %, the
anterior by 13% and the posterior by 14%. These findings were also seen in the human by
Tei et al. using echocardiography [107]. The tricuspid annulus was described as pearshaped with its narrower end close to the antero-septal commissure and its wider end
corresponding to the midpoint of the posterior leaflet in pressurized post mortem human
[108] and sheep hearts [41]. In-vivo, the sheep model of Hiro et al. showed the opposite
with the narrow end at the level of the postero-septal commissure. Like the mitral
annulus, the tricuspid annulus is a three-dimensional structure with its three highest
points at the level of the mid-posterior and mid-anterior annulus and the anteroseptal
commissure (Figure 8). Three minimal points were found at the antero-posterior and
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postero-septal commissures and the midpoint of the septal leaflet [41]. This complicated
3-D structure of hyperbolic paraboloid-like for the saddle shape of the tricuspid valve
may reduce the stress exerted on the leaflets [101].

Figure 8: The saddle shape of the tricuspid annulus.

The three lowest points are the anteroposterior commissure (AP), the posteroseptal
commissure (PS), and the mid of the insertion of the septal leaflet on the annulus (S). A
and P: mid points of the anterior and posterior leaflets on the annulus. AS anteroseptal
commissure. (From CMG Duran in Surgery of the chest, pl337 [57])

PS

AP
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1-2-2: The leaflets:
Commonly, the tricuspid valve is described with three leaflets separated by three
commissures (the anterior, the septal and the posterior leaflets separated by the
anteroseptal, anteromedial and posteromedial commissures). The leaflets are named
according to the level of their insertion on the annulus. At the level of the commissures
that don’t reach the annulus, can be found small commissural leaflets [57]. The anterior
leaflet is the largest, followed by the posterior leaflet with the septal leaflet being the
smallest (figure 9 A & B). However, the number of leaflets of the tricuspid valve is
highly variable [93]. In a study of 100 normal human hearts, Victor et al. showed
numbers of subdivisions for the anterior and posterior leaflets attached to the free right
ventricle wall. They described six main different types with a minimum of one and a
maximum of five scallops dividing the anterior and posterior leaflets:
-Type A: No division between anterior and posterior leaflets (one scallop) (1%)
-Type B: Division in posterior and anterior leaflets (31%)
-Type C: Type B -f antero-posterior commissural scallop (three scallops) (40%)
-Type D: Type C -i- Presence of a posterocommissural scallop (four scallops) (17%)
-Type E: Type D -t- Presence of an anterocommissural scallop (five scallops) (10%)
-Type F: Absence of tissue at the antero septal junction. (1%)
The septal leaflet remains constant and is always described by anatomist [93] [50] [57].
However, the anterior and posterior cusps are dominant in tricuspid valve function [109].
Higashidate et al. showed in dogs that resection of the septal leaflet did not result in TR
and that the two remaining valves were sufficient for closure of the tricuspid orifice
[110].

46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 9: The Tricuspid valve in a pig heart.

A: Atrial face of the tricuspid valve viewed after section of the anterior wall of the right
ventricle. Septal (s), Anterior (a) and posterior (p) leaflets.
B: Tricuspid valve viewed from the atrium.
C: Detail of the finger-papillary muscle and of the marginal chordae tendinae.

;
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1-2-3: The chordae tendinae and papillary muscles
In most cases, three tricuspid papillary muscles can be found and identified as
anterior, posterior and septal. Anterior and posterior muscles are practically always
present, however, the septal muscle might be absent in 20% of patients. The anterior
papillary muscle is the longest and sustains the highest number of chordae [57]. In their
anatomical work on 100 human hearts, Viktor et al. found that the papillary muscles
exhibited endless variations in number, size, shape, fusion and location (Figure 9C)[93].
Marginal and basal chords connect the papillary muscles to the leaflets. Marginal chords
are inserted on the free edge of the leaflets and basal chords are inserted into the
ventricular surface of the leaflets. The role of the basal chords in the right ventricle is
probably the same as in the left ventricle in maintaining the valve and ventricular
geometry [57].
The interest and therefore knowledge of the tricuspid valve has always lagged
behind the mitral valve. Because of the paucity of clinical signs when diseased and the
imprecision of available diagnostic tools, the tricuspid valve has been generally ignored
by cardiologists and surgeons. In the case of the mitral valve, more precise nomenclatures
have been developed to fit the demands of complex repair maneuvers; however, no such
terminology is available for the tricuspid valve.

2: Materials and Methods
Fifty pig hearts collected from a local abattoir (Hamilton Packing Inc., Hamilton,
Montana, United States) were studied. The pulmonary artery was incised longitudinally.
The incision was extended apically between the anterior and right pulmonary cusps and
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across the free wall of the right ventricle to ensure that no papillary muscle, muscle band,
or chordae was divided. After sectioning the ventricular muscle band, the anterior leaflet
was cut from its free edge to the annulus. The tricuspid valve and right ventricle were
then fully opened.
To design a terminology for the tricuspid valve, all observations were based on
the traditional understanding that the tricuspid valve has three main leaflets and three
papillary muscles. Recognizing the high variability of all its structures, an attempt was
made to use this classic assumption because it is familiar to surgeons and cardiologists.
The leaflets were classified according to their heights (free edge to base) and
their chordal insertions. The three main leaflets were defined as having the largest heights
and being supported by chords from two different groups of papillary muscles. They were
identified with the classic terms of septal (S), anterior (A), and posterior (P). The
remaining leaflets were defined as “commissural” if they had smaller heights and were
supported by chords arising from a single papillary muscle group.
The papillary muscles were grouped according to their chordal distribution to a
single commissure and two contiguous main leaflets. The group corresponding to the
anteroseptal commissure was termed “anteroseptal,” the group corresponding to the
anteroposterior commissure was termed “anteroposterior,” and that corresponding to the
posteroseptal commissure was called “posteroseptal”. The shape of the papillary muscle
within the same group was described as “finger-like” if one-third of the muscle protruded
into the ventricular cavity, as “tethered” if the body of the papillary muscle was
embedded within the ventricular wall and only its tip could be identified [104], and as
“vestigial” when the chords arose directly from the ventricular wall (Figure 10).

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Maximum distances between the lateral aspects of the papillary muscles furthest
apart within the same group were measured. According to this distance, each papillary
muscle group was classified as “small” (1 to 2 cm), “medium” (2 to 3 cm), or “large” (> 3
cm).
The right ventricular band was defined as “atrophic” (< 2 mm width), “medium”
(2 to 4 mm), or “large” (> 4 mm).
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Figure 10: The three different types o f papillary muscles.

F: finger-like; T: tethered; V: vestigial.
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3: Results
3-1: The Leaflets and Their Commissures
In all hearts, the tricuspid valve had three main leaflets. As commonly accepted,
they were termed septal, anterior, or posterior according to their base attachment to the
annulus. Between each main leaflet, one or more commissural leaflets were commonly
present. These commissural leaflets did not reach the annulus with more than 5 mm of
tissue between its free edge and the annulus. These commissural leaflets were mostly
found between the anterior and the posterior leaflet (1.02 per heart, range 0-3) and
between the posterior and the septal leaflet (0.98 per heart, range 0-2). The presence of a
commissural leaflet between the septal and the anterior leaflet occurred in only eight
hearts (0.16 per heart, range 0-1). Every heart studied had at least one commissural
leaflet. In one heart, one anteroposterior and one posteroseptal commissural leaflet had
the same height as the main leaflet. The number of commissural leaflets present at the
anteroposterior, posteroseptal, and anteroseptal commissure is shown in Table 2.

Table 2: Number of commissural leaflets at each commissure.
Commissures
Number of commissural leaflets per Anteroposterior Posteroseptal Anteroseptal
commissure
8
8
42
1
2
35
35
8
6
7
0
3
1
0
4
0
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3-2: The Papillary Muscles and Chordae Tendinae
Three groups of papillary muscles were found in every heart studied. The three
groups were defined according to the distribution of their chords to the two adjacent halfmain leaflets and their corresponding commissure. The number of separate papillary
muscles per group is reported in Table 3.
In the anteroseptal group, a separate conus papillary muscle was always
identified. The other muscles were constantly attached to the ventricular septum below
the conus. The shapes of these 89 muscles were finger-like in nine cases, tethered to the
wall in 12 cases, and vestigial in 68 cases. The overall width or maximal distance
between muscles of the same group was small (< 2 cm) in 22 groups, medium (between 2
and 3 cm) in seven groups, and large (> 3 cm) in three groups.
The anteroposterior group of papillary muscles was better defined than the other
groups. In 48 of 50 hearts, it consisted of a single papillary muscle located in the free
wall. This finger-like papillary muscle had one head in 25 hearts, two heads in 20 hearts,
and was multi-headed in three hearts. The other two hearts presented an anterior group
formed by two finger-like papillary muscles in one case and by four in the other. In both
cases, the distance between the lateral aspects of the papillary muscles was medium
(between 2 and 3 cm).
The posteroseptal papillary muscle group had the highest variability in shape,
size, number, and location of the three groups. This posteroseptal group was always
attached to the septum, except in one case. In this heart, there was one finger-like
papillary muscle attached to the posterior free wall with the remaining papillary muscles
anchored to the posterior septum. In all specimens, at least one papillary muscle was
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found on the septal wall close to the corner with the free wall. The shapes of the 115
papillary muscles that constituted this group were fmger-like in 60 cases (with a single
head in 73.3%, double head in 11.6%, and multi-headed in 15.1%). Of the remaining
papillary muscles, 50 were tethered to the wall; in five, the papillary muscle was vestigial
with the chords inserted directly onto the ventricular wall. The width or maximum
distance between papillary muscles in that group was < 2 cm in 10 hearts, between 2 and
3 cm in 22 hearts, and > 3 cm in 12 hearts.
A right ventricular band was always present. Its thickness or diameter was
atrophic (< 2 mm) in 14 hearts, medium (2 to 4 mm) in 19 hearts, and thick (> 4 mm) in
17 hearts. In all specimens, this band linked the base of the anterior papillary muscle to
the base of the conus papillary muscle.
In two hearts, it was difficult to determine the appurtenance of a single vestigial
papillary muscle located on the septal wall between the anteroseptal and posteroseptal
groups. Their chordae tendinae were inserted into the midpoint of the free edge of the
septal leaflet.

Table 3: Number of separate papillary muscles per papillary muscle group.

Number of separate papillary
muscles per papillary muscle group
1
2
3
4
5
Average number per group

Papillary muscle groups
Anteroseptal Anteroposterior Posteroseptal
18
26
5
1
0
1.78

48
1
0
1
0
T08
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6
22
18
3
1
2.42

3-3: Proposed Terminology and Classification
Careful analysis of the literature and of our findings revealed that the more
preeise the description of the leaflets, the more confusing and useless it was for the
surgeon. Like Kumar et al. [97], who focused on the anatomical elements that are
observed by the surgeon through the atriotomy, we divided the struetures into three
elements: the papillary muscles, the leaflets, and the chords. The three groups of papillary
muscles were then defined by the numerals 1 for the anteroseptal; 2 for the posteroseptal,
and 3 for the anteroposterior.
Each leaflet was divided in two areas that were named according to both the
traditional leaflet’s names (S, A, P) and the papillary musele origin of the chords inserted
on it (1, 2, 3). Figure 11 shows the suggested tricuspid valve terminology and Figure 12
shows the combined mitral and tricuspid valve nomenclatures.
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Figure 11 : Tricuspid valve terminology.

The valve has been opened with a vertical section through the middle of the anterior
leaflet. A1 & A3: anterior leaflet; P2 & P3: posterior leaflet; SI & S2: septal leaflet; C l,
C2, & C3: commissural leaflets.

SI . «
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A1

Figure 12: Diagram of the mitral and tricuspid valves as seen by the surgeon through left
and right atriotomies.

Circles represent the papillary muscles and straight lines represent the division of the
leaflets according to their chordal insertion into the papillary muscles. The shape of both
annuli is based on sonomicrometric information.
For the mitral valve: A1& A2: anterior leaflet, PI, FMI, PM2 & P2: posterior leaflet.
Cl & C2: commissural leaflets, 1 & 2: papillary muscles.
For the tricuspid valve: A1 & A3: anterior leaflet; P2 & P3: posterior leaflet; SI & 82:
septal leaflet; C l, C2, & C3: commissural leaflets, 1, 2 & 3: papillary muscles.
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4: Discussion
4-1: A New Nomenclature for the Tricuspid Valve
Semantics has always been the main stumbling block to progress. A lack of
precise definitions results in subjective meanings, variable interpretations, and
subsequent confusion. This problem is particularly apparent in heart valve surgery, where
more precise anatomic knowledge is required as new techniques are developed. The old
terminology soon becomes insufficient to describe pathologic findings, surgical
maneuvers undertaken, and evaluation of the results. Also, new surgical procedures
demand a common set of anatomical definitions for the reporting of precise pre- and
postoperative echocardiographic information between the echocardiologist and surgeon.
This situation, which has been largely improved in the case of the mitral valve, is still
missing for the tricuspid valve. To clarify this issue, we took the same familiar
parameters used by surgeons and echocardiographers for the mitral valve as guidelines
and applied them to the tricuspid valve. The aim of the present study was not a strict
anatomical description, but a search for parameters common to all atrioventricular valves
so that a unified terminology could be applied in clinical practice. Due to the variability
in the number of leaflet scallops and number of chords present in the normal valve, we
based both terminologies on the papillary muscles. Although the number of papillary
muscle heads is also variable (particularly in the tricuspid valve), it was always possible
to identify two groups in the mitral valve and three groups in the tricuspid valve. The
Duran mitral valve classification was based on the fact that the mitral valve consists of
two symmetrical structures supported by two papillary muscles (Figure 3). All elements
supported by the anterior papillary muscle (situated to the left of the surgeon) were
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identified with the numeral 1; those supported by the posterior papillary muscle (situated
to the right of the surgeon) were identified with the numeral 2. Therefore, the papillary
muscles were identified as M l & M2, the trigones were identified as T1 & T2, the
commissures were identified as Cl & C2, the anterior leaflets were identified as A1 &
A2, the lateral posterior scallops were identified as PI & P2, and the mid scallop was
identified as PM l or PM2 according to whether its chords arose from M l or M2 [97].
The earlier classification described by Carpentier [111] was probably based on the fact
that the most fiequent surgical maneuvers are applied to the posterior leaflet, so he
defined its three scallops as PI, P2, and P3 and defined the anterior leaflet into the
corresponding opposite A l, A2, and A3. This classification does not encompass the
commissures, trigones, and papillary muscles, which must be identified with the old
terminology based on anterior/posterior and lateral/medial terms.
The tricuspid valve is more complex than the mitral valve, not only because it is a
trileaflet valve but, more importantly, because of its high variability. Traditionally, the
tricuspid valve has been described as formed by three very thin leaflets attached to the
annulus at their base and to the papillary muscles through the chordae tendinae[49,95].
Although the number of tricuspid leaflets varies according to author [93], it is commonly
accepted that the tricuspid valve consists of three leaflets (septal, anterior, and posterior)
that are separated by three clefts or commissures [112]. These commissures do not reach
the annulus but delineate small commissural leaflets. By defining the main leaflets as
tissue receiving chords from two different groups of papillary muscles, we always found
three main leaflets associated with a variable number and size of commissural leaflets
(interpreted as additional scallops by other authors [93]). Since our focus was on the

59

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

surgical classification of the tricuspid valve and not on a precise anatomical report, we
did not fully size all leaflets and commissures. The septal leaflet was present in all of the
hearts studied, which is always described by others [50,93,112].
As previously reported [93], we found endless variations in the number, size,
shape, fusion, and location of the papillary muscles. However, when observing the
insertion of the chords into the three leaflets, we were able to identify three different
groups of papillary muscles corresponding to the anteroseptal, anteroposterior, and
posteroseptal commissures. The anteroposterior muscle was the longest and sustained the
highest number of chordae. It was single in 96% of our hearts. The posteroseptal
papillary muscle group, although most variable, was always present in our series.
Although the anteroseptal muscle has been reported as absent in 20% of patients [112], if
we classified it as an anteroseptal group giving rise to chords to the septal and anterior
leaflets, we constantly found one papillary muscle on the conus.
The three papillary muscle groups were always present in 1) the middle of the free
wall; 2) on the septum close to the corner between the posterior wall and the free wall;
and 3) at the level of the conus. Although the main papillary muscle variations were
always present on the septal wall, these aberrant muscle heads could always be classified
into the posteroseptal or the anteroseptal groups according to the distribution of their
chords. It was difficult to classify two septal papillary muscles into either the anteroseptal
or the posteroseptal group in only two cases; their chords were inserted exactly in the
middle of the septal leaflet.
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4-2: Clinical Relevance and Limitations of the Study
The present anatomical study was conducted on pig tricuspid valves, which
probably differ from human tricuspid valves. However, the goal of this study was not to
provide an exact anatomical description of the porcine tricuspid valve, but rather to
attempt to unify the nomenclatures of both atrioventricular valves and find a simple
method for surgeons and echocardiologists to describe and record pathologic findings and
repair techniques employed. The porcine model was used to determine whether a
classification of the different structures of the valve was possible despite the variability
between individual hearts. Although tricuspid valve replacement and simple ring
armuloplasty do not require detailed knowledge of the valve, newer surgical techniques
demand a terminology that identifies the exact location of the pathologic findings and
surgery performed. Clear examples of this need include commissurotomy of rheumatic
lesions [112], leaflet resection of advanced myxomatous lesions [113], excision of
infective vegetations [114], transfer and rotation of leaflet segments in traumatic [115]
and bioptome-induced [116] ruptures, and autotransplantation into the mitral valve of
whole commissures carrying their corresponding leaflets and papillary muscle [117,118].
In all of these organic lesions, a clear terminology is absolutely required to (at a
minimum) record the surgery performed. More recently, the awareness of the high
incidence of functional ischemic tricuspid regurgitation [60] and the poor results obtained
from standard aimuloplasties [79] are promoting studies on its physiopathology and
possible new, more complex surgical techniques. Again, precise anatomic definitions
become imperative.
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The tricuspid valve has been generally ignored by cardiologists and surgeons
because of the paucity of clinical signs when diseased and the imprecision of available
diagnostic tools. The tricuspid valve has been traditionally described as formed by three
leaflets and three or more papillary muscles [49] [50] [95], although a recent anatomical
study describes it as a bicuspid valve with endless variations in leaflet scallops, chords,
and papillary muscles. This complicated anatomy has resulted in the absence of a
systematic classification of the valve. To standardize the description of both
atrioventricular valves, we studied the tricuspid valve from 50 pig hearts and described a
new terminology for this valve based on the same principles previously applied to the
mitral valve. We found that the tricuspid valve may be divided into three elements: three
groups of papillary muscles, the chords and the main leaflets. The three groups of
papillary muscles were defined by the numerals 1 for the anteroseptal; 2 for the
posteroseptal, and 3 for the anteroposterior. Each main leaflet was divided in two areas
that were named according to both the traditional leaflet’s names (S, A, P) and the
papillary muscle origin of the chords inserted on it (1, 2, 3). Without expecting rapid and
universal acceptance of this nomenclature, it is hoped that this attempt will constitute a
step toward the goal of more precise data collection, both for particular groups and also
between different surgical centers.
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Animal Welfare and Anesthesia Protocol for Experiment 2 to 5:
Animal Welfare
All animals were cared for in accordance with the “Principles of Laboratory
Animal Care” formulated by the National Society of Medical Research and the “Guide
for the Care and Use of Laboratory Animals” prepared by the Institute of Animal
Resources, National Research Council, and published by the National Academy Press,
revised 1996. The protocol for the use of the animals for this project was also reviewed
and approved by the Institutional Animal Care and Use Committee (lACUC) of The
University of Montana.

Anesthesia protocol:
Tar ghee sheep (weight range 50 to 80 kg) had a left jugular catheter placed and
were premedicated with intravenous (i.v.) administration of ketamine 1.0 mg/kg, atropine
0.03 mg/kg, and propofol 4.0 mg/kg. Artificial ventilation was maintained with a volume
regulated respirator (North American Drager, Telford, PA, USA) supplemented with
oxygen at 2-4 L/min. Anesthesia was maintained with intermittent propofol and
continuous isoflurane (1.5% to 2.5%). A Swan-Ganz catheter was introduced through the
left external jugular vein into the pulmonary artery. At baseline, three consecutive sets of
measurements of cardiac output and right ventricular (RV) and pulmonary artery (PA)
pressures were taken.
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Experiment 2; Geometrical Changes of the Mitral and Tricuspid Valves
during the Cardiac Cycle
1: Introduction
The following elements constitute both atrioventricular valves: the annulus,
leaflets, chordae tendinae and papillary muscles [95]. These elements work together with
the ventricles to maintain the competence of the valves. Studies on cadavers showed the
remarkable geometry of the valves. Functional studies in animals showed the geometrical
changes of the mitral [119,120] and the tricuspid [41] valves. The dynamic interactions
between the mitral annulus and the aortic valve were shown Lansac et al. [121]. To
understand the relationship of the normal mitral and tricuspid valves, it was necessary to
study the normal geometry and dynamic interactions of the tricuspid and mitral valves in
the same animal. Therefore, we undertook the following experiment.

2: Materials and Methods
2-1: Definition of the Different Phases of the Cardiac Cycle
The different phases of the cardiac cycle were defined from the LV and aortic
(Ao) pressure curve. End-diastole or beginning of systole (isovolumic contraction or
JVC) was defined as the beginning of an increase in LV pressure (dP/dt>0). Lndisovolumic contraction was defined as the beginning of ejection (Lj) at the point where
the LYP curves crosses the aortic pressure curve (gradient AoP/LVP=0). The dichrotic
notch on the aortic pressure curve defined end-ejection and the beginning of isovolumic
relaxation (IVR). The end of lYR was defined by the lowest pressure point of the LY
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pressure curve (D). Mid-diastole point (midD) was defined by the middle-time point
between the D and the beginning of systole.

2-2: Digital Sonomicrometry
Originally developed by Smith and Vesely [122], the digital sonomicrometer is
available from Sonometrics Corporation (London, Ontario, Canada). Sonomicrometry is
the measurement of distances in an aqueous medium within soft tissue by using sound
energy. Small piezoelectric crystals are utilized as both transmitters and receivers of short
pulses of ultrasound energy. The time for a transmitted pulse signal from a transmitter
crystal to be received by a receiver crystal is measured. The computer converts this time
to distance by using the Doppler formula. When a transmitting crystal is activated, all
digital distance counters are reset to zero. The instant that a receiving crystal receives a
burst of transmitted ultrasound, its respective digital counter is halted and the resulting
numbers are transferred directly to the RAM buffer of the computer. There is no analog
conversion process involved in these distance measurements, therefore eliminating the
need to calibrate the system.
The circuitry in the digital sonomicrometer (Sonometrics Corporation, London,
ON, Canada) allows for up to 32 simultaneous distance measurements to be performed.
The range of measurement is software limited from 0 mm to 196 mm. The typical range
is from 10 mm to 120 mm. The smallest measurable change in distance is 0.024 pm.
In addition to the digital sonomicrometer readings, a circuit board interfacing
directly with the PC-AT bus inside the computer performs the function of digitizing up to
16 external analog signals. The conversion of each analog signal to digital is performed
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simultaneously with virtually no phase shift and occurs once per block of
sonomicrometry measurements. Analog signal allows the recording of LV and aortic
pressures and distances between the crystals during the same time period. The user can
select the active transmitters, receivers and analog channels. These parameters including
the time and date of data acquisition, are stored along with the raw data.

2-3: Data Acquisition
Sonometrics Digital Ultrasonic Measurement System TRX Series 16 and 1 and 2
mm transmitter/receiver crystals were used to measure displacements. A post-processing
program (Sonometrics Corporation, London, Ontario, Canada) was used to examine each
individual length tracing between crystals. Data sampling rate was 200 Hz. A filter
algorithm eliminates possible signal corruption by analyzing the pattern of both the true
distance and the corrupted data. Millar pressure transducer eontrol units TCB 600 and
MIKRO-TIP pressure transducers (Millar Instruments, Inc. Houston, TX, USA) were
used to obtain the LV and Ao pressures. To ensure stability, the micromanometer
catheters were immersed in saline for a minimum of 2 hours before use then placed into a
water bath warmed to 37°C and zeroed in the dark. All distances and pressures were
displayed and recorded simultaneously on the same screen by the Sonomicrometrics
system. This ensures that all data are synchronized and recorded during the same
timeline.
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2-4: Surgical Preparation
The animals underwent implantation of 19 ultrasonic crystals on the mitral and
tricuspid valves using cardiopulmonary bypass. The animal was placed in the right lateral
decubitus position on the operating table. The heart was exposed through a T-shaped
incision of the pericardium by a standard left thoracotomy into the 4* intercostal space.
The heart was then suspended in a pericardial cradle. Heparin at a dose of 300 U/kg i.v.
was injected as a bolus in preparation for cardiopulmonary bypass with a target ACT of
480 seconds or more. The ascending aorta was cannulated with a #16 Fr Medtronic
arterial cannula. A #32 Fr single venous cannula was inserted into the inferior vena cava
and a #24 Fr into the superior vena cava. Cardiopulmonary bypass (CPB) was then
instituted. Two cotton umbilical tapes were placed around the superior vena cava and the
inferior vena cava. A LV vent line was inserted into the LV apex. The ascending aorta
was cross-clamped followed by the infusion of cold crystalloid cardioplegia into the
aortic root.

2-4-1: Surgical Implantation of Crystals for the Mitral Valve Study
Ten ultrasonic crystals were used to study the mitral valve complex. The
following 2-mm ultrasonic crystals were placed and secured with a 5/0 polypropylene
suture on the mitral valve through a left atriotomy. Six crystals were placed on the
annulus to delineate the longitudinal (PI, P2) and antero-posterior (AM, PM) diameter,
and the intertrigonal distance trigone (Tl, T2); 1 crystal on the tip of each papillary
muscle at the insertion of the anterior leaflet’s basal chordae (M l, M2); 1 crystal on the
anterior wall of the LV at the level of the papillary muscle (ALV); 1 crystal on the apex
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of the LV. The crystal electrodes were exteriorized through the ventricular wall for M l,
M2 and ALV and through the left atriotomy for the annulus crystals. One high fidelity
catheter-tipped pressure transducer (model 510, Millar Instruments, Houston, TX) was
placed within the lumen of the proximal ascending aorta and one within the LV cavity
through the apex (Figure 13).

2-4-2: Surgical Implantation of Crystals for the Tricuspid Valve Study
Nine 2-mm ultrasonic crystals (Sonometrics Corp, London, Ontario, Canada)
were implanted and secured with a 5/0 polypropylene suture through a right atriotomy to
study the tricuspid valve complex. Six crystals were located along the tricuspid annulus:
at the anteroseptal (AS), the posteroseptal (PS) and the anteroposterior (AP)
commissures, and at the relative mid point of the base of the septal (S), anterior (A), and
posterior (P) leaflets. Three crystals were located inside the RV on the tips of the septal
(Spm), anterior (Apm) and posterior (Ppm) papillary muscles. The crystal sutured at the
apex of the LV was used as a reference crystal. The electrodes of crystals inside the RV
were exteriorized through the right ventricular wall and the electrodes of the tricuspid
annulus were exteriorized through the right atriotomy.
High fidelity, catheter tipped pressure transducers (model 510; Millar Instruments,
Houston, TX, USA) were placed within the lumen of the pulmonary artery and in the RV.
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Figure 13: Surgical implantation o f the sonomicrometry crystals.

The posterior part of the heart is in front.
AM: Anterior mitral annulus
PM: Posterior mitral annulus
Tl and T2: Left and right trigone
PI and P2: Left and right lateral mitral annulus
M l and M2: Anterior and posterior papillary muscles in the LV. ALV: crystal on the LV
wall at the level of M l and M2.
Spm, Apm and Ppm: Septal, anterior and posterior papillary muscles in the RV.
S, AS and PS: Septal, anteroseptal and postero septal tricuspid annulus
A, AP and P: Anterior, anteroposterior and posterior tricuspid aimulus.
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After discontinuing the eardio-pulmonary bypass, and after the animal was
hemodynamieally stable for at least 15 min, crystal distances on the mitral valve and the
left ventricle were recorded along with left ventricular and aortic pressures. Then, crystal
distances on the tricuspid valve and the RV were recorded along with right ventricular
and pulmonary trunk pressures. Epicardial two-dimensional echocardiography with color
Doppler was used to assess the competence and anatomy of the tricuspid valve. At the
end of experiment the heart was arrested by lethal injection of potassium chloride and
explanted from the body cavity. The correct positions of the crystals were checked.

2-5: Definition of Anatomical Regions
The mitral and tricuspid valve complexes were divided in 3 planes: the annulus,
the annulo-papillary, and the papillary muscle plane. Several lengths and areas defined
each plane. Heron’s formula was used to calculate the area of a triangle with lengths a, b
and c as follows: S = !4(a+b+c) and Area = V[S (S-a)(S-b)(S-c)].
-

Annulus:
The distance changes defined by the intertrigonal distance (T1-T2), the

anteroposterior (AM-PM), commissural-commissural (P1-P2) diameters and by the
distance between each consecutive crystals sutured on the mitral annulus defined the
deformation of the mitral annulus. The distance changes defined by the S-A, the S-AP
and the S-P lengths (the short axis diameters), by P-AS, P-A and A-PS (the long axis
diameters) and by the distance between consecutive crystals sutured on the tricuspid
annulus defined the deformation of the tricuspid annulus. The motion of both annuli was
analyzed at the five time points by computing the changes of both annulus areas and
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diameters at the same time. The respective mitral and tricuspid areas were calculated with
Heron’s formula using four triangles that characterized the mitral and tricuspid annulus
planes.
Annulo-papillary muscle plane:
The variations of distances between each papillary muscle and the mitral annulus
were explored (Ml-Mitral annulus crystals and M2-Mitral annulus crystals). The
distances between the apex and the papillary muscle tips (apex-Ml and apex-M2) and
between the apex and the crystals of the mitral annulus were analyzed. The change of the
average of the distances between the apex and each crystal of the mitral annulus defined
the average change of the LV (apex-annulus). Apex-aimulus changes were compared
with the Apex-M2 and Apex-M2 changes. The annulo-papillary muscle plane of the
mitral valve was divided into two functional units: the anterior annulo-papillary apparatus
defined by each length of the quadrilateral T1-T2-M1-M2 and the posterior annulopapillary apparatus defined by each length of the quadrilateral P1-P2-M1-M2. Variations
and relationships between these distances were described. The variations of distances
between each papillary muscle and the crystals of the tricuspid annulus were explored
(Spm-trieuspid aimulus, Apm-tricuspid annulus and Ppm-trieuspid annulus). The annulopapillary muscle plane of the tricuspid annulus was divided into three fiinetional units:
the septo-annulo-papillary apparatus defined by each length of the quadrilateral AS-PS-PS, the anterior-annulo-papillary apparatus defined by each length o f the quadrilateral AS
AP-A-S and the posterior annulo-papillary muscle apparatus defined by each length of
the quadrilateral AP-PS-P-A. Variations and relationships between these distances were
described.
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-

Papillary muscle plane:

One area (M l-M2-ALV) using Heron’s formula and one length (M l-M2) defined the
papillary muscle plane of the mitral valve. In addition, one area (Spm-Apm-Ppm) using
Heron’s formula and three lengths (Spm-Apm, Spm P-pm and Ppm-Apm) defined the
papillary muscle plane of the tricuspid annulus. The distance between the crystal at the
apex and crystals placed on the papillary muscles and both annuli were also studied.

2-6: Measurement and Statistical Analysis Methods
After examination of the data, three consecutive heartbeats that contained the least
amount of noise were chosen for analysis for each animal. Once these calculations were
complete, summary statistics were reported for each location as mean ± 1 S.D. Between
the five time points of the cardiac cycle, the percentages of change were calculated for
each sheep and reported as mean ± S.D. The distance changes during the cardiac cycle
were analyzed with repeated measures analysis of variance (ANOVA) and distance
changes between two time-points of the cardiac cycle were analyzed with
Bonferoni/Dunn test. The unpaired student t-test was used to compare the relative change
between different distances. A value of p<0.05 was considered significant.

3; Results
Seven Targhee sheep (72 ± 21 kg) underwent implantation of crystals on the
mitral valve and the triscuspid valve. Average cardiopulmonary bypass time was 136 ± 9
minutes and average cross-clamp time was 88 ± 6 minutes. The following hemodynamic
characteristics were recorded: Arterial pressure 67/40 ± 2/3 mmHg, cardiac output 2.9 ±
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0.4 L/min, pulmonary artery pressure 20/11±1/1 mmHg. At the time of recording, there
was no mitral or tricuspid regurgitation on epicardial echocardiography. At necropsy all
crystals in the mitral and tricuspid annuli, RV and LV were verified to be in the correct
position.

3-1: Geometrical changes in Tricuspid and Mitral annuli
3-1-1: Mitral annulus
The main contraction of the mitral annulus occurred during the systole and was
mainly dependent of the contraction of the anteroposterior (AM-PM) and the septolateral
(P1-P2) diameters. These distances presented the major changes during the cardiac cycle
(AM-PM: 15.9 ± 10%, p=0.01, ANOVA and P1-P2: 13.1 ± 4% of change, p=0.013,
ANOVA). T1-T2 presented a change of 10.5 ± 5%, but was not significant during the
cardiac cycle (p=0.2, ANOVA). The changes of these diameters were different through
time. During JVC, AM-PM presented a 4 ± 4% decreased (p=0.17) while T1-T2 and P lP2 slightly expanded (+2 ± 3% and +2 ± 4%, p=0.3). During the time of ejection AM-PM
and T1-T2 increased (+3 ± 5%, p=0.14 and +4 ± 8%, respectively) and P1-P2
significantly decreased (-10 ± 6%, p=0.0012). During IVR, AM-PM and P1-P2 expanded
(+9 ± 5 %, p=0.2 and +6 ± 1%, p=0.019, respectively) while T1-T2 decreased (-3 ± 2%).
Between end of IVR and midD, PI-P2 and AM-PM decreased (-1 ± 3 %, p=0.8 and -3 ±
2%, p=0.3, respectively) while T1-T2 expanded (-2 ± 5%). A significant change for AMPM was observed between the beginning of IVR and midD (p=0.0033, Bonferoni/Dunn).
Figure 14 reports the variations of TI-T2, P1-P2 and AM-PM during the cardiac cycle.
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Figure 14: Heterogeneous variations of the intertrigonal (T1-T2), P1-P2 and antero
posterior diameter (AM-PM) of the mitral annulus through the phases of the cardiac
cycle in one sheep.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Ao: Aorte, LV: Left ventricle
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mm

During the cardiae eycle, Tl-AM and AM-T2 (anterior segments of the annulus)
presented 11 ± 7% and 12 ± 7% of change, respectively (p<0.05). PI-PM and P2-PM
(posterior segments) presented 12.6 ± 4% and 14.3 ± 3.5% of change, respectively
(p<0.05). P l-T l and P2-T2 (lateral segments) presented 10.7 ± 6.5% and 16 ± 6% of
change, respectively (p<0.05). The motions of the different segments of the mitral
annulus were not homogenous over time (Figure 15). Posterior segment and lateral
segment lengths decreased during systole while anterior segment lengths increased.
During diastole, posterior and lateral segment lengths increased while Tl-AM and AMT2 lengths decreased.
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Figure 15: Variations o f the segments o f the mitral annulus during the phases o f the

cardiac cycle in one sheep.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Ao: Aorte, LV: Left ventricle
AM & PM: Anterior and posterior annulus
T l & T2: trigones
PI & P2: lateral annulus
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3-1-2: Tricuspid Annulus
The antero-posterior (A-P: 13.4 ± 7%, p=0.017, ANOVA), the postero-septal (SP: 21.6 ± 8.4 %, p=0.001, ANOVA) and anteroseptal-posterior (AS-P: 15.8 ± 5%,
p=0.0013, ANOVA) diameters of the tricuspid annulus had significant and major changes
throughout the cardiac cycle. The septal-anteroposterior (S-AP) and the septo-anterior (SA) diameters presented minor non-significant variations during the cardiac cycle (11.1 ±
4.5%, p=0.25 and 11 ± 5%, p=0.2, respectively, ANOVA). The antero-posteroseptal (APS) presented the least variation during the cardiac cycle (7 ± 3%, p=0.6, ANOVA). The
changes of the tricuspid diameters are reported in Figure 16. The short axis diameters (SAP, S-A and SP) and A-PS (one of the long axis diameter) had the smallest change and
presented the same kind of variation during the cardiac cycle. During IVC, the segments
S-AP, S-A, A-PS and S-P trend to decrease (-1 ± 4%, -0.5 ± 4% and -0.5 ± 5% and -4 ±
5%, respectively with for S-P, p<0.05 Bonferoni/Dunn). During most of ejection time,
these distances decreased and just before beginning of IVR increased again (percentages
of change were respectively: -2 ± 4%, -3 ± 5%, +3 ± 3% and +11 ± 6%, respectively with
for S-P, p<0.05, Bonferoni/Dunn). During IVR, these diameters slightly expanded (+2 ±
2, +2 ± 1, +1 ± 2% and +2 ± 4%, respectively). Between end of IVR and the end of
diastole, these diameters decreased, reaching their smallest length for S-A and S-AP
before midD (S-AP: -3 ± 5%, SA: -4 ± 7%, A-PS -4 ± 5% and SP: -10 ± 5%,
respectively with for S-P, p=0.006, Bonferoni/Dunn). Then between midD and beginning
of IVC, S-A, S-AP and S-P increased while A-PS decreased (+5 ± 2 %, +3 ± 4%, +1 ±
4% and -1 ± 4%, respectively). The main contraction of the tricuspid annulus occurred
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between IVC and end of ejection. The contraction was mainly due to the decrease of the
segments between P and the anteroseptal (A, AS and S) part of the annulus.

Figure 16: Variations of the diameters (A-PS, P-AS and A-PS) of the tricuspid annulus
during the phases of the cardiac cycle in one sheep.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, PA: Pulmonary artery, RV: right ventricle.
A, AS & PS: Anterior, anteroseptal & postero septal tricuspid annulus
A, AP & P: Anterior, anteroposterior & posterior tricuspid annulus.
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Dimensions of the antero-septal segments of the annulus (S-AS and A-AS) did
not present significant variations during the cardiac cycle (19 ± 13% and 11 ± 7 %,
respectively, p>0.05 ANOVA). These distances decreased between IVC and D and then
increased during the last part of the diastole. The changes of the antero-posterior part of
the annulus (A-AP and P-AP) were not significant during the cardiac cycle (17 ± 10%
and 16.6 ± 10 %, respectively, p>0.05 ANOVA). The distances increased between Ej and
D before contracting again between the last part of diastole and the IVC. The postero
septal part of the annulus did not contract homogeneously; The P-PS segment (20.5
±12%, p>0.05 ANOVA) decreased between end of diastole (D) to IVR and increased
between IVR and D. The S-PS (20 ± 10% of change, p<0.05 ANOVA) segment
followed the motion of P-AP. For S-PS, Bonferroni/Dunn test showed significant
expansions between Ej and IVR and between IVR and significant diminution between D
and MD (p<0.01). During the cardiac cycle, the different segment changes of the
tricuspid annulus were homogenous in proportions, but did not happen at the same time
(Figure 17).

79

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 17: Variations o f the segment lengths o f the tricuspid annulus during the phases of

the cardiac cycle in one sheep
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, PA: Pulmonary artery, RV : right ventricle
A, AS & PS: Anterior, anteroseptal & postero septal tricuspid annulus
A, AP & P: Anterior, anteroposterior & posterior tricuspid annulus.
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3-1-3: Motion of the Mitral and Tricuspid Annuli
Expansion of mitral and tricuspid annulus areas did not occur at the same time.
The mitral annulus area expanded significantly from 5.5 ± 0.9 cm^ in IVR to 6.08 ± 1 cm^
at the end of diastole (+ 10%) and the tricuspid annulus area expanded significantly from
6 ± 1.4 cm^ in Ej to 6.8 ±1.4 cm^ (+14%) in midD. Tricuspid annulus area was maximal
while mitral annulus area was minimal. Antero-posterior diameter (AM-PM) of the mitral
annulus and long axis diameters (P-AS and P-A) of the tricuspid annulus had the same
trend during the cardiac cycle except during the ejection period. P1-P2 changes of the
mitral annulus and short axis diameters (S-A, S-AP and S-P) of the tricuspid annulus
presented also the same trends during late diastole, IVC and the early ejection period.
During the end of ejection and diastole, tricuspid short axis diameters seemed to expand
earlier than P1-P2. Both contracted between D and midD and expanded in late diastole
(Figure 18). The lengths of the different segments of both annuli are reported in Table 4.
Motions of the septal segments of both annuli were the same in change and timing (S-AS:
19 ± 13%, and T2-P2: 16 ± 6%, maximal contraction in IVR and maximal expansion in
end-diastole). Figure 19 shows a reconstruction of both annuli at end-diastole and endsystole.
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Figure 18: Motion of the mitral and tricuspid annuli.

Variations of the mitral and tricuspid annulus areas, of the antero-posterior (AM-PM) and
commissure-commissure diameters of the mitral annulus and long axis (P-AS) and short
axis (S-AP) diameters of the tricuspid annulus. The earlier expansion of the long axis
diameter of the tricuspid aimulus compared to AM-PM is well represented. Thick
tracings correspond to the mitral valve and thin tracing to the tricuspid.

IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Ao: Aorte, LV: Left ventricle
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Table 4: Average measurement of the segments of both aimuli during the different phases
of the cardiac cycle.
p<0.05 repeated measurement ANOVA. **Bonferroni/Dunn test showed a significant
difference between IVC and IVR and between Ej and D (p<0.01).
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole,
S,AS & PS: Septal, anteroseptal and posteroseptal tricuspid annulus,
A, AP & P: Anterior, Anteroposterior, posterior tricuspid annulus
Tl & T2: Trigones, AM & PM: Anterior & posterior mitral annulus, PI & P2: lateral
mitral annulus

AS-A
A-AP
Tricuspid
S-AS
20.57±6.54
15.12±4.54
12.73=4:2.09
IVC
Ej
IVR
D
midD

Mitral
IVC
Ej
IVR
D
midD

20.39±6.04
19.84±6.57
19.92±6.96
20.44±6.50

14.85±5.35
14.73±5.58
14.55±5.57
14.70^=4.86

12.43=4=1.69
12.97=1=2.88
13.03=t2.54
12.85±1.63

AP-P* **

P-PS

PS-S* **

18.56±5.59
18.10±5.69
19.60=1=6.35
20.2U6.71
18.63=1=5.42

16.32=1=5.78
17.50=4:5.37
17.65=1=5.47
17.25=^6.27
16.57=4=6.72

34.4U 8.85
34.22=1=8.46
35.4U 9.22
35.76=^9.88
34.67=1=9.19

PM-P1* **

P1-T1* **

11-AM

AM-T2

T2-P2* **

P2-PM* **

20.32±3.65
19.23±3.86
18.65±3.53
19.80±3.83
19.92±3.41

13.33=t2.82
13.13=t2.69
12.94±2.37
13.63=t3.34
13.55=4:3.34

11.81±2.27
12.39=t2.51
12.36=t2.39
11.84=4=2.42
11.6U2.21

13.90=t3.94
14.28=1=3.81
14.96=t4.09
13.88=1=3.62
13.48^=3.85

20.54=1=4.20
20.5U 4.26
20.15=1=4.82
21.22=1=4.91
20.25=1=4.36

14.32=4=2.17
14.03=1=2.07
13.54=11.64
14.82=1=1.86
14.55=4=2.07
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Figure 19: Reconstruction of the mitral valve annulus (left) and of the tricuspid annulus
(right).
Variations of segments of both annuli between end-diastole (black) and end-systole
(gray). AM: Anterior mitral annulus, PM: Posterior mitral annulus
T l and T2: Left and right trigone
PI and P2: Left and right lateral mitral annulus
S, AS and PS: Septal, anteroseptal and postero septal tricuspid annulus
A, AP and P: Anterior, anteroposterior and posterior tricuspid annulus.
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3-2; Geometrical Changes in Tricuspid and Mitral Annulo-papillary Muscle Planes
3-2-1: Annulo-papillary Muscle Apparatus of the Mitral Valve
The variations of distances between Ml-Mitral annulus and M2-Mitral annulus
are reported in Table 5. There was no significant distance change for M l-T l (3.5 ± 2% of
change, p=0.9, ANOVA), M l-Pl (5 ± 2% of change, p=0.07, ANOVA) and M l-PM (5 ±
3% of change, p=0.4, ANOVA) during the cardiac cycle. Significant changes in distances
between M1-T2 (11.7 ± 3% of change, p<0.005, ANOVA), M1-P2 (23 ± 6% of change,
p<0.005, ANOVA) and M l-AM (6 ± 3% of change, p<0.005, ANOVA) were observed.
These significant changes occurred mostly between IVC and D for M1-T2 and M1-P2 (10 ± 4%, p=0.0008 and -20 ± 5%, p=0.002, Bonferroni/Dunn test, respectively) and
between IVR and midD (+6.4 ± 4%, p=0.0007 and 15.5 ± 8%, p=0.004, Bonferroni/Dunn
test, respectively). The distance changes for M2-T2 (2.7 ± 2% of change, p=0.24,
ANOVA), M2-P2 (6.1 ± 3% of change, p=0.07, ANOVA) and M2-AM (4.2 ± 3 % of
change, p=0.63, ANOVA) were not significant. However, significant changes in distance
for M2-T1 (8+3%, p=0.04, ANOVA), M2-P1 (10.5 ± 6%, p=0.031, ANOVA) and M2PM (12.6 ± 8%, p<0.005, ANOVA) were observed. These significant changes occurred
mostly between beginning of IVC and end of ejection for M2-T1, M2-PI and M2-PM (-6
± 5%, p=0.003; -10 ± 6%, p=0.004 and +9 ± 5%, p=0.002, Bonferroni/Dunn test
respectively). During the cardiac cycle, Apex-Ml presented 12.9+1% (p=0.021,
ANOVA) and Apex-M2 10.5+1% (p<0.005, ANOVA) of change. The averaged distances
between the apex and the crystals of the mitral annulus also presented significant changes
during the cardiac cycle (8.3 + 1%, p<0.001, ANOVA). The distance changes for apexpapillary muscle tips and apex mitral annulus crystals are reported in Table 6.
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Table 5: Variations in distance between Ml-Mitral annulas and M2-Mitral annulas
during the phases of the cardiac cycle.
* = p<0.05 (repeated-measures ANOYA). Significant Bonferroni/Dunn test with p<0.05,
** = IVC versus IVR, ***= lYC versus D, f= ejection versus isovolumic relaxation, %=
Ejection versus D, j=Isovolumic relaxation versus mid diastole.
lYC: Isovolumic contraction, Ej: Ejection, lYR: Isovolumic relaxation, midD & D:
Diastole, M l & M2: Papillary muscles of the LY, XI & T2: Trigones, AM & PM:
Anterior & posterior mitral annulas, P1& P2: lateral mitral annulas

IVC

Ej

IVR

D

MidD

M1-P1

26.21±1.39

26.86+1.81

26.94±1.79

27.22+2.16

26.35±1.58

M1-T1

28.60±3.09

28.45+2.71

28.58±2.44

28.62±3.16

28.68±3.21

33.01+1.21$

32.06±0.88

3 1 64+ 159

32.68±1.45

M1-AM* 32.90±1.40**
M1-T2*

36.94+2.46** *** 36.51± 1.94tî

33.58+1.12f

34.06±2.69

35.88+3.26

M1-P2*

37.68±4.05**

36.96±4.21

32.10±7.05

34.71±5.71

37.86±5.31

M1-PM

33.14±2.01

34.27±1.68

33.39±0.63

32.85±1.63

33.1811.84

M2-PM* 31.89±2.79**

34.61±3.33

35.04±3.05

33.40±3.55

31.8014.03

M2-P1*

39.75±2.06**

39.34±1.89

36.24±0.52

38.81+1.08

38.8412.85

M2-T1*

43.08±0.87**

41.06±1.55

39.98±2.42

40.49+1.62

41.2010.92

M2-AM

38.04±2.00

37.78±2.67

38.25±2.35

37.98+2.35

37.5011.52

M2-T2

29.72±2.65

30.08±2.63

30.20±2.35

29.81±2.50

29.68l2.58

M2-P2

26.37+2.77

27.29+2.79

28.03±2.52

26.81+2.60

26.51l2.92
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Table 6: Changes through the cardiac cycle of average distances Apex-Annulus, ApexM1 and Apex-M2
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, M l & M2: Papillary muscles of the LV, T1 & T2: Trigones, AM & PM:
Anterior & posterior mitral annulus, P1& P2: lateral mitral annulus

Apex-Annulus
IVC
Ej
IVR
D

88.50+4.33
92.46±4.02
86.19i5.66
85.21+5.95

MidD

87.12+5.28

Average change

Bonferoni/Dunn
test

IVC versus Ej
Ej versus IVR
IVR versus D
D versus
midD
MidD versus
IVC

5.2±1%
-8.3+2%
1.5±1%
-09+0.6%

P=0.0001
P=0.0001
P=0.035
P=0.096

2.1±1%

P=0.93

IVC versus Ej
Ej versus IVR
IVR versus D
D versus
midD
MidD versus
IVC

1+4%
-7+5%
1±3%
4±3%

P=0.81
P=0.0011
P=0 6
P=0.035

2±1%

P=0 12

IVC versus Ej
Ej versus IVR
IVR versus D
D versus
midD
MidD versus
iVC

0.8±2%
-8±2%
1±3%
7+6%

P=0.001
P=0.002
P=0.007
P=0.0012

2±0.5%

P=0.91

Apex-M1
IVC
Ej
IVR
D

46.13±3.21
47.06±3.52
43.20±2
41.32±3.7

MidD

44.13±4.01

IVC
Ej
IVR
D

33.82±3.85
35.28±3.48
32.79+3.29
3101+4 03

MidD

33.84+2.5

Apex-M2
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Apex-annulus changes were significantly different from Apex-Ml (p=0.002,
unpaired t-test) and Apex-M2 (p=0.017, unpaired t-test) changes during the cardiac cycle.
During IVC, Apex-Annulus, Apex-Ml and Apex-M2 increased (table 6), however
percentages of expansion were significantly different (Apex-annulus: 5.2 ± 1%, ApexM l: 1 ± 4% and Apex-M2: 0.8 ± 2%, p=0.01 for apex-annulus versus Apex-Ml and for
apex-annulus versus Apex-M2). During the ejection period, Apex-annulus reached its
maximum value and started to decrease until the IVR period during which it reached its
minimum value. Apex-Ml and Apex-M2 followed the same pattern. During these periods
of the cardiac cycle, no significant differences were found for the percentages of change
between Apex-annulus and Apex-Ml or Apex-M2. Figure 20 shows the variations of the
distances between the apex, both papillary muscles and the mitral annulus during the
cardiac cycle. The flat curves of the distances between papillary muscles and mitral
annulus show that there are almost no variations in distance. Variations of the distances
between apex and papillary muscle tips or apex-mitral annulus are also represented.
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Figure 20: In one sheep, variations through the phases of the cardiac cycle of the
distances apex-Mitral annulus, Apex-Ml, Apex-M2, Ml-Mitral annulus (PM, PI, T l,
AM) and M2- Mitral annulus (PM, P2, T2, AM).
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, M l & M2: Papillary muscles of the LV, TI & T2: Trigones, AM & PM:
Anterior & posterior mitral annulus, P1& P2: lateral mitral annulus, Ao & LV: Aorta and
Left ventricle
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3-2-2: Annulo-papillary Muscle Units of the Mitral Valve
Between IVC and IVR, the lengths of the quadrilateral T1-T2-M1-M2 that
defined the anterior annulo-papillary apparatus and the ones of the quadrilateral P1-P2M1-M2 that defined the posterior annulo-papillary apparatus remained the same, except
for the distance between M1-M2. M l-T l was almost equal to M2-T2 and that o f M l-PI
was almost equal to M2-P2 (Table 7). The ratios between the lengths of the quadrilateral
were close to one (Table 8). Because of these consistent lengths and the relationship close
to one in systole and diastole, these two quadrilaterals stayed trapezoid-like during
systole and diastole.

Table 7: Lengths of the two functional unit and their variations between IVC and IVR

P1-P2
M1-P1
M2-P2
M1-M2
T1-T2
M1-T1
M2-T2

IVC

IVR

% change

32.08±6.5
27.68±4.1
26.61±4.9
28.11 ±6.1
25.84±2.15
28.43±3.3
31.66±2.9

30.57±6.9
28.83±3.9
28 57+4 1
21.29±5
26.8±3.8
28.56±3
30.65+4.6

5%
-4%
-7%
32%
-2%
0.5%
3%
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Table 8: Relationship between segment of the quadrilaterals of anterior and posterior
functional unit.

Anterior functional unit
T1-T2/M1-M2
T1-T2/T1-M1
T1-T2/T2-M2
T1-T2/P1-P2
Posterior functionai unit
M1-M2/P1-P2
P1-P2/P1-M1
P1-P2/P2-M2

IVR

IVC

0.9±0.1
0.9±0.2
0.8+0.1
0.8±0.1

1.2±0.2
0.9±0.1
0.9+0.1
0.9±0.1

0.9+0.1
1.3±0.2
1.2±0.2

0.7±0.1
1.2±0.2
1.1±0.2

3-2-3: Annulo-papillary Muscle Apparatus of the Trieuspid Valve
The distances between each papillary muscle and the crystals of the tricuspid
annulus and the percentage of change through the cardiac cycle were analyzed and
reported in Table 9. No significant change were observed by repeated measures ANOVA
(p<0.05) for the segment lengths between each papillary muscle and its corresponding
commissural crystals of the tricuspid annulus. Bonferroni/Dunn test was used to evaluate
significant differences found by ANOVA resulting in significant differences for IVC
versus IVR and IVR versus MD with p<0.01.
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Table 9: Distance between the three papillary muscles of the tricuspid valve and the
tricuspid annulus.
* = p<0.05 (repeated-measures ANOVA).
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Spm, Apm & Ppm: Papillary muscles of the RV,
S, AS, PS: Septal, anteroseptal and posteroseptal tricuspid annulus,
AP, P and PS: Anteroposterior, posterior and posteroseptal annulus

Spm-S

Spm-AS

Spm-A

Spm-AP

Spm-P

Spm-PS

IVC
Ej
IVR
D
midD

26.58+1.68
25.88+2.83
25.76+2.79
26.41±2.06
26.76±1.53

20.62±5.08
20.99+5.47
20.65±4.55
19.90±4.16
19.73+4.25

26.11 ±7.22
28.26±6.13
28.47±5.42
27.04±4.83
24.63±7.39

28.48±5.43
29.84±3.81
31.53±2.74
30.11 ±4.37
27.51±5.17

36.24±2.54
35.74±1.38
39.34±1.94
39.18±2.65
36.78±2.51

38.05±4.06
37.28±3.38
39.85±2.89
40.43±4.21
38.45±3.77

% change

7.00±4.70

5.00±3.80

14.00±8.20*

16.00±9.30*

14.90±4.00*

10.10±1.40*

Apm-S

Apm-AS

Apm-A

Apm-AP

Apm-P

Apm-PS

IVC

38.25±3.31

35.85±6.35

28.14±2.73

21.22±3.97

28.10±6.84

39.33±4.42

Ej
IVR
D
midD

37.06±4.88
33.67±4.92
36.08±3.31
38.38±3.19

34.75+6.68
33.04+6.28
34.04±5.51
35.48±6.46

28.52±2.91
28.00±3.29
27.86±3.00
28.18±3.26

21.31±3.85
21.32±3.64
21.40±3.62
21.2U 3.55

27.70±6.02
27.27±6.66
27.73±7.52
28.23±7.03

38.76±4.59
36.69±4.96
38.33±4.74
39.8U 4.96

% change 11.70±7.90*
Ppm-S

8.60±2.40*

4.50±2.10

3.90±1.60

5.10±1.90

8.20±2.40*

Ppm-AS

Ppm-A

Ppm-AP

Ppm-P

Ppm PS

Ej
IVR
D
midD

28.41±2.75
28.04+2.53
27.60±2.59
28.00+2.32
28.66±3.03

41.61±5.41
41.08+3.79
41.34±4.16
41.19+4.96
40.50±6.04

43.26±5.78
43.47±4.54
44.30±4.47
44.29±5.24
42.11±6.52

33.32±5.99
33.89±4.56
34.89±3.93
34.88±4.77
32.68±6.16

25.3U 2.42
26.48±3.93
27.08±4.16
26.44±2.70
24.18±2.23

19.82±2.95
19.99±4.08
19.90±3.82
19.64±2.85
19.75±2.89

% change

7.9±2.7

7.9±2.6

9±5.1*

11 ±6.9*

13.5±7.2*

5.4±3

IVC
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The distances between the septal papillary muscle and the crystals of the annulus
expanded between Ej and D and decreased during the end of diastole and the end of
isovolumic contraction. The distance between the anterior papillary muscle and the
crystals of the annulus increased between IVR and the end of diastole and decreased
between IVC and the end of ejection. The distance between the posterior papillary muscle
and the annulus followed the same trend as the one of the anterior papillary muscle.
Figure 21 shows the variations through the cardiac cycle of the distances between each
papillary muscle tips and their corresponding commissural crystal, of Spm-P, Apm-S and
Ppm-A.
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Figure 21 : In one sheep, variations through the phases of the cardiac cycle of the
distances between the PM tips and the corresponding commissures.
The flat line between the PM tips and their corresponding commissure showed no
variations during the cardiac cycle.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Spm, Apm & Ppm: Papillary muscles of the RV
S, AS, PS: Septal, anteroseptal and posteroseptal tricuspid annulus
AP, P and PS: Anteroposterior, posterior and posteroseptal annulus
PA & RV : Pulmonary artery and right ventricle
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3-2-4: Annulo-papillary Units of the Tricuspid Valve
During the different times of the cardiac cycle, the relationships of the lengths of
the quadrilateral AS-AP-A-S that defined the anterior annulo-papillary apparatus, the
quadrilateral AS-PS-P-S that defined the septal annulo-papillary apparatus and the
quadrilateral AP-PS-P-A that defined the posterior annulo-papillary muscle apparatus are
in Table 10. Each ratio remained consistent during the cardiac cycle. The ratios that
involved a segment of the annulus and the segment between the two corresponding
papillary muscles and the ratios that involved two distances between the tip of a papillary
muscle and its corresponding commissural crystal were close to one. However, they were
different from one when the ratios involved a segment of the armulus and the distance
between the tip of the papillary muscle and the corresponding crystal for the septal and
posterior annulo-papillary apparatus. These last ratios were also close to one for the
anterior annulo-papillary unit. These consistent ratios showed the same percentage of
change of lengths for the different segments during the cardiac cycle. Therefore, as for
the mitral papillary unit, these three quadrilaterals stayed trapezoid-like during the
cardiac cycle.
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Table 10: Relationships between the segments of the septal, anterior and posterior
papillary muscle apparatus.

IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Spm, Apm & Ppm: Papillary muscles of the RV
S, AS, PS: Septal, anteroseptal and posteroseptal tricuspid armulus
AP, P and PS: Anteroposterior, posterior and posteroseptal annulus

Anterior Annuio-Papiliary apparatus
AS-PA/Spm-Apm
AS-PA/Spm-AS
IVC
Ej
IVR
D
midD

0.901
0.887
0.853
0.842
0.878

0.992
0.969
1.030
1.054
0.997

Septal Annulo-Papillary apparatus
AS-PS/Spm-Ppm
AS-PS/AS-Spm
IVC
Ej
IVR
D
midD

0.940
0.961
0.947
0.949
0.928

1.652
1.648
1.748
1.829
1.706

AS-PA/Apm-PA

AS-Spm/PA-Apm

0.974
0.945
0.979
0.963
0.940

1.019
1.026
1.052
1.095
1.062

AS-PS/PS-Apm

AS-Spm/PS-Apm

1.764
1.711
1.815
1.864
1.747

0.937
0.963
0.963
0.981
0.976

Posterior Annulo-Papillary apparatus
PA-PS/Apm-Ppm
PA-PS/PA-Apm
PA-PS/PS-Spm
IVC
Ej
IVR
D
midD

0.930
0.973
0.993
0.977
0.946

1.542
1.526
1.571
1.632
1.553

1.418
1.432
1.438
1.463
1.429

PA-Apm/PS-Spm

0.919
0.939
0.915
0.896
0.920
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3-3: Geometrical Changes in the Mitral and Trieuspid Papillary Musele Planes
3-3-1: Papillary Museles of the Mitral Valve
M1-M2-ALV presented a 72% decrease from 2.15 ± 0.45 cm^ to 1.24 ± 0.34 cm^
between IVC and IVR. The inter-papillary muscle distance M l-M2 decreased from 29.8
± 6 mm to 23.8 ± 7 mm (-32%) between IVC and IVR. Distance between M l and ALV
decreased from 23.14±5.4-mm to 15.7 ± 3.5 mm (-47%) between IVC and IVR. Distance
between M2 and ALV decreased from 19.1 ± 4.2 mm to 15.5 ± 3.6 mm between IVC and
IVR. Table 11 shows the significant variations of the mitral papillary muscle plane during
the cardiac cycle. Figure 22 shows the variation through the cardiac cycle of the distances
of the papillary muscle plane of the mitral valve.

Table 11 : Variations of distances through the cardiac cycle for the papillary muscle plane
of the mitral valve.
* = p<0.05 (repeated-measures ANOVA). Significant Bonferroni/Dunn test with p<0.05,
** = IVC versus IV R , ***= IVC versus D, f= ejection versus IVR, J= ejection versus D,
]= Isovolumic relaxation versus midD, IVC: Isovolumic contraction, Ej: Ejection, IVR:
Isovolumic relaxation, midD & D: Diastole,
M l-M2: Papillary muscles of the LV, ALV: Crystal on the LV wall at the level of the
papillary muscles.

IVC
Ej
IVR
D
MD

M1-M2 (mm)

Ml-ALV (mm)

29.8+6.1******
2 8 .7± 5.52n
23.8±7
25.13±6.2
27.97±6.16

21.65±4.79* ** ***
20.77±4.43t
15.80±2.81f
18.41±4.63
21.22+4.62

M2-ALV (mm)

21.39+4.95* *****
21.08±4.73tt
17.28±4.27[
18.52±4.84
20.19+5.41

M1-M2-ALV
Area (cm*)

2.1+0.45* ** ***
2.02± 0.41tt
1.24±0.34f
1.28±0.35
1.7±0.39
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Figure 22: Variations of M l-M2, Ml-ALV, M2-ALV through the phases of the eardiac
cycle.
Contraction of the ventricle during the systole is shown by the diminution of the
interpapillary muscle plane distance.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, M l-M2: Papillary muscles of the LV, ALV: Crystal on the LV wall at the level
of the papillary muscles. Ao & LV: Aorta and Left ventricle
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3-3-2: Papillary Muscles of the Tricuspid Valve
The area defined by the septal (Spm), anterior (Apm) and posterior (Ppm)
papillary muscles crystals contracted by 22 ± 14% (p>0.05, ANOVA) between IVC and
IVR. The three segment motions (Spm-Apm, Spm-Ppm and Ppm-Apm) were
homogeneous during the cardiac cycle in distance and time. Spm-Apm presented a total
change of 15 ± 12% (p>0.05, ANOVA), Apm-Ppm, of, 12 ± 5% (p>0.05, ANOVA) and
Spm-Ppm of 10 ± 4% (p>0.05, ANOVA). These lengths decreased during the systole and
increased during the diastole (Table 12 & Figure 23).

Table 12: Variation of the inter-papillary muscle distance of the tricuspid valve during
the phases of the cardiac cycle.
Spm, Apm & Ppm: Septal, anterior and posterior papillary muscles of the RV
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole,

IVC
Ej
IVR
D
midD

Spm-Apm (mm)

Apm-Ppm (mm)

Spm-Ppm (mm)

Area (cm^)

31.51±5.33
31.48+3.25
29.55+4.20
29.88+6.10
31.11±5.31

32.36±4.80
31.38±5.21
30.86±5.98
32.04+5.57
32.02+4.53

36.59±5.37
35.62±4.12
35.38+3.26
37.68±3.71
36.72±4.65

3.8+1.5
3.6±1.1
3.3±1.1
3.4+1.3
3.6+1.4
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Figure 23: Variations of the interpapillary musele distances of the tricuspid valve during
the phases of the cardiac cycle.

Spm, Apm & Ppm; Septal, anterior and posterior papillary muscles of the RV
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, PA & RV : Pulmonary artery and right ventricle
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3-3-3: Motion of Both Papillary Muscle Planes:
Both papillary muscle plane areas decreased during systole from IVC to IVR (see
table 11 & 12 for values). During the contraction of the ventricles. M l-M2, Spm-Apm
and Apm-Ppm decreased by 32%, 15 ± 12% and 12 ± 5% respectively; however, SpmPpm (10 ± 4% of change) decreased during the IVC, but increased during the ejection
period. Figure 24 represents the variation of the interpapillary musele distance at the 5
time points of the eardiac cycle.
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Figure 24: Variations of the papillary-muscles distances of both atrioventricular valves
during the cardiac cycle.

M l & M2: papillary muscle of the LV
Spm, Apm & Ppm: Septal, anterior and posterior papillary muscles of the RV
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole,
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4: Discussion
4-1: Mitral and Tricuspid Valve Annuli
It was first shown in dogs that the shape and size of the mitral and tricuspid annuli
varied continuously during the cardiac cycle [99,123]. Other studies with
sonomicrometry array localization, marker angiography and three dimensional
echocardiography confirmed their dynamic changes during the cardiac cycle
[26,41,101,102]. Our findings on the diameter and segment length changes of both annuli
resulting in shape and area variations during the cardiac cycle are consistent with
previous reports of different groups who studied separately the mitral and the tricuspid
annuli. In our experiment, the mitral annulus decreased in size during systole with the
contraction of the antero-posterior (AM-PM: 15.9 ± 10 %) and commissure-commissural
(PI-P2: 13.1 ± 4%) diameters of the annulus. These results are different from the findings
of Gorman et al. who studied the mitral valve in sheep using sonomicrometry and
reported an expansion of the AM-PM diameter of the annulus during the IVC and an
expansion of P1-P2 during ejection [119], while we found in our experiment a
contraction (figure 14). These differences may depend on the variability between sheep
breeds. The time variations of AM-PM and PI-P2 diameters were associated with the
motion of the posterior (PM-Pl : 12.6 ± 4% and PM-P2: 14.3 ± 3.5%) and lateral
segments (TI-Pl; 10.7 ± 6.5% and T2-P2: 16 ± 6%) of the annulus during the cardiac
cycle. The intertrigonal distance that was previously considered to remain constant or to
change minimally during the cardiac cycle was actually found to expand during ejection
along with the expansion of the aortic root. The expansion of the intertrigonal distance
(T1-T2 10.5 ± 5%, p>0.05) during the cardiac cycle was associated with significant
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expansion of the anterior segment lengths of the annulus (Tl-AM: 11 ± 7%, AM-T2: 12
± 7%) and corresponded to the dynamic balance of the aorto-mitral junction [121]. Mitral
annulus deformation is closely related to aortic root dynamics. The intertrigonal distance
expands during systole and allows for aortic root expansion, probably to maximize
ejection.
For the tricuspid valve, the long axis diameter centered on the posterior part of the
annulus (P-S: 21.6 ± 8.4 %, P-AS: 15.8 ± 5 % and P-A: 13.4 ± 7%) and the short axis
diameters, septum-anteroposterior free wall (S-A: 11 ± 5 % and S-AP: 11.1 ± 4.5%)
presented the major changes during the cardiac cycle. The minimal change corresponded
to the segment A-PS (7 ± 3%). Thus the deformation of the annulus was associated with
the motion of the posterior part of the annulus. According to Hiro et al. [41], the
posteroseptal commissure in Tar ghee sheep corresponds to the tail of the pear shape of
the tricuspid annulus. In humans, the change of the tricuspid valve depends on the
expansion of the free wall segment of the narrow tail of the pear shaped annulus or the
anteroseptal portion of the annulus [108]. We found the same relative distance changes
(15-20%) between each segment defined by the six crystals of the annulus as Hiro et al
[41] showed an homogenous change (12%) of the insertion of the three leaflets. The
motion of these annulus segments was, however, not homogeneous in time. The
anteroposterior segments (A-AP and P-AP) of the free wall and the postero-septal (S-PS)
part of the annulus were increasing during ejection while the anteroseptal annulus (S-AS
and A-AS) and the posterior segment P-PS were contracting. Thus the lateral annulus
motion was following the septal annulus motion and the anterior annulus motion was
following the posterior free wall motion.
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According to our knowledge, there was no previous report describing the motion
of both annuli during the cardiac cycle. We described the variations of the annulus shapes
by their diameter changes. The mitral annulus had more significant changes in the axis
parallel to the septum than in the free wall-septum axis AM-PM: 15.9 ± 10 % versus P lP2: 13.1 ± 4%, which correspond to the findings of Gorman et al. [119]. The long axis
(P-AS) of the tricuspid annulus expanded during ejection while the short axis (S-AP) was
decreasing, following the motion of the diameters of the mitral valve. The tricuspid
annulus long axis increase was associated with an early expansion of the tricuspid area
during ejection. The contraction of the LV and the mitral annulus may create a dynamic
balance of the atrioventricular valve septal junction. Our finding about the area of the
mitral valve corresponds to that of Ormiston et al. who showed that the mitral annular
area was increasing gradually during diastole and then was decreasing until midsystole.
The mitral area started to increase again during late systole [100]. By using the Heron
formula, we added triangles that were not on the same plane and respected the saddle
shape of the annulus.

4-2: Annulo-papillary Muscle Apparatus of Mitral and Tricuspid Valves
In cadaveric hearts, the distances between the tip of both papillary muscles and
the trigones or the point between the middle and lateral or septal scallops of the posterior
leaflets were measured and found to be equal [124]. It has been shown in dogs that the
orthogonal distance between the plane of the mitral annulus and the tips of both papillary
muscles had a variation of less than 1-mm during the cardiac cycle with different heart
rates and preload conditions [120]. In our study, the distance between each papillary
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muscle tip and the hemicorresponding mitral annulus remained the same during the entire
cardiac cycle. We studied the Apex-PM tip changes during the cardiac cycle and
observed an elongation followed by a shortening of the distance during systole. Komeda
et al. reported the same variations of the papillary muscle lengths [120]. We compared
Apex-PM tip changes to the variations of the averaged distances between the apex and
the mitral annulus crystals, which correspond to an average of the LV wall variations. We
found a significant difference for the average change during the cardiac cycle (Apex-Ml
versus Apex-annulus, p=0.002 and Apex-M2 versus Apex-annulus, p=0.017) and for the
relative expansion during the IVC (Apex-Ml versus Apex annulus, p=0.01 and Apex-M2
versus Apex-annulus, p=0.01). The constant distance between the papillary muscles tips
and the differences in changes between the apex-annulus distance and apex-papillary
muscle distances suggest that both papillary muscles do not present the same changes as
the ventricular wall during the phases of the cardiac cycle. The papillary muscles seem to
be functionally different from the LV wall. The papillary muscles have variable
morphology [104,105] and were always described as part of the LV in the conventional
anatomy textbooks. Their muscular fibers of the body and base were understood to be in
direct continuity with the myocardium of the LV. However, using x-ray multidetector CT
with interactive 3-D images. Axel [125] has shown that the base of the human papillary
muscles is not in continuity with the LV wall but through trabeculae carneae with clear
demarcation spaces between both structures. These facts suggest that anatomically, the
papillary muscles are different from the LV wall. Therefore, the papillary muscles,
functionally and anatomically different from the LV wall, may function as independent
structures that serve to maintain a constant distance between the annulus and their tip.
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This continuity between the mitral valve armulus and the papillary muscles has to be
preserved for LV performance and prevents postoperative mid-ventricle rupture in cases
of mitral valve replacement [126].
For the tricuspid valve, our results also showed a remarkable geometry of the
annulus-papillary muscle complex. According to our knowledge, no one previously
reported that each papillary muscle of the tricuspid valve remained at a constant distance
from its corresponding commissure. Traditionally, in the RV, three tricuspid papillary
muscles are described and identified as anterior, posterior and septal. In their anatomical
work on 100 human hearts, Viktor et al. found that the papillary muscles of the tricuspid
valve exhibited endless variations in number, size, shape, fusion and location [93]. We
showed that a single anterior muscle constituted the tricuspid valve predominantly and
that numerous muscles among the septum constituted the posteroseptal and anteroseptal
groups (Experiment 1). Among these muscles, a posteroseptal one at the comer between
the septum and the free wall and the conus PM were always present at the level of the
anteroseptal and posteroseptal commissures. These muscles corresponded to the
placement of the crystals during the experiment. L. Axel also studied the RV papillary
muscles and found also that they were not attached to the RV wall but to the trabeculae
tendinae [125] and that they were anatomically distinct from the RV wall. In the case of
the RV, the papillary muscles may also correspond to independent structures that
maintain a constant distance between their tips and the annulus.
We studied the relationships between the segments of the quadrilateral constituted
by two PM tips and the intertigonal or the latero-lateral mitral annulus and by two
papillary muscles and their corresponding commissures in the tricuspid valve. For the
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mitral valve our results showed a constant ratio close to one in each calculation. For the
tricuspid valve, our results showed a constant ratio (different from one) during the phases
of the cardiac cycle between interpapillary muscle and commissure-commissure distances
and equal to one between papillary muscle -commissure distances. The mitral and
tricuspid valves may be described as two (for the mitral) and three (for the tricuspid)
annulo-papillary units constituted by two papillary muscles and the corresponding
annulus with the leaflet base in between.

4-3: Papillary Muscle Motion
During systole, with the contraction of the ventricles, the interpapillary muscle
distance in the LV decreased by 32% while the Apm-Ppm and Apm-Spm decreased by
15% and 12%, respectively. However, the distance between Spm and Ppm, the papillary
muscles inserted on the septum in the RV increased by 10%. We demonstrated that the
long axis diameter (P-AS) and the septal segment (S-PS) of the tricuspid annulus
expanded during ejection (figure 16 & 17) while the septum was contracting. At the level
of the papillary muscles, the PM tip motion seemed to reproduce the motion of the
tricuspid annulus. The contraction of the LV may create, not only at the armulus level but
also at the papillary muscle level, a dynamic balance with the sub-valvular apparatus of
the tricuspid valve during ejection. One explanation for this finding may be a physiologic
bulging of the septum during contraction. According to the anatomical concept of
Torrent-Guasp, a muscular band wrapped upon itself forms the heart [36]. The RV is
formed by horizontal fibers wrapped on the helical bands that constitute the LV. During
systole the successive contractions of the basal and apical loop of the LV band make the
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muscle thicker and more spherical [127]. The septum may become prominent inside the
RV during ejection, while the pressure inside the LV is increased, and thus the distance
between the Spm and Ppm increases.
In conclusion, we studied the motion of both atrioventricular valves in vivo in
normal ovine hearts with sonomicrometry array localization. Both annuli were linked by
the septum and presented the same directional change during the cardiac cycle. The
subvalvular apparatus of both valves was associated with the annuli in a remarkable
geometrical pattern. The LV papillary muscles remained at a constant distance from the
hemi-correponding mitral valve and the RV papillary muscles remained at constant
distance from their corresponding commissures. The papillary muscles within each
ventricle were associated with the each other to form with the trigones and the lateral
mitral annulus or with their corresponding commissure areas on the tricuspid armulus a
trapezoid-like quadrilateral. These quadrilateral sides presented constant ratios during the
cardiac cycle.
Although sonomicrometry has an outstanding spatial and temporal resolution
[119], differences in surgical placement and anatomic variations of the animals may
explain deviations in measurements between research groups or even within the same
group. To minimize this problem, the same surgeon performed all surgeries. This
experiment was also conducted as an acute, open chest, open pericardium study on an
anesthetized animal. This associated with the deleterious effect of cardio-pulmonary
bypass and ischemia could have resulted in abnormal valve behavior.
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Experiment 3: Comparison of Sonomicrometry and TTE Data in Sheep
1: Trans-thoracic echocardiography in sheep
The traditional long axis (aortic root to apex), short axis (perpendicular to long
axis) and four chambers (traversing both ventricles and atria through mitral and tricuspid
valves) views [128] of trans-thoracic echocardiography in sheep are obviously different
from human patients. The TTE in human patients has been described as iterative and
dependent on anatomical characteristics of the patient and manipulation of the operator
[129]. The three dimensional structures are sliced in two-dimensional images and allow
the measurements of intracardiac structures. To recognize precisely the structures that are
measured by TTE in sheep where no references are available, comparisons between TTE
data and sonomicrometry data were undertaken.

2: Materials and Methods
2-1: Echo data acquisition
Tar ghee sheep (n=6) were anesthetized and a trans-thoracic echocardiography
was performed (HP, 5500) by the same operator. The sheep was positioned on its right
side on the operating table. A short-axis view was acquired through the 5* left intercostal
space about 4 cm above the sternum. A long-axis view was acquired trough the 4* left
intercostal space 4 cm above the sternum. The short axis view allowed seeing the LV and
its papillary muscles but did not allow any measurements on the RV. Only the long axis
view allowed the analysis of both annuli and both ventricles because of the anatomical
conformation of the sheep.
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Left ventricular and RV measurements were performed. For the LV: on short-axis
view, maximum and minimum inter-papillary muscle distances (M l-M2) at the level of
the head of papillary muscles were measured. On long-axis view, maximum and
minimum M2-posterior annulus dimension and M2-anterior annulus (tethering distance)
were measured. On the same view, maximum and minimum antero-posterior mitral
annulus diameters were measured. Only the long-axis view was used for the
measurements in the RV. The annulus diameter, the distance between the apex and the
septal part of the annulus and the distance between the apex and the free wall part of the
annulus were measured in systole and diastole. The distance between the tip of the free
wall papillary muscle and the free wall annulus and the distance between the free wall
PM and the septal annulus were acquired in systole and diastole. The distance between
the septal papillary muscles and the septal annulus and the distance between the septal
papillary muscle and the free wall annulus were also measured in systole and diastole.

2-2: Surgical experiment
Sonomicrometry data from crystals implanted in the sheep described above in the
LV, RV, mitral and tricuspid annuli were used in this experiment. Three beats were
selected from the filtered sono data, using Sonometric’s software (SonoSOFT Version
3.1.4, Sonometrics Corp, London, Ontario, Canada). Maximum and minimum distances
between the following crystals were found for each beat and were used for comparisons.
For the LV dimension; The interpapillary muscle distances measured on TTE were
compared with the inter-papillary muscle distance using the crystals implanted on the
head of both papillary muscles (M l-M2).
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For the mitral and tricuspid annuli: The TTE a mitral annulus diameter was compared
with the antero-posterior distances of the mitral annulus defined by the following
crystals: AM-PM, T l-P l, T2-P2, Tl-PM, T2-PM, AM-Pl and AM-P2. The TTE
tricuspid annulus diameter was compared with the distance defining the septo-lateral
diameter (S-A, S-AP or S-P).
For the LV: M2-posterior annulus distances from TTE were compared with the distance
between the head of the postero-medial papillary muscle and the posterior annulus M2P l, M2-PM and M2-P2. The tethering distance (M2-anterior annulus) from TTE was
compared with the distance between M2-AM, M2-T1 and M2-T2.
For the RV: The distance between free wall PM and the septal annulus from TTE were
compared with Apm-PS, Apm-S and Apm-AS. The distance between free wall PM and
the free wall annulus from TTE were compared with the Apm-A, Apm-AP and Apm-P.

2-3: Statistical analysis:
Samples of sheep were drawn randomly from a population of Targhee sheep with
an assumed normal distribution. Because of the small number of our samples and to
allow the use of parametric tests, normal distribution of our numbers was checked by a
normal-probability-plot. Statistical analysis was performed using the unpaired t-test with
p<0.05 significance.

3: Results
3-1: Data Comparison
The validity of the comparison of the sono and TTE groups was determined by
matching the weight and hemodynamic characteristics of the two groups. The weight of
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the TTE group was not significantly different from the weight of the sono group (57.6 ± 6
kg versus 72 ± 21kg respectively, p= 0.2). Comparison of cardiac output (CO) and aortic
systolic pressure were not significant (3.3 ± 0.4L/min versus 2.9±0.4 L/min, p=0.24 and
72 ± 5 mmHg versus 67 ± 2 mmHg, p=0.26, respectively).
In short axis view, the interpapillary muscle distance (M l-M2) measured in TTE
was 27.7 ±6.1 mm in ED and 26.4 ± 5.8 in ES. These measurements were not different
from 29.8 ±6.1 mm in ED (unpaired t-test, p=0.24) and from 23.8 ± 7 mm in ES
(unpaired t-test, p=0.12).
In long axis view, the TTE measurements for the mitral and tricuspid annulus
diameters are reported in table 13. The TTE diameter of the mitral annulus was not
significantly different from AM-PM and from AM-Pl in ED and ES and from Tl-PM in
ED. The TTE measurement of the tricuspid annulus was not significantly different from
S-AP, S-P and AP-AS in ED and ES. Altogether, the 2-D picture acquired by TTE
corresponded to a slice of the heart through the mitral annulus at the level of the segments
AM-Tl and PM-P2 and through the tricuspid annulus at the level of the segments S-AS
and AP-P (Figure 25).
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Table 13; Comparison of TTE long axis view and sonomicrometry measurements (in
mm) of the two groups for the LV and the mitral valve.

ED; end diastole. ES: end systole.
AM & PM: anterior & posterior mitral annulus
T1 & T2: trigones
PI & P2: Lateral mitral aimulus
S, AS & PS: septal, anteroseptal & posteroseptal tricuspid annulus

Echo

Sonomicrometry

N=10

mitral annulus diameter
Mean
SD
ED
ES

30.30
29.10

2.67
3.28

AM-PM
T1-P1
T2-P2
T1-PM
T2-PM
AM-Pl
AM-P2

Mean

SD

ED
ES
ED
ES
ED
ES
ED
ES
ED
ES
ED
ES
ED
ES

27.94
26.44
13.22
12.41
14.20
13.86
28.16
25.53
11.93
12.65
28.60
26.8
13.04
13.64

2.70
4.07
2.84
2.40
3.16
2.28
4.75
3.75
2.11
2.61
1.1
1.2
4.23
3.94

Mean

SD

ED
ES
ED
ES
ED
ES
ED
ES
ED
ES

29.68
29.57
25.85
25.97
20.46
22.71
28.73
31.00
20.66
20.59

5.57
6.37
6.01
6.42
5.84
5.71
6.24
6.45
4.72
5.72

Tricuspid annulus diameter
Mean
SD
ED
ES

22.75
22.02

1.75
1.73

S-A
SAP
S-P
AS-P
AS- AP

N=7
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Unpaired ttest

0.44
0.05
<0.05
<0.05
<0.05
<0.05
0.66
0.01
<0.05
<0.05
0.05
0.07
<0.05
<0.05

0.02
0.04
0.18
0.28
0.55
0.99
0.07
0.02
0.53
0.41

For the mitral valve, the TTE tethering distance (ED: 39.54 ± 5.24; ES: 40 ± 5.27)
was not significantly different from the sono measurements of M2-AM (ED: 38.22 ±
4.57,p=0.76; ES: 38.62 ± 5.2, p=0.99) and of M2-T1 (42.54 ± 4.97, p=0.14; ES: 41.62 ±
5.12,p=0.17) but was significantly different from M2-T2 (ED: 30.17 ± 4.5, p<0.005; ES:
30.6 ± 4.6, p<0.005). M2-posterior mitral annulus (ED: 25 ± 3.23 and ES: 25.7 ± 2.83)
was not significantly different from M2-PI (ED: 41.01 ± 8.26, p=0.59; ES: 39.51 ± 7.47,
p=0.6) M2-PM (ED: 32.34 ± 6.41, p=0.25; ES: 34.4 ± 5.7, p=0.54) but was significantly
different from M2-P2 (ED: 26.7 ± 4.9, p<0.005; ES: 28.24 ± 4.8, p<0.005). These results
are consistent with the previous results on the mitral annulus.
For the tricuspid valve, the TTE distance papillary muscle free wall-septal
annulus (ED: 31.48 ± 6.04; ES: 36.08 ± 2.87, p=0.12) was not significantly different from
the sono measurement of Apm-S (ED: 38.25 ± 2.86, p=0.14; ES: 36.08 ± 2.87, p=0.12)
and of Apm-AS (ED: 35.85 ± 5.5,p=0.53; ES: 34.04 ± 4.8, p=0.38) but was significantly
different from Apm-PS (ED: 39.33 ± 3.83, p=0.03; 38.33 ± 4.1,p=0.04). For papillary
muscle free wall-free wall annulus, the TTE measurement was not significantly different
from Apm-P (ED: 28.1 ± 5.92, p=0.97; ES: 27.73 ± 6.51, p=0.32), from Apm-AP (AD:
21.22 ± 3.44, p=0.1; ES: 21.4±3.14, p=0.05) Apm-A (ED: 28.14 ± 2.36, p=0.98; ES:
27.86 ± 2.6, p=0.22). These results were consistent with the previous results if we
consider that Apm-P and Apm-A present the same dimension.
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3-2: Correlation of Trans-thoracle Echocardiography and Sonomicrometry
Measurements:
Altogether, the 2-D picture acquired by the TTE corresponded to a longitudinal
slice of the heart (Figure 25):
At the level of the LV :
- through the mitral annulus at the level of the segments AM-Tl and PM-P2,
through the postero medial papillary muscle M2.
At the level of the RV :
- through the tricuspid annulus at the level of the segments S-AS and AP-P,
- through the septum between Spm and Ppm,
-

through Apm
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Figure 25: Correlation in sheep between a slice of the sound waves at the level of the
annuli (left) and the TTE picture (long axis view acquired trough the 4*'’ intercostal
space).
AM: Anterior mitral annulus
PM: Posterior mitral annulus
T1 and T2: Left and right trigone
PI and P2: Left and right lateral mitral annulus
S, AS and PS: Septal, anteroseptal and postero septal tricuspid annulus
A, AP and P: Anterior, anteroposterior and posterior tricuspid annulus.
LV and RV: Left and right ventricle
Apm: Anterior papillary muscle of the right ventricle.
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4: Discussion
In experimental studies with sheep, different methods may be used to measure the
geometrical variations of the heart. Sonomicrometry crystals were developed by Smith et
al. [122]. Using sound waves and piezoelectric crystals, records of distances between
crystals can be obtained 200 times per second. The sonomicrometry technology was used
to study the mitral valve physiology [119], the importance of the stay chords [66] and the
aortic valve during the cardiac cycle [130]. Another technology to measure the geometry
of the heart is to implant radiopaque markers to silhouette the LV, annulus and papillary
muscles. Using a biplane videofluoroscopic machine, two-dimensional images from the
two X-ray views are acquired and analyzed through a computer at 60 Hz. With that
technology in the research laboratory of cardiovascular sciences at Stanford University,
geometrical changes of the LV after Ml or chordal cutting [65] were studied. These two
technologies measure at high frequency and with great precision the variations of the
distances between two crystals or between two radiopaque markers. However, a
cardiopulmonary bypass is needed to implant crystals and radiopaque markers. The
advantage of the sonomicrometry is the 200 Hz frequency of data acquisitions. However,
sonomicrometric crystals have to be connected to the sono-computer to record the data.
In case of a survivor model, the chest of the animal has to be closed with the crystal wires
under the skin and additional measurements must be performed by opening the skin
again. The use of radiopaque markers allows researchers to study the sheep while
anesthetized only. Thus, in a survivor model, two sets of measurements with these
technologies can be “safely” recorded: After implantation, and at sacrifice. The surgeon
places the crystals or the radiopaque markers under direct view. All the distances
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measured are between anatomical places chosen and known by the surgeon. Because of
the non-invasiveness of TTE image acquisition, the measures can be made repetitively
and allows the follow-up of geometrical changes of the ventricle and the mitral valve in a
survivor model. The TTE allows the measurement on 2-D pictures of distances between
structures that have an assumed precise position on a 3-D heart. Further the 2-D
echocardiography can be done with the sheep not anesthetized, restrained in a sling for
example, and therefore, avoids the surgical implantation of sonomicrometry crystals or
radiopaque markers thus reducing the morbidity and mortality associated with a survivor
model. TTE technique in sheep is different from humans and no reference on TTE
technique exists for the sheep. Due to the anatomy and the position of the transducer,
traditional TTE views are not possible to acquire in sheep. As in humans, the heart is
closer to the ribs in the left side of the chest in sheep. The acquisition of an image
through the right part of the chest was not possible because of the presence of the right
lung. The air in the lung does not transmit the sound waves of the crystal vibration and
does not allow one to acquire reliable pictures. Therefore, the view of the heart was taken
on the left side of the chest. A four to five centimeter space between the inferior and
superior part of the lung, at the level of the sternum and the 4* and 5th intercostal space
was used (Personal observation on 50 sheep). Through this space it was possible to
acquire a long- and short-axis view of the heart. The short-axis view allows the
acquisition of an image at the level of the papillary muscles of the mitral valve, but the
view through the annulus was not possible. The measurements of the interpapillary
muscle distance were comparable to the M l-M2 distance as measured by
sonomicrometry. To analyze both atrioventricular valves, only a long-axis view through
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the 4*'’ intercostal space was available. We compared TTE distances available to
sonomicrometry measurements. The comparison of our data showed that the long-axis
view acquired by TTE in sheep corresponded to the analysis of the antero lateral part of
the mitral annulus (around AM-Pl) and to the short-axis diameters (S-AP or S-P) of the
tricuspid valve (Figure 25). The presence on the TTE image of a papillary muscle head in
the LV close to the septum corresponded to the postero-medial papillary muscle, M2. The
presence of a PM in the RV close to the free wall corresponded to the anterior papillary
muscle Apm that we described as well isolated and constant (Experiment 1).
The TTE examination in sheep is not standardized and as in humans is iterative and
largely determined by the anatomic characteristics of the sheep and manual manipulation
of the transducer by the operator. The presence of a good “window” that enables the
transmission of the ultrasound signal to the heart is not predictable. The same operator
performed all the echocardiograms and the measurements to minimize any differences.
Conscious of the complexity and invasiveness of sonomicrometry, we undertook
a study comparing sonomicrometry versus TTE measurements. In an attempt to study the
geometry of both atrioventricular valves in sheep we compared sonomicrometry findings
with TTE measurements obtained on anesthetized sheep and found that TTE
measurements were comparable to sonomicrometry measurements. The long axis view
acquired through the 4^’’ left intercostal space in sheep provided the distance between the
postero-lateral and anteromedial mitral annulus and between the septal and lateral part of
the tricuspid annulus. This view allowed the analysis of both leaflets and postero-medial
PM of the mitral valve and of the Apm of the tricuspid valve. These findings confirmed
the possibility of performing chronic animal studies with TTE follow-up.
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Experiment 4: Percutaneous induction of a postero-lateral infarct by
injection of 100% ethanol and analysis of LV and RV geometrical
changes.
1: Review of Existing Animal Models of Heart Failure:
The objectives of the animal model are to mimic the condition of human ischemic
MR, which corresponds with a LV dysfunction associated with functional MR. The
chronic experimental models have been directed towards inducing either global
cardiomyopathy or a localized infarction. Ischemic heart failure can be studied with a
large animal model to evaluate the effects and benefit-to risk ratio of new medical and
surgical therapies.

1-1: Heart Failure Induced by Toxin:
Toxin administration to animals can mimic heart failure. The most commonly
used toxin is doxorubicin, an anti-neoplastic drug, well known for its cardiac toxicity.
Eighty-nine cases of heart transplantation in patients with doxorubicin -induced
cardiomyopathy were reported by United Network for Organ Sharing between 1990 and
1996. In animals, many experiments demonstrate a decrease in cardiac function after
doxorubicin administration.
Tessier et al [131] associated the use of low dose doxorubicin (0.5-1 mg/kg)
systemic infusion with the surgical creation of an arterio-venous (carotid-jugular vein)
fistula. Evaluation of the heart dysfunction was done with 2-D echocardiography
measuring the LVEDD, LVESD and LV shortening fraction. They showed in goats that
0.5 mg/kg of doxorubicin injected weekly during 13 weeks created an increase in LVESD
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of 48 ± 12% and in LVEDD of 24 ± 4%. Also, shortening fraction decreased
concomitantly by 32 ± 1%. When 1 mg/kg was injected, similar but more pronounced
results were observed with a 38 ± 23% increase in LVESD and 10.3 ± 5.6% in LVEDD
as well as a 41.7 ± 3.2% decrease in shortening fraction. All these results remain stable
during three months after the 13* injection. The respective role of the doxorubicin
infusion and the arterio-venous fistula could not be determined because of the absence of
a control group. Chekanov et al. [132] used the same protocol with a daily injection of
doxorubicin resulting in a creation of acute stable heart failure.
To avoid systemic toxicity, intracoronary injection of doxorubicin was reported
by Shah et al. [133]. In 20 dogs, 1mg/kg of doxorubicin was administrated through a 2"**
diagonal catheter resulting in accelerated heart failure in 12 weeks. Results were assessed
by 2-D echocardiography measurements. All measurements were significantly different
through the follow-up (LVEDD: +17.5%, p<0.0001; EF: - 38.3% p<0.0001).
Histological changes in both ventricles included myocyte hypertophy, loss of myofibrillar
material and vacuolization, which are comparable to findings in clinical human heart
failure. However 60% survival rate were reported at 12 weeks with nine sudden cardiac
deaths.
Reviewing the intracoronary doxorubicin administration as a chronic heart failure
model in dogs, shows that this drug can be used effectively to produce heart failure
without systemic complications [134-136]. However, LV depression and mortality rates
are dose-dependent and vary from one study to the other (mortality reported from 0% to
40-50 %[135]). This high mortality rate is likely unacceptable for most heart failure
studies and result variations question the reproducibility of this method in dogs.
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LV intramyocardial injection of snake cardiotoxin induced a well-delineated
transmural lesion. Rajnoch et al [137] reported the snake cardiotoxin Naja Mossambica
Mossambica injected directly in the LV wall exposed through a LV thoracotomy in nine
sheep. This method created a scar and was followed by remodeling of the LV. This
original method was used to study LV wall motion after the implantation of satellite cells
into the myocardium. All these techniques can create heart failure with LV dilatation.
However, the presence of mitral or tricuspid insufficiency was not reported in these
studies.

1-2: Heart Failure Induced by Rapid Pacing
Rapid ventricular pacing or tachycardia induced heart failure is the most common
heart failure animal model associated with MR. Dogs were most commonly used [138]
and to a lesser degree swine and sheep[139]. At 240 bpm during 3-4 weeks, dogs
develop heart failure with many features of human end-stage heart failure, but rapid
reversal of signs with profuse diuresis occurs at termination of pacing [140]. Byrne et al
[139] created a pacing protocol which allowed a slower heart failure development. The
pacing rate was modified through the study according to cardiac output and the clinical
status of the animal. Therefore the authors were able to measure and study the distinct
levels of heart failure. Patel showed also that increasing the duration of ventricular pacing
to ten weeks created a long-term model of heart failure [141]. Results were assessed by 2D echocardiography measuring a 155% increase in LV volume at 12 weeks.
Timek et al [142] studied the mechanism of the MR associated with an ovine
model of tachycardia-induced cardiomyopathy. Timek showed that the mechanism of the
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MR was not associated with a tethering effect. LVES and LVED volumes, mitral annulus
area (36 ± 14% and 46 ± 13% in end diastole systole respectively), interpapillary muscles
distance (from 29.9 ± 4.2 to 35 ± 4.1 mm in end diastole and from 23.9 ± 3 mm to 30.4 ±
3.7 mm in end systole) increasing significantly. However, impaired mitral leaflet
coaptation was not due to a displacement toward the ventricle of the coaptation point of
the anterior and posterior leaflet. Mitral leaflets were at the same position relative to the
annulus in systole. Therefore, incomplete mitral coaptation and resulting MR were due to
mitral annulus dilatation.
In this ovine model of tachycardia-induced cardiomyopathy, the annulus dilated
more in the septal-lateral (+25+12 %) than in the commissure-commissure dimension
(+9+5%). The saddle shape of the annulus was preserved but flattened [143].
Tachycardia-induced heart failure is effective for a stable LV dilatation and depression of
EF if associated with a long and slow pacing protocol. Associated MR is mainly due to a
dilatation of the mitral annulus in the septo-lateral dimension.

1-3: Heart Failure Indueed by Isehemia
Several animal models reproduced ischemic events in the animal heart to mimic
the development of ischemic heart failure in humans. Gelatin sponge intracoronary
embolization created LV failure in pigs [144]. In a controlled study, pigs underwent
catheterization of the LAD using a 2.5Fr catheter, with the tip of the catheter placed
between the first and the second diagonal branches. Small gelatin sponge particles
homogenized and mixed with heparanized saline were then infused in the distal part of
the LAD. Recanalization of the LAD occurred in all animals with poor run-off at 1 week.
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LVEDD and LVESD increased significantly at 4 and 8 weeks. Plasma BNP levels,
reported to increase with the severity of congestive heart failure [145,146], were
significantly higher in infarcted animals than in the control group.
Microembolization of microsphere was also used in dogs to create a model of
heart failure [147]. The technique that used cardiac catheterization of the left coronary
ostium followed by injections of microspheres was performed and discontinued when EF
measured by 2-D echocardiography was between 30 and 40%. LVED and LVES volumes
increased significantly at three months from 62 ± 4 to 78 ± 4 ml (p-0.001) and from 38 ±
3 to 47 ± 3 ml (p=0.001), respectively.
Llaneras et al [35] described a model of coronary ligature in sheep. Ligation of
the L* and 2"‘^marginal branches (group 1) infarcted 23 ± 3% of LV mass, did not infarct
the posterior papillary muscle and increased significantly LV cavity size. Ligation of
OM2 and 0M 3 (group 2) infarcted 21.4 ± 4% of the LV and completely infarcted the
PPM. Ligation of 0M 2, 0M3 and PDA (group 3) infarcted 40.4 ± 7.2% of the LV mass
and included PPM and the posterior one third of the ventricular septum. Group 1 and 2
sheep were followed during 8 weeks and MR was measured by echocardiography. MR
developed in group 2 (average MR: +2.7) and not in group 1. Severe MR developed
immediately in group 3 and 83% of sheep died within 3 hours. Ventricular dilatation was
assessed by angiography measuring LVED and LVES areas. LVED and LVES dilatation
were significant in Group 2 at 8 weeks (p<0.01) and in group 3 one hour after the
infarction (p<0.01).
Gorman et al [148] and Moainie et al [149] observed that ligation of the first two
diagonal branches of the left descending artery in sheep produced massive dilatation of
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the LV within 8 weeks. Both groups reported that around 24% of the LV mass with 82%
of the anterior PM mass were infarcted. LVED and LVES volumes increased
significantly (+73.2% and +115.3% respectively) at 8 weeks after the procedure and the
EF significantly decreased (p<0.05). Gorman et al also reported the acute ligation of the
L* and 2"‘*diagonal and OMl which infarcted 33 % of the LV and the entire APM.
LVESD and area increased by 12.5% and 34.2%, respectively. However no MR was
reported when coronaries which supplied the anterior wall were ligated. Therefore
according to Gorman et al [148], infarct size and location determined the development of
MR in the ovine model.

2: Materials and Methods
2-1: Induction of the Myocardial Infarction
The sheep were heparinized with 10,000 Units i.v. plus an additional 5,000
Units/hour. A catheter was introduced (6F Pinnacle, Terumo, Inc., Somerset, NJ, USA)
via the left carotid by percutaneous puncture or cut down. An angiogram was performed
using a C-arm (OEC 9400, GE Medical Systems, Inc., Waukesha, WI, USA) via a
guiding catheter (LA6HS1, multipurpose hockey stick 1, Medtronic, Inc., Minneapolis,
MN, USA) to identify the second (0M2) and third (0M3) obtuse marginal branches of
the circumflex artery. A balloon catheter (D3S3020, Over-the-Wire Balloon Dilatation
Catheter, Medtronic, Inc., Minneapolis, MN, USA) was positioned in the origin of 0M 2
and inflated beyond the first branch (4 bar). Therefore, the distal part of OM2 was
isolated from the coronary circulation. Without deflating the balloon, 1 to 3 ml of 100%
ethanol (EtOH) was injected into the distal part of 0M2. After 5 minutes, the balloon was
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deflated and the heart was allowed to recover for 30 minutes. The guide wire and the
balloon catheter were then advanced into 0M 3, inflated again distal to its origin (4 bar),
and 2 to 3 ml of 100% EtOH was injected. We empirically decided to limit the total
volume of EtOH injected to 5 ml. After 5 minutes, the balloon catheter was deflated.
Aortic pressure was recorded through the angiocatheter. Cardiac output and pulmonary
artery pressure were measured through the Swan-Ganz catheter before and after the
procedure. During the entire procedure, amiodarone (40 mg/h) and lidocaine (4 mg/min)
were infused to prevent arrhythmia. Before each EtOH injection, magnesium (Ig i.v.),
lidocaine (60 mg i.v.) and bretylium (25 mg i.v.) were injected.

2-2: Data Acquisition and Follow-up
Transthoracic echocardiography was performed before the procedure (baseline),
after the procedure, at weekly intervals, and at sacrifice. The sheep was positioned
upright in a fenestrated sling for the TTEs. Left ventricular end-systolic (LVESD) and
end-diastolic (LVEDD) dimensions and the interpapillary muscle tips distance at endsystole (M l-M2 ES) and end-diastole (M l-M2 ED) were recorded through a short axis
view. The mitral valve annulus diameter was measured and the presence of IMR and/or
ITR was evaluated in the long axis view. The severity of IMR and of ITR was determined
by the length of the jet (1+ present; 2+ half the distance to the atrial walls; 3+ reaching
the atrial wall, and 4+ for reverse pulmonary vein flow or if the jet reached the inferior
vena cava) [150]. Displacement of the papillary muscles was calculated as the distance
between their tips and to the contralateral mitral annulus (“tethering distance”). Valve
coaptation height or “tenting distance” was measured as the distance between the leaflet’s
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coaptation point and the mitral annulus plane at end-diastole. The ejection fraction (EF)
was calculated using the Teichhotz formula for the end-diastolic and systolic volumes
[151]. The following RV dimensions were measured at baseline and at sacrifice in ES
and ED on the long axis view: the tricuspid annulus diameter, Apm-free wall annulus,
Apm-septal annulus and RV diameter at the level of the Apm.
After 6 to 10 weeks, the animals were again anesthetized. The chest was opened
through the fourth intercostal space. An epicardial echocardiogram was performed to
analyze LV and RV function and the degree of IMR and ITR. A Swan-Ganz catheter was
placed via the left jugular vein to record pulmonary artery and RV pressures and cardiac
output. After heparinization with 10,000 Units, the animal was euthanized with an
injection of 60 mEq of KCl in the ascending aorta and the heart was excised.

2-3: Macroscopic and Histology Analysis
The hearts were cut into eight or nine 1-cm thick transverse slices. The slices
were incubated in 2% triphenyl tétrazolium chloride (Sigma Chemical, St. Louis, MO,
USA) for 30 minutes at room temperature [152]. The individual slices were weighed and
photographed (Canon Powershot A70). The left ventricular and infarcted areas were
quantified using planimetry software (AutoCAD Autodesk, San Rafael, CA) to determine
the percentage of LV area infarcted, which was used to determine the LV mass infarcted.
The slices were fixed in 10% formalin for histologic analysis. The fixed samples were
dehydrated and embedded in PolyFin wax (Polyscience, Inc, Warrington, PA, USA),
sectioned at 5 pm, and collected on Superfrost® plus slides (VWR Scientific, West
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Chester, PA, USA). Representative sections were stained with hematoxylin and eosin
(H&E) for general tissue and cellular morphology.

2-4: Statistical Analysis
Data were evaluated with repeated measures analysis of variance (ANOVA)
explored by 3 paired student t-test comparing each time point (baseline versus immediate
post-infarction, post-infarction versus sacrifice, and baseline versus sacrifice). A p-value
<0.016 was defined as statistically significant (Bonferroni corrected).

3: Results
3-1: Percutaneous Induction of Myocardial Infarction
The EtOH ablation procedure was performed in six sheep with an average weight
of 53.6 Kg (range 64.5 to 39.5 Kg). The left carotid introducer was placed percutaneously
in 4 and with a cut-down in 2 sheep. The baseline coronary angiograms showed that the
LV apex was supplied by the left anterior descending artery in five cases (type A) and by
the circumflex branches in one case (type B). These findings were similar to those
reported by Llaneras et al. [35]. In five cases, it was easy to visualize OMl and 0M 2 by
videofluoroscopy. In four sheep, the coronary anatomy was similar. The origins of 0M 2
and 0M 3 were well-individualized branches off the circumflex artery. In three of these
cases, each branch had two EtOH injections (Figure 26). In one case, 0M 2 and 0M 3
were very small, and 0M 4 was injected followed by irreversible ventricular fibrillation
that terminated the procedure. In two other cases (one type A and one type B), a large
branch of the circumflex artery divided distally into 0M 2 and 0M 3. In these cases, a
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single bolus of EtOH was injected in the large branch (4 and 5 ml respectively). The
mean volume of 100 % EtOH injected was 1.5 ml in 0M 2 and 2.6 ml in 0M 3 (for a total
of 4 ml/animal). The hemodynamic and echocardiographic data at baseline and
immediately after the procedure are shown in Table 14. In all cases, frequent multiform
ventricular nonsustained tachycardia occurred at the time of injection, which stopped
spontaneously, when the injection was terminated. In all animals the EKG, showed
severe ST segment elevation after the EtOH injection (Figure 27).
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Figure 26: Coronary angiogram o f the left coronary before (left) and after (right) 100%
EtOH injection.

The distal part of the artery is no more apparent after the injection of contrast product in
the coronaries. EtOH: ethanol, 0M 2 & 0M3: Obtuse marginal arteries 2 and 3.

Figure 27: EKG at the end of the procedure showing S-T segment elevation.
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3-2: Development of Ischemic Cardiomyopathy
Five animals were followed for an average of 8 ± 1.3 weeks. The two animals
with a single large OM that received only one injection of EtOH developed early clinical
heart failure at 2 weeks post-procedure, requiring the administration of furosemide (20
mg twice/week) followed by daily doses (20 mg) during the last week before sacrifice at
6 and 7 weeks. The other three animals showed signs of clinical heart failure after the
fourth week. They were sacrificed at weeks 8 and 9. At the time of sacrifice, all animals
were in heart failure. They were breathing rapidly, had pale noses, stretched their hind
legs, increased their water intake and retained fluid. The average weight increased by
16% (p==0.043), from 56.4 ± 7.6 kg (range 44 to 64.5 kg) to 65.3 ± 3.9 kg (range 63.1 to
71.2 kg). The hemodynamic and echocardiogram data at the end of the study are shown
in Table 14. At sacrifice, the mean grade of IMR was 2.8 ± 0.45+ and ITR was 2.1 ±
0.5+. The LVEDD increased from 43.9 ± 3.51 mm to 58.4 ± 5.94 mm (33.7 ± 17%,
/?=0.009) and the LVESD increased from 31.7 ± 3.4 to 50.6 ± 8.47 mm (62 ± 40%,
/?=0.015). The diastolic distance between papillary muscles increased from 28.2 ± 6.8 to
36.4 ± 5.4 mm (32 ± 24%,/?=0.01). The systolic distance between papillary muscles
increased from 21.3 ± 3.4 to 29.6 ± 6.2 mm (40.7 ± 32%). The tethering and tenting
distances increased by 32.7 ± 28% and 108 ± 65% (p=0.036), respectively. The mitral
annulus diameter had enlarged by 18.5 ± 15.3% in diastole and by 29.7 ± 41.3% in
systole.
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Table 14: Hemodynamic and echo data, before and after EtOH injection and at sacrifice.

M l : antero-medial left papillary muscle
M2: postero-lateral left papillary muscle
LVEDD & LVESD: Left Ventricular End-Diastolic/Systolic Dimensions in short axis
view
MR&TR: Mitral and Tricuspid regurgitation, PAP; Pulmonary artery pressure
0M 2 & 0M 3: Obtuse marginal arteries 2 & 3
*: Repeated measure analysis of variance, p<0.05 repeated measures ANOVA significant
**: Comparison between baseline and sacrifice, p<0.016 (Bonferroni corrected)
***: Comparison between after injection and sacrifice, p<0.016 (Bonferroni corrected).
The differences were not significant for the paired t-test between baseline and after
injection. Significant dilatation of the left ventricle occurred during the follow-up after
the EtoH injection.

PAP mm Hg
Cardiac output L/min
Aortic pressure mmHg
EKG
EF%*
M1-M2 ED mm*
M1-M2 ES mm
MR*
LVEDD short axis, mm*
LVESD short axis, mm*
TR*
Tethering distance
Tenting distance mm*
Mitrai annuius ES
Mitrai annuius ED

Baseiine

After injection OM2-OM3

Sacrifice

25/18
3.18
87/66
normal
56.4+7
28.2+6.8
21.3+3.36
0
43.9+3.51
31.7+3.4
0.2
37.1+6
4.7+1.3
29.6+5.6
31.5+5.4

28.6/22
2.87
86/67
ST-segment elevation
48+9
32.4+4.64
25.4+2.25
0.2
48.8+5.08
37.5±3.15
0.5
37.5 ±6.59
6.6 ± 1.6
31 ±2.4
33.2 ±4.7

28/13
3.92
72/55
29.6±14** ***
36.4±5.4** ***
29.6±6.23
2.8±0.45** ***
58.4±5.94**
50.6±8.47**
2 i± 0 5** ***
47.2±3.76
10.25±0.5**
36.3±2
37.3±2.9
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We also observed the development of a TR during the development of the MR. At
sacrifice we observed a directional jet toward the atrial septum on epicardial
echocardiography (figure 28). The dimension of the tricuspid annulus increased by 11 +
7% (p=0.03) in ED, and by 8 ± 6% (p=0.04) in ES. The distance between the papillary
muscle on the free wall (Apm) and the annulus at the level of the free wall increased by 5
± 3% (p=0.05) in ED, and by 3 ± 7% (p=0.48) in ES. The distance between Apm and the
annulus at the level of the septum increased by 8 ± 5% (0.03) in ED, and by 16 ± 24
(p=0.26) in ES. The distance between the septum wall and the free wall increased by 21 ±
17% (p=0.04) in ED, and by 0.35 ± 23% (p=0.01) in ES. The dimension of the RV and
the tricuspid valve are reported in table 15. Figure 29 shows the progressive TTE changes
during the follow-up.

Table 15: Variations of RV dimensions at baseline and at sacrifice.
FW: Free wall, Apm: Anterior papillary muscle of the RV, ED: End diastole, ES: End
systole

Tricuspid annulus ED
ES
Apm-FW annulus ED
ES
Apm-septal annulus ED
ES
RV diameter at level of Apm ED
ES

Pre EtOH
21.1±1.2
19.5±1.8
29 ±5.6
28.8±11.3
28.2±1.2
24.1 ±4.8
14±2.2
9.6±1.9

Sacrifice
23.6±2.2
21±1.9
30.9±6.9
28±7.9
30.6±1.3
26.3±1.1
16.5±1.2
12.7±2

Paired t-test
0.03
0.04
0.05
0.87
0.03
0.26
0.04
0.01
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Figure 28: Directional jet o f the ITR at sacrifice.

The directional jet toward the atrial septum corresponded to a tethering of the septal
leaflet.
RA: Right atrium,
RV : Right ventricle
LV : left ventricle

L
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Figure 29: Mean variations o f all sheep in MR, TR, LVEDD, EF and M l-M2 ED (during

the follow-up).
MR & TR: Mitral and Tricuspid regurgitation
EF: Ejection fraction
M l-M2 ED: Interpapillary muscle distance in end diastole
LVEDD: Left ventricle end diastolic dimension
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3-3: Histology Analysis
The infarct area was 22 ± 3.5% (range 19.1% to 24%) of the LV area and had a
mean calculated weight of 48.2 ± 6.1g. Macro and microscopically, the posterior
papillary muscle was not infarcted. Histology of the infarcted area showed marked
thinning of the ventricular wall with no inflammatory response (Figures 30 A and 32B).
Small bundles of eardiomyocytes were present in the subendocardial area (Figure 30C).
The remainder of the wall consisted of bands of fibroblasts alternating with adipocytes
within a finely fibrillar background. Ghost cells without residual nuclear material and
with a waxy eosinophilic cytoplasm were occasionally observed (Figure 30D). Small
vessels surrounded by occasional normal looking lymphocytes could be seen near the
periphery of the infarct. No foreign body giant cell response was identified. These
changes abruptly gave way to a normal appearing myocardium at the periphery of the
induced lesion. No epicardial abnormalities were identified.
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Figure 30: Histologie sections o f the infarcted ventricular wall (H & E stained)

A : x4, Border zone. Normal cardiomyocytes: White arrow.
B : xlO, small bundles of cardiac myocytes present in a subendocardial location
C : x40, Border zone, bands of fibroblasts in a finely fibrillar background with bundles of
eardiomyocytes
D : x40, ghost cell (white arrow), collagen and fibroblastes
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4: Discussion
The incidence of functional IMR after acute myocardial infarction has been
reported to be between 13% [18] and 39% [19]. Its presence doubles the long-term (5
years) mortality [3], even in cases with mild or moderate regurgitation [22]. Although,
IMR is known to be related to the location and extension of the infarct [23], successful
early reperfusion does not reduce mortality [33]. Due to the high level of interest in this
subject, it is obvious that far more questions than answers remain regarding the
pathophysiology of IMR and, indeed, of the mechanisms involved in the remodeling of
the well-perfused remote areas from the infarct [153]. In fact, it has been recently
questioned whether IMR is the main cause for the poor prognosis of these patients or
only a reflection of poor LV function secondary to remodeling [154]. These questions
highlight the need for reproducible chronic experimental models. Furthermore, reduction
annuloplasty, considered the standard surgical treatment for IMR, has been shown to
have a 30% failure rate and no improvement in 5-year survival [59]. These unsatisfactory
results have spurred interest in new surgical alternatives that need to be tested in large
animals. Current chronic experimental models have been directed toward inducing either
global cardiomyopathy or a localized infarction. Systemic or intracoronary injection of
doxorubicin hydrochloride in dogs and goats [131,135], local transmural injection of
snake cardiotoxin [137], and coronary micro-embolization [144,147] result in a variable
degree of heart failure, but with absent or unmentioned IMR. The rapid pacing model of
cardiomyopathy requires several weeks to create chronic heart failure but usually
achieves only mild or moderate MR that is reversible when pacing is discontinued
[139,143]. The mechanism responsible for the MR might be different according to the
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experimental method used. In the rapid pacing ovine model, Timek and associates [142]
have described significant mitral annulus dilatation, particularly in the septolateral
direction, without papillary muscle displacement and leaflet tethering.
In a seminal anatomic study of the coronary artery distribution in sheep, Llaneras
et al. [35] demonstrated the absence of collaterals and, the very precise and localized
effects of selective coronary ligature. This systematic approach revealed that IMR did not
follow the selective ligature of OMl and 0M 2 while occlusion of 0M 2 and 0M 3
induced a posterolateral infarct with development of significant IMR at about 8 weeks.
When ligature of 0M 4 was added, severe IMR appeared followed by death within hours.
These models, extensively applied by Gorman and associates [148,155], have the
disadvantage of needing a thoracotomy to access the selected arteries. Although a
thoracotomy is often required to fully instrument the animal when radiopaque or
ultrasound crystals are used, a previous or second thoracotomy is needed to either induce
the infarction or to test a particular surgical procedure.
A previous review of the use of percutaneous alcohol injections in the
interventricular septum for the treatment of hypertrophic cardiomyopathy suggested to us
the possibility of applying it to induee IMR by infarcting the myocardium served by 0M 2
and 0M 3 [156-159]. Our results confirm the findings of Llaneras and associates [35]. In
both cases, ligature or EtOH injection of CM2 and 0M 3 resulted in a localized and welldefined posterolateral infarct and significant IMR In the current study, a central IMR
appeared in all five survivors between 2 and 4 weeks after the proeedure and evolved to
2.8+ at 8 ± 3.1 weeks. The development of significant functional tricuspid regurgitation
was seen in all cases. Beeause of the difficult imaging of the tricuspid valve in sheep, we
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could not evaluate the RV function when the animal was standing in a sling. Therefore
we analyzed the geometry of the RV at baseline and sacrifice. A significant ITR appeared
in all survivors between three and four weeks and its development followed the
progression of the MR. This finding has not been previously reported in animals
subjected to occlusion of the circumflex branches. It confirms its similar high incidence
found in human cases with IMR [44].
The histology of the EtOH-induced infarct was similar to that described after
alcohol septal ablation [160], i.e. an appearance typical of an old, well-defined infarct
with signs of inflammation absent. Interestingly, contrary to Llaneras et al. [35], who
reported the presence of an infarcted posterior papillary muscle in all cases, we found an
intact posterior papillary muscle in all of ours independently of whether the LV apex was
supplied by the left anterior or by the circumflex artery (type A or B heart). The infarct
area and degree of IMR were similar in both the Llaneras report (21.4% and 3.18+
respectively) and in our model (22%.and 2.8+). These similar end results in spite of the
different status of the papillary muscle might be explained by the LV remodeling that
displaees a perfused posterior papillary muscle. Also, the reports of Messas and
associates in sheep [28] and of Khankirawatana et al. in humans [161] deseribed
paradoxical decrease in IMR severity in the presence of an ischemic papillary muscle.
Recently, in a pig model of alcohol injection into the circumflex arteries, Li et al. [162]
showed that the size of the infarct is related to the volume injected and not to the velocity
of delivery [163]. In our study, the maximum volume was arbitrarily limited to 5 ml and
the velocity of injection was controlled by hand and according to the arrhythmias that
occurred during the injection.
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Transthoracic echocardiography allowed us to follow each animal weekly
avoiding a thoracotomy before sacrifice. The echocardiographic findings in our series
confirm those reported in patients [23] and in sheep [27,28]. The mitral annulus dilated
by 32% in systole and by 13% in diastole and the interpapillary muscle distance increased
by 32% in diastole and by 40% in systole, resulting in an increase in leaflet tethering
(32%+) and coaptation (108%+) distances. The 3-D data at 8 weeks post infarction
reported by Otsuji et al [27] are similar to our 2-D data (Table 14). However, while
Messas et al. [28] and Otsuji and assoeiates have reported significant 3-D differences
between pre and immediate post infarction, these differences obtained with 2-D
echography did not reach statistical significance [148].
In the RV, between the baseline and sacrifice in our study, the annulus
measurement increased by 11% in diastole and 8% in systole and the distance between
the free wall and the septum increased by 21% in diastole and 35% in systole. As in our
sheep, ITR has been associated with annulus dilatation [47,49] and RV enlargement [50].
Right ventricle enlargement may result in leaflet tethering [51,53]. Also, the distance
between Apm and the septal annulus increased significantly in diastole by 8% in our
sheep. However, the 16 ± 24% increase in systole was not significant. No significant
increase was found for the distance between the Apm tip and the annulus at the level of
the free wall (+5% in diastole and + 3% in systole).
According to experiment 3, the measured dilatation of the mitral annulus oecurred
in an antero-posterior axis and the measured dilatation of the tricuspid annulus occurred
in the short axis. The dilatation of the mitral armulus in case of IMR has been deseribed
as homogeneous in the antero-posterior and septo-lateral dimensions [30]. The increase
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of the short-axis diameter of the tricuspid armulus on our sheep corresponds to the
segmental free wall dilatation observed by Deloche et al. in human valves [49].
Following the EtOH infarction, we observed the development of IMR and ITR associated
with annulus, LV and RV enlargement. These enlargements resulted in tethering of the
anterior mitral leaflet (the tethering distance increased by 32.7 ± 28% between baseline
and sacrifice in systole) and an increase of the Apm-annulus distance at the level of the
septum (+16 ± 24% in systole) in the RV. All these variations resulted in geometrical
distortion of the remarkable and very precise geometry of the annuli and their
eorresponding subvalvular apparatus. The increased Apm-annulus distance at the level of
the septum did not result in eventual tethering of the septal leaflet because no chord
linked the Apm to the septal leaflet [93]. Tethering of the septal leaflet may have
occurred by displacement of the Ppm and Spm that are linked by chords to the septal
leaflets. The displacement of the papillary muscles inserted on the septum may be
associated with LV enlargement. We showed in experiment 2 that both annuli and
ventricles at the level of the papillary muscle were linked by the septum. According to the
Laplace law, with the increasing dimensions of the LV, the pressure on the LV wall
increased and resulted in significant bulging inside the RV. The bulging of the septum
inside the RV had been described as associated with functional TR [164]. The increased
bulging of the septum may have displaced the Spm and Apm enough to distort the
geometry of the septo-anterior papillary muscle unit of the trieuspid valve. By minimal
distortion of all the annulo-papillary units of the tricuspid valve, the moderate armulus
and RV enlargement may have also facilitated the development of the ITR. The eccentrie
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jet described in human cases of septal bulging with ischemic LV dysfunction [164] was
also observed at sacrifice on epicardial echocardiography in our sheep model (figure 28).
The small number of animals is obviously one major limitation of the studies.
However, in the development of the animal model the fact that all but one reached the
intended objective of inducing a significant IMR confirms the feasibility, simplicity and
reproducibility of the method. Also, the results in sheep can not be applied uncritically to
the human where, for instance, there is a diffuse eoronary vaseular inflammation, which
has been associated with acute coronary syndrome. Whether our animal model of IMR
following a postero-lateral infarct is similar to the clinical situation of an IMR secondary
to an inferior infarct remains to be answered [23]
In conclusion, to study the functional tricuspid regurgitation from ischemic origin,
we developed an original animal model of heart failure. The percutaneous seleetive
injection of 100% EtOH in the second and third marginal coronary arteries of sheep heart
resulted in a transmural LV infarction with no PM damage. During the eight weeks
follow-up, remodeling of both ventricles was at the origin of ischemic mitral and
tricuspid regurgitation. The non-invasiveness of this technique opens the field of chronic
experimental ischemie cardiomyopathy to study the remodeling of the heart.
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Experiment 5; Change in eNOS and nNOS expression by distance from
the infarct in an ovine ischemic heart failure model
1: Nitric Oxide Synthase
1-1: Background
Nitric oxide (NO) is an endothelium derived relaxing factor synthesized from Larginine by activation of NO synthase (NOS). Three isoforms of NOS are known:
constitutive forms, discovered in neurons (NOSl = nNOS) and endothelial cells (N0S3 =
eNOS), and the inducible isoform (N0S2 = iNOS) discovered in macrophages. The three
NOS isoforms share 50 to 60% homology of their amino acid sequence and are encoded
by three different genes (respectively NOSl, N 0S2 and N0S3). All three isoforms
combine two functionally complementary portions, a carboxyl-terminal reductase domain
homologous to cytochrome P450 reductase and an amino-terminal oxygenase domain
containing binding sites for heme, L-arginine, and tetrahydrobiopterin (THB4). A
calmodulin-binding domain in the middle connects the two portions. The three isoforms
function presumably as homodimers (Figure 31). Within each monomer, the chemical
reaction is the following:

O2

O2

L-arginine -----------► N-hydroxy-L-arginine
NADPH

^

L-citrulline + NO

1/2NADPH
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Figure 31 : Nitric Oxide Synthase principles.

Within each monomer, electrons provided by NADPH are transferred from the flavins
(FAD or FMN) in the carboxyl-terminal portion of the molecule to the heme iron (Black
arrows). This is activated to bind O2 and in presence of L-arginine, to catalyze the
synthesis of NO and L-citrulline (Grey arrow). Calmodulin seems to be required to allow
the transfer of the electron. THB4 appears to stabilize the homodimeric conformation of
the enzyme (modified from Xu et al.. Nitric Oxide Website, www.wxumac.demon.co.uk).
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1-2: Nitric Oxide Synthase and the Heart
NO is a highly diffusible gas that permeates eell membranes and cannot be stored.
Its theoretical diffusion is limited within the cardiac tissue by the abundance of
superoxide anions produced by actively contracting myocytes, which combine with NO
to produce nitrogen derivatives, and by the abundanee of cytoplasmic myoglobin, a
heme-protein with a high affinity for NO. The autocrine effect is therefore predominant
and may explain the multiple NOS synthases within the same tissue. The source of NO
may be a predictor of its functional impact and thus the signaling specificity of NO is
likely controlled at the level of its synthesis [94]. Both eNOS and nNOS are
constitutively expressed in eardiomyocytes [94]. These isoforms are localized in key
organelles that regulate cell function [165]. Endothelial NOS is localized in cellmembrane caveolae, which are organelles that link extracellular hormones with
appropriate intracellular signaling effectors (eNOS is mostly associated with caveolin-3,
the cardiomyocyte-specific structural protein of caveolae) [166]). It has been shown in
endothelial cells that multiple protein interactions in caveolae regulate eNOS activity and
its coupling to extracellular stimuli [167]. Endothelial NOS interacts with the major
protein of caveolae, caveolin, which inhibits eNOS. In presence of Ca^^, calmodulin
causes dissociation of eNOS from caveolin [168]. This is modified by heat shock protein
90 (Hsp90), which binds to eNOS and facilitates the displacement of caveolin by
calmodulin. Hsp90 belongs to a family of proteins that are synthetized by the cell in
response to stress sueh as elevated temperature [167]. Among the NOS isoforms, nNOS
is unique in containing a PDZ domain, a specific peptide sequence that allows it to
recognize and bind to other proteins [169]. This PDZ domain may play a major role in
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targeting the nNOS to spécifié cellular membranes [167]. In eardiomyocytes, nNOS
localizes to the sarcoplasmic reticulum, the organelle responsible for the intracellular
caleium cyele that drives exeitation-eontraction coupling [170]. Endothelial NOS is also
expressed in endothelial and endocardial cells and nNOS is present in adrenergic and
cholinergic fibers.

2-3-1: Endothelial NOS, nNOS and Cardiac Function in the Normal Heart
Endothelial NOS is localized in sarcolemmal caveolae with ^-adrenergic
receptors and L-type Ca^^ channels and nNOS is localized in the SR [170]. In the
unstimulated heart, eNOS is not expressed at significant levels and has little impact on
basal contractile [171] and relaxation [172] functions. In vivo studies showed an inerease
of contractility in nNOS -/- mice compared to wild type (WT) controls and on isolated
cardiomyoeytes, an increase of L-type calcium current and amplitude of contractile
shortening were found [173]. When stimulating hearts or isolated LV myocytes from
nNOS -/- mice, an attenuated positive force-frequency response in conjunction with
impaired inerease in SR calcium load in comparison to WT mice were found [174].
These findings showed a role for nNOS in reducing calcium entry, facilitating SR load
and, thus, promoting relaxation. A promoting effect of nNOS on SERCA activity remains
under question [94]. Nitric oxide synthase isoforms affect the contractile response to IBadrenergic stimulation. The P-adrenergic effect of isoproterenol was enhanced by L-NGmonomethyl-arginine (L-NMMA, a competitive inhibitor of all NOS isoforms) treatment
in isolated rat eardiomyocytes. An in vivo study of eNOS -/- mice has shown a role for
eNOS in limiting the inotropic effect of catecholamines [172]. However, no change was
seen in normal subjects who received an intravenous dobutamine infusion and a
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concurrent intracoronary infusion of L-NMMA [175]. The significant impact o f eNOS on
the contractile response to P-adrenergic stimulation is due to the stimulation of a P3adrenoreceptor isoform on cardiac myocytes. This receptor signals through G-protein
coupling to eNOS activation and cGMP increases. Cyclic GMP was demonstrated to
antagonize the effect of beta-adrenergic signaling in eardiomyocytes through degradation
of cAMP, phosphorylation of calcium channel or ryanodine receptor or Troponin I
(decreases myofilaments Ca^^ sensibility) (Figure 32) [94]. Neuronal NOS was also
shown to decrease the inotropie response to p-adrenergic stimulation in isolated
eardiomyocytes. In isolated LV myocytes from nNOS -/- mice, increased inotropic
response was found after exposure to a low concentration of isoproterenol [176]. The
limiting effect of nNOS-derived NO on L-type Ca^^ current may be implicated in the
positive response to P-adrenergic stimulation. However, in nNOS -/- animals in vivo, this
positive response was not seen and could even be reversed [170]. The profound alteration
of Ca^^cycling in the stressed heart may be a major factor influencing the increase in
sarcolemma Ca^"^ influx. Thus, nNOS may have a more important role in promoting
SERCA funetion and SR calcium load to promote diastole in response to catecholamines
in vivo. Endothelial NOS may act as a balance to prevent P-adrenergic overstimulation
[94]. Spatial localization of eNOS and nNOS in proximity with effector signaling
pathways allows NO to exert complex and precise autocrine regulation of cardiac
contraction, relaxation and rate [172]. Endothelial NOS was also shown to facilitate
excitation/contraetion coupling in response to sarcomere stretch. Petrof et al. showed that
SR Ca^^release was proportional to length change of the sarcomere and was abrogated in
cardiomyoeytes from eNOS -/- mice. The mechanism appeared to involve an activation
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of the ryanodine receptor facilitated by the localization of both proteins. Endothelial
NOS-derived NO may serve as a local messenger that plays a role in the Anrep effect
[177].

Figure 32: Endothelial and neuronal Nitric Oxide Synthase in the normal heart.
In the normal heart, eNOS promotes calcium increases in response to stretch (double
black arrow) and protects the myocardium against excess catecholamine stimulation
through the cGMP activation, that degrades cAMP, phosphorylates the calcium channel,
ryanodin receptor and Troponin I (bold black arrow). Neuronal NOS limits the betaadrenergic increase in calcium transient (bold grey arrows). This function may be less
relevant in vivo compared with its activation of SERCA activity to sustain SR calcium
load in response to inotropic interventions and promote cytosolic calcium removal and
diastolic relaxation. These two isoforms would then cooperatively sustain
excitation/contraction coupling and cardiac contraction. (Modified from Pelat et al. [94])
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2-3-2: Endothelial NOS, nNOS and Cardiac Function in the Diseased Heart
Nitric oxide synthase isoforms appear to have a role in cardiac remodeling.
Indeed, in a mouse model of an anterior myocardial infarct, the infarct size was
unchanged in eNOS-/- mice in comparison with WT. However, the remodeling of the
eNOS-/- mouse hearts presented decreased capillary density and greater myocyte width,
as well as diastolic and systolic dysfunction in comparison with the WT at both day two
and 28 after the MI [178].
Intracoronary L-NMMA infusion in moderate heart failure patients with an
ethiology of dilated cardiomyopathy had no significant effect on basal function and the
pacing of these patients was not altered either. Thus, NO may have little influence on
cardiac basal function and force-frequency relationships in moderate heart failure patients
[179]. However, Hare et al showed that NO inhibited the positive inotropic response to Padrenergic stimulation in LV dysfunction patients using the same kind of protocol with
dobutamine infusion [180]. This study supported the role of NO in modulation of cardiac
function in heart failure patients.
In heart failure patients with idiopathic dilated cardiomyopathy, eNOS has been
reported to be down-regulated [181,182]. Damy et al reported up-regulation of nNOS in
these patients with a translocation of the enzyme from the SR to the sarcolemma
membrane [182]. The decreased nNOS activity in the SR associated with the increased
nNOS activity in the sarcolemma membrane may be a central pathological event that
enhances the importance of the spatial confinement of NOS isoforms within the
cardiomyocyte [169]. The role of nNOS as an adaptative mechanism to preserve diastolic
Ca^^ levels and SR calcium load in the failing cardiomyocyte is not yet established.
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The failing dilated heart is limited in the amount it can increase stroke volume as
any increase in diastolic volume greatly increases the filling pressure of the ventricle. The
sarcomeres in the wall are at their maximal length and cannot adapt [83]. The eNOS
down-regulation and nNOS up-regulation and translocation may participate in the altered
Frank-Starling adaptation of the failing heart through defective stretch-dependent
contractile reserve and altered relaxation [171].
Dynamic changes in expression of the enzymes, substrates and cofactors as well
as change in repartition of NOSs in the different structures of the cardiomyocyte are
probably associated with the heart failure [94].

2: Materials and Methods
The hearts from the animals who underwent a percutaneous injection of 100%
EtOH in the 0M 2 and OM3 (experiment 4) and five control hearts from age-matched
animals obtained from a local abattoir (Lolo Locker, Lolo, MT, USA) were analyzed.

2-1: Preparation of Tissue
The right and left ventricles were cut into 8 to 9 transverse slices. On the 5* slices
from the apex, samples, about 1cm wide, of myocardium from seven different areas were
removed, snap frozen in liquid nitrogen and stored at -70°C until used. The areas were
sampled from the LV anterior wall (Al), LV posterior wall (A2) RV posterior wall (A3),
inferior septum (Bl), RV free lateral wall (B2), superior septum (Cl) and RV anterior
wall (C2). The distances between the sampled areas and the Ml were also measured.
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2-2: Protein isolation, SDS-polyaciylamide gel electrophoresis (SDS-PAGE) and
Western Blot Analysis
For protein isolation, the snap-frozen heart tissue was allowed to thaw on ice and
then was weighed. The samples were homogenized using a Tissuemizer in 4 vol/wet
weight of sample in Triton lysis Buffer [20mM Tris.HCl (pH 7.6), 0.5% Triton X-100,
and 20% glycerol] supplemented with protease inhibitors (Leupeptin, Aprotinine and
PMSF). Extracts were then clarified by centrifugation (14,000 X g for 20 min) and the
supernatant was removed for protein determination, SDS-PAGE and Western blot
analysis. Final protein concentration of the myocardial extracts was determined with a
standardized colorimetric assay (Bio Rad Protein Microassay from Bio-Rad Laboratories,
Hercules, California, USA) according to the package insert. Protein concentration was
adjusted to the appropriate concentration with PBS-T followed by the addition of
Laemmli denaturing buffer at the ratio of one volume/volume. The samples were then
heated at 100°C for 20 minutes. The Laemmli denaturing buffer contains sodium
dodecylsulfate (SDS) that denatures the proteins by wrapping around the polypeptide
backbone. SDS also confers a negative charge to the polypeptides in proportion to their
lengths, leaving the proteins with a constant charge-to-mass ratio. The protein extracts
isolated from ovine heart samples were separated on a 6% denaturing polyacrylamide gel
and electrophoretically transferred to Hybond-PVDF membrane (Amersham, Arlington
Heights, IL, USA). The membranes were incubated with a blocking solution of 5% non
fat dry milk in tris-buffered saline containing 0.1% Tween (TBS-T) to block all the non
specific binding sites of the proteins. After blocking, the membranes were incubated for
one hour at room temperature with a 1;250 dilution of the primary antibody either eNOS
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or nNOS antiserum (Transduction Laboratories, Lexington KY, USA). The primary
antibody was followed by the secondary antibody at a 1:1000 dilution (goat anti-mouse
horseradish peroxidase conjugated antibody. Pierce Inc, Rockford, IL, USA). All
dilutions were made in 5% non-fat dry milk in TBS-T. The membranes were washed
three times between each step with TBS-T. Immunoreactive bands were visualized by
incubation with 5 ml of the luminol enhancer solution and 5ml of the stable peroxidase
buffer provided in the kit for 1 minute (SuperSignal West Femto Maximum Sensitivity
Substrate, Pierce Inc, Rockford, IL, USA). Bands were quantified with a computer-based
imaging system (ID Image Analysis Software, Kodak Digital Science, Scientific Imaging
System, Eastman Kodak Company, Rochester, NY, USA). To compare the optical
density of the bands between the different gels, we used the lowest optical density for the
area corresponding to a distance of 3 cm from the infarct as a reference value on each gel.
The optical densities of the other bands were normalized according to the reference band
density within the same gel.

2-3: Immunohistochemistry
The snap frozen heart tissues were used for immunohistochemistry. Representative slices
from each area were placed in optimum cutting temperature compound, frozen on dry ice
(-70“C) and cut in sections (6 pm) with a Cryotome (Thermo Electron Corporation,
Milford, MA, USA) and transferred to aminoalkylsilane-treated slides (Superfrost Plus;
Fisher Scientific, Santa Clara, CA). Cryostat sections were post fixed with 100% ethanol
and stored at -80°C until used. The tissue sections were first incubated in PBS-T and 1%
goat serum for 30 minutes, to eliminate non-specific binding of the primary antiserum to
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tissue sections and to block endogenous peroxidase activity. Then, the sections were
incubated with the eNOS antiserum or nNOS antiserum (Transduction Laboratories,
Lexington KY, USA) at a 1:250 dilution for 1 hour at room temperature. After washing
with PBS-T, the sections were incubated with appropriate fluorescent secondary
antibodies (Alexa Fluor 546, Molecular Probes™, Invitrogen Inc, Carlsbad, CA, USA) at
a dilution of 1:1000 for one hour at room temperature in the dark. Sections were washed
again with PBS-T and mounted. An Olympus 1X51 microscope (Olympus America Inc.,
Melville, NY, USA) equipped with epifluorescence optics was used to visualize the
immunofluorescence. Immunostaining intensity was quantified at a magnification of
200X for ten different layers per area using an image program analysis (Image Pro Plus,
version 5.0.1, Media Cybernetics Inc., Silver Spring, MD, USA).

2-4: Statistical Analysis
Data are expressed as mean ± standard deviation. Statistical significance was
determined by using the unpaired student-t test in case of comparison of two groups.
ANOVA was used in case of comparison of more than two groups. p<0.05 was
considered significant.

3: Results
Four hearts of the animals (53.3 ± 6.4 Kg body weight) that underwent the EtOH
infarction procedure were available for this experiment.

155

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3-1: Development of Ischemic Cardiomyopathy
The left carotid introducer was placed percutaneously in three and with a cutdown in one sheep. The total volume of 100 % EtOH injected was 2.5 ±1.5 ml/animal.
These four animals were followed for an average of 7.5 ±1.5 weeks and they all
developed clinical heart failure after the fourth week. Their weight presented a 24%
increase from 54.3 ± 5 kg to 67.4 ± 3, p=0.04. As reported previously in experiment 4,
the hemodynamic characteristics were not significantly changed (cardiac output varied
fi-om 3.3 ± 0.4 to 3.9 ± 1, p=0.2 and aortic systolic pressure did not change). The
echocardiographic data showed, as previously described an increase in distance between
baseline and before the sacrifice (Table 16). The infarct area was 21 ± 2% of the LV area
and had a mean calculated weight of 44.6 ± 3.6 g.

Table 16: Geometric variations between baseline and sacrifice measured with
Echocardiography in four sheep
EF: Ejection fraction, LVEDD & LVEES: Left ventricle end diastolic & end systolic
dimension. M l-M2 ED & M l-M2 ES: Interpapillary muscle distance in end diastole and
end systole, MR & TR: Mitral & tricuspid regurgitation

EF
LVEDD short axis
LVEES short axis
M1-M2 ED
M1-M2 ES
TR
MR

Baseiine

At Sacrifice

54±5%
43.7±4
32.3+3.8
25.7±6.7
21 +3
0
0

32±12%
56±2.9
47.2±4.6
34.2±2.9
27+2.6
2.1
2.7

Variation

40%28%+
46%+
33%+
25%+
Yes
Yes

Paired Student t-test:
p vaiue

0.04
0.06
0.02
0.03
0.03
<0.05
<0.05
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3-2: Expression of eNOS and nNOS
The expression of eNOS was barely detectable in normal hearts and was
expressed in all areas of the diseased heart as shown by western blot analysis (Figure 33).
Among the ICM group, no significant difference was found for eNOS expression in the
LV, RV and septum according to the area sampled (ANOVA: p=0.712). However,
relative expression of eNOS presented significant variations when samples where
regrouped according to the distance from the MI (ANOVA, p=0.0I8). The relative
optical density of eNOS expression appeared to be inversely correlated with the distance
from the MI with an R-value of 0.723 (Figure 34). The immunohistochemical analysis
(Figure 35) confirmed that eNOS was expressed in cardiomyoeytes and that the intensity
of eNOS staining was greater in ICM tissue. The measure of optical density intensity was
increased ten fold in ICM hearts compared to controls (grades: I ± 4.5 versus O.I I ± 0.32,
p=0.002). The eNOS-staining pattern appeared to be peripheral. The staining did not
appear to encompass the entire periphery of the majority of stained cells.
Neuronal NOS was not detected on Western blot analysis even with increased
concentration of proteins loaded (25, 50 and 100 pg/lane) using a 1:250 dilution of nNOS
antibody. Immunoreactivity for nNOS was also not seen on stained tissue sections (1:250
dilution).
Immunoreactive bands at the level of 70Kda were seen by Western blot analysis for
eNOS and nNOS. These bands may correspond to degradation products from eNOS.
Cross-reaction with nNOS antibodies may explain their appearance on nNOS Western
blots (Personnal communication from the technical service representative of
Transduction Laboratories, BD Biosciences, Lexington, KY, USA)
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Figure 33: eNOS expression in sheep heart eight weeks after infarction.

A: eNOS band in ICM, expression in all areas (50 pg per lane);
B: eNOS bands in control hearts, expression detectable in A l, A2 and A3 areas and
undetectable in other areas (50 pg per lane);
C: eNOS band in A2 area of the nine sheep, expression barely detectable in control hearts
(20 pg per lane).
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Cl

Figure 34: Plot showing a significant correlation between relative expression of eNOS in
the diseased heart samples and the distance from the Ml.
ROD: Relative optical density
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Figure 35: Representatitive immunofluorescence micrographs of ovine heart sections of
failing heart and controls, labelled with eNOS (200X magnification).
A l= anterior LV wall, A 2- posterior LV wall, A3= posterior RV wall, B l= posterior
septum, B2= RV free lateral wall, Cl = anterior septum, 02= anterior RV wall.
Endothelial NOS was up-regulated in ischemic heart and seemed to be more expressed
closer to the infarct.
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4: Discussion
Our finding of weak cNGS expression in normal cardiomyocytes of sheep origin
corresponds to previous studies in human hearts [182,183]. This insignificant level of
cNGS expression in the cardiomyocyte may be due to the minor effect of cNGS-derived
NG on the basal contractile function of the heart [94]. Gur study demonstrated increased
expression of cNGS in ovine heart failure eight weeks after a postero lateral infarction.
This result is consistent with a report by Baker et al. [184] who showed that chronic
hypoxia increased eNGS expression in the immature rabbit heart. Fukuchi et al. [183]
studied 28 failing human hearts with various etiologies and reported increased expression
of eNGS irrespective of the underlying pathogenesis of heart failure. In dogs, Yamamoto
et al [185] reported increased eNGS activity in isolated LV cardiomyocytes from
tachycardia-induced heart failure. In our sheep model of early heart failure, the peripheral
eNGS-staining pattern suggested the presence of eNGS in the sarcolemma. This result is
consistent with previous studies that reported eNGS localizing to membranae caveolae
where it can regulate the P-adrenergie stimulation [169]. With heart failure, the decrease
in cardiac output stimulates the sympathetic nervous system with an increase in
cireulating level of catecholamines [90,186]. Endothelial NGS has been reported to limit
the inotropic effect of the catecholamines [172] and thus may be up-regulated in our
sheep to counteract a P-adrenergic overstimulation of the heart. This finding is different
from other studies where it was reported that eNGS is down regulated in human late heart
failure [94,182]. However, the studies that reported eNGS down-regulation in heart
failure were done on end-stage heart failure patients whose etiologies were mostly due to
idiopathic dilated cardiomyopathy. In these studies, samples of patient hearts were
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obtained after death or during cardiac transplantation and the duration of end-stage heart
failure of these patients was not reported [94,182]. In end-stage heart failure, a
desensitization of the heart to catecholamines caused by a decrease in p-receptor density
has been shown [187]. The mechanism that accounts for myocardial P-adrenergicreceptor down-regulation is presumably related to exposure to increased levels of
catecholamines [90]. Taken together, these results suggested in our sheep a temporal
“adaptative” up-regulation of eNOS to mitigate the excessive P-adrenergic stimulation of
the heart in early heart failure. This might have been followed by a down-regulation of
eNOS assoeiated with the decrease in the P-adrenergic-receptor density. The alteration of
eNGS expression may be dynamic during the course of development of a specific disease
thus participating in the altered Frank-Starling adaptation of the terminally failing heart
[94].
The up-regulation of eNGS was observed in cardiomyocytes from sheep hearts
eight weeks after an MI. Heart failure symptoms and evidence of geometrical remodeling
of the hearts, such as a significant increased LV diameter and the presence of functional
MR and TR, were observed in all sheep after the fourth week. Endothelial NGS was upregulated in all areas of the heart and we found that the level of eNGS expression was
correlated with the distance from the MI. This eorrelation has not been previously
reported in the littérature. Fukuchi et al. reported increased eNGS expression mostly in
the subendocardial area in failing human myoeardium irrespective of the site of infarction
in ischemic cardiomyopathy [183]. The mechanism responsible for our finding may
correspond to stretch since the quantitative loss of cardiomyocytes following an MI
results in work overload. The reduced stroke volume is compensated by an inereased end-
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diastolic volume. Thus the filling pressure increases on cardiomyocytes that are already
lengthened. During the progression toward heart failure, the cardiomyocyte stretch tends
to remain at a high level with persistent reduced EF [90]. According to Wilson et al. [89],
the remodeling of the heart results in differences in the level of stretch of the
myocardium: the further from the MI, less stretch is applied. The stretch of the sarcomere
has a faeilitatory effect on the Ca^^ release process resulting in an increased contraction
[85]. In vitro, Petroff et al [177] showed that eNOS-derived NO enhanced the release of
Ca^^ in response to sareomere stretch through a direct activation of the ryanodin receptor
independently from eGM? [177]. Altogether, this suggested that in early heart failure the
expression of eNOS might be up-regulated to potentiate the SR calcium release according
to the amount of stretch exerted on the cardiomyocytes. Direct activation of signaling
molecules or release of paracrine or autocrine signaling factors appears to be among the
different pathways to adapt the cardiomyocyte to stretch [188]. The exact mechanisms
underlying the production of eNOS-derived NO that modulates the excitation/contraction
coupling, as observed by Petroff et al. [177] in the case of increased stretch, remain
unknown and eNOS may be associated with or may act as a “stretch sensor”.
Endothelial NOS was assumed to be the only constitutive isoform expressed in
the cardiomyocyte until the report of Xu et al in 1999, who showed that nNOS localized
to the murine and human SR [189]. Damy et al [182] reported a weak expression of
nNOS in the SR of normal human heart. Using the same antibody, we were unable to
detect nNOS in our samples by western blot analysis or immunohistochemistry. After a
review of the literature, no previous report was found on the detection of the different
NOS isoforms in the sheep cardiomyocyte. A lack of nNOS expression in the sheep
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cardiomyocytes may explain the absence of detectable levels of nNOS in our samples.
However, the presence of nNOS in many mammalian cardiomyocytes such as humans
[182,189], mice [173,176,189] and rabbits [189] has been reported. The sheep
cardiomyocytes may express a different isoform of nNOS, therefore the difference in
species may be the reason for a potential lower cross reactivity between the nNOS
antibody (mouse anti-rat antibody) that we used and the nNOS isoform in sheep
myocardium.
It has been reported that nNOS derived NO regulates myocardial contraction by
controlling Ca^"^ handling in cardiomyocytes [173]. In late human heart failure, eNOS
expression that localizes to the sarcolemma is down-regulated [94,182] while greater
expression and activity of nNOS and its translocation from the SR to the sarcolemma has
been reported [182]. The defeet of eNOS-derived NO in the sarcolemma might be
compensated by the translocation of nNOS from the SR to the cell membrane. This
implicates an altered regulation of therole of nNOS in the autocrine control of cardiac
contractility. The loss of NO in the SR and thus, the regulation on the Ca^^ load of this
organelle, may be a central pathophysiological event [169]. In our failing heart, there was
up-regulation of eNOS that appeared to be localized to the sarcolemma. The increase of
NO in the sarcolemma may be related with an adaptative response to the increased
systemie catecholamines in heart failure. The absence of deteetable nNOS in our model
may be due not only to the reasons cited above (absence of expression or difference in
species), but also its dynamic expression. The NOS isoforms may present a dynamic
pattern of expression in the development of heart failure as postulated by Pelat et al. [94].
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Limitations of the study
We used a sheep model to study the expression of eNOS and nNOS in early
ischemic heart failure. We did not find any report on the expression of eNOS and nNOS
in sheep cardiomyocytes in the literature. The physiology of eNOS and nNOS expression
in sheep cardiomyocytes might be different from the other species studied.
The controlled hearts in our study were obtained from a local abattoir from agematched sheep. These sheep were assumed to be healthy and to present a normal
expression of eNOS and nNOS.
The induction of an MI in our sheep model of heart failure was done by the
percutaneous injection of 100% EtOH that created a MI of 21 ± 2% of the LV. The
histology showed a well-defined MI surrounded by a fibrillar web. In humans, RauteKreinsen [160] studied the myocardial tissue from patients who underwent EtOH ablation
of the septum in the case of hypertrophic cardiomyopathy. The myocardial tissue from
patients who died minutes to two years following the EtOH ablation showed a preserved
fixed necrotic area that was not infiltrated by leukocytes. After one month, a web of
collagen was produced by the fibroblasts around the fixed myofibrils (ghost cells). The
border zone of the damaged myocardium was, however, transformed to scar tissue by
leukocytes. The pathophysiology of the transformation and stabilization of the 100%
EtOH ablated area is not known and may have its own signaling characteristics that may
have influenced the eNOS and nNOS expression level. In our model, the MI was also
induced acutely in a sheep model that did not present any evidence of coronary disease.
In humans, the progressive evolution of atherosclerotic lesions and inflammation that

165

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

plays a key role in coronary disease [2] may influence the NOS expression in the
infarcted heart.
Furthermore, the pathophysiology of the different diseases that lead to heart
failure may also be different. The heart failure syndrome can be defined as a constellation
of signs and symptoms caused by inadequate performance of the heart, but the subject of
heart failure requires a number of definitions to denote hemodynamic alterations, clinical
symptoms and pathology. More precise analysis and classification might be based on
differences in pathology and biochemistry [90].

Mechanisms of Functional Ischemic Tricuspid
Regurgitation
1: Heart Remodeling and Stretch
The analysis of the normal geometry of the tricuspid valve in isolated pig hearts
(Experiment 1) and the study of the normal geometrical variations of the mitral and
tricuspid valves during the cardiac cycle (Experiment 2) allowed us to understand the
remarkable geometry of both valves that are linked by the septum. In Experiment 4, we
demonstrated that, following an MI, both mitral and tricuspid valve regurgitations were
due to ventrieular enlargement that altered the geometry of the mitral and tricuspid
valves. More precisely, these valve distortions oeeurred at the level of the annulopapillary musele apparatus. These geometrical alterations were consistent with the
ventricular remodeling observed in human cases of heart failure [2]. According to the
Laplace Law, the ventricular enlargement increases the mechanical stress exerted on the
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ventricular wall, thus the stretch on the cardiomyocytes [90]. The macroseopic
remodeling of the myocardium is associated with alterations of the cardiomyocytes and
the extra-cellular matrix [90]. During the remodeling process, the stretched
cardiomyocytes change their phenotype with marked enlargement in size associated with
deterioration in contractile function [1]. In heart-failure patients with an apparently
normal mitral valve, it has been shown that the mitral valve leaflets had significant
alterations in both cellularity and extracellular matrix [190]. These findings suggest that
not only the myocardium, but also the mitral leaflets, thus, the entire heart, remodel as an
adaptative response to overload [191]. The cardiomyocyte hypertrophy with the laying
down of new sarcomeres in parallel is accomplished with biochemical alterations in both
the contraetile proteins and activating membrane systems [1]. It has been shown that the
stretch of cultured cardiomyocytes results in gene transcription and protein synthesis that
mimics the load-induced hypertrophic response in vivo [192]. The activation of a large
number of cellular signal transduction pathways follows an ischemic event [188]. These
signals may compensate for the increased wall stress on the surviving myocardium.
Within the myoeardium, the biochemical alterations include dysregulation of myosin
gene expression [91], loss of myofilament and alterations of cytoskeletal proteins [193],
alterations in excitation/contraction coupling [90,194] and desensitization of P-adrenergic
signaling [187]. The dynamic equilibrium of the extracellular matrix, regulated by the
metalloproteinases (MMPs) and their inhibitors (tissue inhibitors of metalloproteinases or
TIMPs) changes also in the myocardium of failing hearts [195,196] and the proliferation
and increased secretory activity of fibroblasts increase also fibrosis and collagen
remodeling of the myoeardium [197]. We demonstrated in our study, that the ventricular
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remodeling was associated with an up-regulation of eNOS that was correlated with the
distance from the infarct (Experiment 5). According to Wilson et ah, the further from the
MI, the less streteh is applied to the cardiomyoeytes [89]. Thus, the up-regulation of
eNOS expression associated with the geometrical alterations of the ventricle appears to
be correlated with the degree of stretch. This finding corresponds to a previous study on
regional changes of MMPs and TIMPs that were also correlated with the distance from an
anterior MI [89]. This eorrelation between protein expression and distance from the MI
suggests that the direct hemodynamic forces may be the drivers of protein expression and
extraeellular matrix changes. The initial stimulus that starts the remodeling proeess is
almost invariably stretching of the myocardium [1]. The remodeling process seems to not
be unidirectional and, according to some authors, might undergo a “reverse remodeling”
process [198,199]. It has been observed in some end-stage heart failure patients, that
unloading the left ventricle with a left ventricular assist device induces reverse
remodeling. Reduction of the mechanical stress on the myocytes through the reduction in
intraventricular volume appears to play an important role in reverse remodeling [200].
However, unloading on its own seems to be inadequate [1]. The explanation for the
cellular and extracellular ehanges observed in heart failure is probably more complex.
Indeed, heart failure involves many compensatory systems to adjust to the reduced
cardiac output [2,90]. These compensatory mechanisms have been shown to have
potential harmful effects on the myocytes, fibroblasts and endothelial cells and may also
participate in the development of contractile dysfunction [2,91,92]. For example, it has
been reported that the increased circulating level of catecholamines following an MI [90]
may produce apoptosis of cardiomyoeytes [1]. In our early heart failure model, the up-
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regulation of eNOS may be an ’’adaptative process” to counteract the excess of padrenergic stimulation and protect the cardiomyoeytes. Heart failure may be viewed as a
“neurohormonal model”, in which heart failure progresses as a result of the
overexpression of active molecules exerting deleterious effects on the heart and
circulation [2]. However, the neurohormonal model fails to explain the disease
progression in heart failure [91]. During the remodeling process, not only the ehanges
that occur in the biology of the failing myocardium but also the geometric alterations of
the LV contribute to the development of the LV dilatation and dysfunction [1,2].
Therefore, the remodeling process appears to be the consequence of both stretehing and
activated compensatory mechanisms. The interrelationship between contractile
dysfunction and cardiac remodeling is responsible for disease progression in heart failure
[91]. The progressive cardiomyocyte hypertrophy considered as a physiological
adaptative response to increased load may eventually become maladaptative resulting in a
self perpetuating pathological process of continuous remodeling leading to irreversible
heart failure [1].

2: Clinical Application
Surgical therapies that directly affect cardiac remodeling should improve eardiac
function and the natural history of heart failure. Restoration of the LV and RV geometry
aims at decreasing myocardial stress and may initiate a reverse remodeling proeess. For
this geometric restoration, mitral annuloplasty is being performed in nearly 80% of
patients with ischemic mitral regurgitation [56]. An undersized mitral ring is the standard
technique that by reducing the mitral orifice increases leaflet eoaptation and consequently
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reduces the IMR [54]. However, mitral annuloplasty is sometimes inadequate, following
annuloplasty for ischemic MR a rate of 30% for recurrent MR has been reported [58,59].
Papillary muscle displacement as well as LV dysfunction and enlargement are
responsible for the reeurrent MR [60]. Chordal cutting was described as a new surgical
approach for the treatment of ischemic MR [201]. However, experimentation on sheep
showed the importance of these chords as essential for the valvular-LV geometry.
Transection of these chords did not prevent acute isehemic mitral regurgitation and
resulted in LV systolic dysfunction in sheep [64,65] and also narrowed the aorto-mitral
angle and inereased the papillary muscles-fibrous trigones distances [66]. To relocate the
postero-lateral papillary muscle, Kron et al. added a suture between the left trigone and
the papillary muscle in patients with previous inferior myocardial infarction and ischemic
MR [56]. In case of papillary muscle displacement, to reestablish constant distances
between the tip of the papillary muscles and the corresponding hemi-mitral annulus could
lead to better outcomes due to the restoration of the geometry of the annulo-papillary
muscle unit. The importance of the annulo-papillary muscle continuity and therefore of
the annulo-papillary unit geometry for global LV function in prosthetic valve
replacement has also been widely recognized. The preservation of papillary musclesannulus continuity is either restored by conservation of chords [126] or by use of
polytetrafluoroethylene to create new chords [124]. In cases of mitral homograft
implantation, conservation of the recipient’s papillary muscles and suturing of the
allograft to their tips preserves the constant distance between the tip of the papillary
muscles and the mitral annulus plane [120].
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For the restoration of the RV, the annuloplasty in the case of ITR has poor results
with a high incidenee of recurrence [79] that may be predicted by tricuspid valve
tethering after annuloplasty [202]. The mechanism of functional TR is not only the result
of tricuspid annulus dilatation, but also the result of a bulging septum [164]. The annulus
dilatation, the RV enlargement and the presence of the septum bulging in the RV resulted
in annulo-papillary muscle apparatus distortion. This finding in a sheep model of heart
failure may explain the recurrence and the persistence of the apical displacement of the
tricuspid lealfets [51]. It is hoped that a better knowledge of the dynamic relationship
between the septum and the RV will promote new surgical techniques.
As previously seen, stretch of the myocardium appears to not be the only factor
involved in the remodeling process. Both eNOS and nNOS appear to regulate
cardiomyocyte functions [169]. The up-regulation of eNOS expression in early heart
failure may be an important step in the pathophysiology of ischemic heart failure. The
correlation of eNOS expression with the distance from the infarct suggested a correlation
with the degree of stretch. A better understanding of the signaling pathway of the NOS
isoforms in the heart may lead to new pharmacologic therapy.

3: Limitations of the Study
Given the many aspects of the present work, a discussion has followed each
experiment. The following limitations are of a general nature that applies to the overall
characteristics of all experiments. To study the normal geometry of the atrioventricular
valves, we based our study on animal hearts, which may present different anatomieal
characteristics compared to human hearts. The remarkable geometry of the mitral and
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tricuspid valves of the sheep may not be exactly the same in the human. However, our
findings about the mitral geometry are consistent with the anatomical finding of Sakai et
al. [124] on human hearts. The small number of animals also involved in all our
experiments is obviously one major limitation. Our findings about the geometrical
changes of the LV and RV that lead to IMR and ITR corresponded to the remodeling of a
sheep heart following a postero-lateral infarction. In sheep, the localization of the infarct
may play a role in the remodeling process. Our original method to induce the infarction
with the percutaneous injection of 100% ethanol may have also its own signaling
characteristics [160] that may have influenced the mieroscopie and macroscopic
remodeling. We also compared the expression of eNOS in our infarcted sheep’s heart to
the expression in normal sheep hearts obtained from an abattoir. These age-matched
sheep were assumed to be healthy without any pathology that may have influenced our
results.
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Conclusion
Patients in heart failure from ischemic origin may present mitral and tricuspid
functional regurgitation. Ischemic mitral regurgitation doubles the mortality at five years
[21] and when tricuspid functional regurgitation is associated, the one-year mortality
doubles [42]. Remodeling of the whole heart results in geometrical distortion of both
atrioventricular valves, ereating valve incompetences. We studied the geometrical
variations of the ventricles in an original sheep model of heart failure. For the mitral
valve, annulus dilatation, LV enlargement and a tethering effect on the anterior mitral
leaflet were at the origin of a eentral regurgitation by lack of coaptation of the leaflets.
For the tricuspid valve, annulus dilatation, chamber enlargement and lateral bulging of
the septum toward the RV were associated with the functional TR. Alteration of the
geometry of the annulo-papillary muscle apparatus were at the origin of the regurgitation
of both valves. These findings may lead to new surgical approaches.
The geometrical distortions are associated with molecular changes in the heart
wall. Seven areas that represented the whole heart - the anterior, LV, RV and septum, the
lateral RV, the middle of the septum, the posterior RV and LV wall were studied eight
weeks following a EtOFl-induced lateral MI in four sheep and compared to five control
hearts from a local abattoir. In the ischemic heart eNOS was increased ten-fold compared
to the controls. The expression of eNOS was correlated with the distance from the MI and
thus the amount of stress. Because eNOS is known to play a role in stretch adaptation, the
up-regulation of eNOS may be correlated with an adapatative process of the stretched
cardiomyocyte. However, we did not find evidence of the presence of nNOS in the
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samples. These, according to our knowledge, previously unreported findings, eight weeks
after a MI resulting in an ovine model of heart failure, may enhance the dynamic
response of eNOS to the resulting stretch.
Whether these findings are applicable to the ischemic human heart is unknown
and further studies are warranted.
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